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Preface
The Health Systems in Transition (HiT) series consists of country-based reviews that provide a detailed description of a health system and of reform and policy initiatives in progress or under development in a 
specific country. Each review is produced by country experts in collaboration 
with the Observatory’s staff. In order to facilitate comparisons between 
countries, reviews are based on a template, which is revised periodically. The 
template provides detailed guidelines and specific questions, definitions and 
examples needed to compile a report.
HiTs seek to provide relevant information to support policy-makers and 
analysts in the development of health systems in Europe. They are building 
blocks that can be used:
• to learn in detail about different approaches to the organization, 
financing and delivery of health services and the role of the main 
actors in health systems;
• to describe the institutional framework, the process, content and 
implementation of health-care reform programmes;
• to highlight challenges and areas that require more in-depth analysis;
• to provide a tool for the dissemination of information on health systems 
and the exchange of experiences of reform strategies between policy-
makers and analysts in different countries; and
• to assist other researchers in more in-depth comparative health 
policy analysis.
Compiling the reviews poses a number of methodological problems. In many 
countries, there is relatively little information available on the health system and 
the impact of reforms. Due to the lack of a uniform data source, quantitative 
data on health services are based on a number of different sources, including 
Health systems in transition  Israelvi
the World Health Organization (WHO) Regional Office for Europe’s European 
Health for All database, data from national statistical offices, Eurostat, the 
Organisation for Economic Co-operation and Development (OECD) Health 
Data, data from the International Monetary Fund (IMF), the World Bank’s 
World Development Indicators and any other relevant sources considered 
useful by the authors. Data collection methods and definitions sometimes vary, 
but typically are consistent within each separate review. 
A standardized review has certain disadvantages because the financing 
and delivery of health care differ across countries. However, it also offers 
advantages, because it raises similar issues and questions. HiTs can be used to 
inform policy-makers about experiences in other countries that may be relevant 
to their own national situation. They can also be used to inform comparative 
analysis of health systems. This series is an ongoing initiative and material is 
updated at regular intervals.
Comments and suggestions for the further development and improvement 
of the HiT series are most welcome and can be sent to info@obs.euro.who.int. 
HiTs and HiT summaries are available on the Observatory’s web site 
http://www.healthobservatory.eu. 
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Abstract
Israel is a small country, with just over 8 million citizens and a modern market-based economy with a comparable level of gross domestic product per capita to the average in the European Union. It has had universal health 
coverage since the introduction of a progressively financed statutory health 
insurance system in 1995. All citizens can choose from among four competing, 
non-profit-making health plans, which are charged with providing a broad 
package of benefits stipulated by the government.
Overall, the Israeli health care system is quite efficient. Health status levels 
are comparable to those of other developed countries, even though Israel 
spends a relatively low proportion of its gross domestic product on health care 
(less than 8%) and nearly 40% of that is privately financed. Factors contributing 
to system efficiency include regulated competition among the health plans, tight 
regulatory controls on the supply of hospital beds, accessible and professional 
primary care and a well-developed system of electronic health records. Israeli 
health care has also demonstrated a remarkable capacity to innovate, improve, 
establish goals, be tenacious and prioritize. 
Israel is in the midst of numerous health reform efforts. The health 
insurance benefits package has been extended to include mental health care 
and dental care for children. A multipronged effort is underway to reduce health 
inequalities. National projects have been launched to measure and improve the 
quality of hospital care and reduce surgical waiting times, along with greater 
public dissemination of comparative performance data. Major steps are also 
being taken to address projected shortages of physicians and nurses. 
One of the major challenges currently facing Israeli health care is the 
growing reliance on private financing, with potentially deleterious effects 
for equity and efficiency. Efforts are currently underway to expand public 
financing, improve the efficiency of the public system and constrain the growth 
of the private sector. 
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Executive summary
Introduction
Israel is a small country located at the juncture of Africa, Asia and Europe. Its population is just over 8 million, and its population density is among the highest in the western world: in the European Union (EU), only Malta and 
the Netherlands are higher. The largest population groups are Jews (75%) and 
Muslim Arabs (17%). In comparison with other developed countries, Israel’s 
fertility rate is relatively high and its age mix is relatively young. Israel has one 
of the highest age dependency ratios among the countries of the Organisation 
for Economic Co-operation and Development (OECD), at 63% compared with 
the EU level of 52%.
Israel has a modern market-based economy with a substantial high 
technology sector. The 2012 gross domestic product (GDP) per capita was 
US$ 32 567, slightly below the EU average of US$ 34 148. At the same time, 
income inequality in Israel is among the highest in the developed countries of 
the OECD, within which only four countries (the United States, Turkey, Mexico 
and Chile) have more unequal income distributions.
Israel is a democratic state with a parliamentary, multiparty system. It is 
an active member in many major international organizations, and in 2010 it 
formally joined the OECD as a full member.
Generally speaking, health status in Israel is similar to that of other developed 
countries, even though the share of GDP spent on health is relatively low (7.6%, 
compared to 8.7% for the EU average and 8.9% for the OECD average). Life 
expectancy in Israel is slightly above the average for the EU Member States 
before 2004 (EU-15) for both men (80.8 years, compared with 79.1 for the 
EU-15) and women (84.4 years, compared with 84.2 for the EU-15), with life 
expectancy for Israeli men being among the highest for OECD countries. As 
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in other countries, Israel’s health status has improved significantly in recent 
decades, even though the share of GDP allocated to health has been stable. 
Gains have been achieved for all population subgroups, but disparities persist. 
Organization and governance
Israel has a national health insurance (NHI) system that provides for universal 
coverage. Every citizen or permanent resident of Israel is free to choose from 
among four competing, non-profit-making sickness funds, called health plans 
(HPs). These HPs must provide their members with access to a statutory benefits 
package. Non-resident workers are not eligible to receive NHI but employers 
are obliged by law to purchase private health coverage for non-resident workers.
The Ministry of Health owns and operates about half of the nation’s acute 
care hospital beds, although they operate increasingly autonomously. The 
largest HP operates another third of the beds, and the remainder of the beds are 
operated through a mix of non-profit-making and profit-making organizations.
Within HPs, patients have a great deal of freedom in choosing their 
community-based physicians – both primary and specialist – from among those 
physicians affiliated with the HP. In most specialties, and in most areas of the 
country, each HP is affiliated with numerous physicians so that there is real 
choice in practice. Nevertheless, there are some specialties (e.g. child psychiatry) 
and regions (e.g. the Negev) where choice is more limited. If a member wants to 
see a physician not affiliated with the HP, access is not guaranteed through the 
basic benefits package, but in many circumstances partial coverage is available 
for those who have enrolled in supplemental insurance programmes.
Since 2010, there has been a surge of large-scale health system changes, 
including expanding the statutory benefits package to include dental care for 
children and mental health services, and strengthening the monitoring of the 
quality of hospital care. 
All the HPs and hospitals have sophisticated information systems that include 
electronic medical records and data on activity levels, services provided and 
quality of care; there also several systems for aggregating data across providers, 
including national registries for conditions such as cancer and diabetes and 
reporting of cases of infectious disease. 
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Israel has a formal, highly sophisticated process for setting priorities for 
the adoption of new technologies. The prioritization process draws upon both 
technical information on costs and health benefits and an intuitive sense of 
public preferences and aspirations. 
The government uses regulation to promote access to care, quality of care, 
financial stability and equity. This is mainly done through regulation directed at 
the HPs, but hospitals, private insurers, manufacturers and health professionals 
are also highly regulated. 
In recent years, Israel had made great strides in making more information 
available to consumers regarding health care services, health insurance options 
and health rights.
Reflecting Israel’s unitary system of government, authority rests with the 
national authorities (and with the national headquarters of the HPs), although all 
have regional organizations. At the national level, the Ministry of Health takes 
an intersectoral approach, with wide-ranging collaborations across government 
and with nongovernmental partners to tackle health issues. 
Israel’s tertiary hospitals attract patients in need of highly specialized care 
from various Mediterranean and Middle Eastern countries. In recent years, 
Israel has emerged as a major medical tourism destination for patients from 
beyond the region, particularly from eastern Europe. Israeli hospitals also 
treat patients from the Palestinian Authority in the West Bank and the Gaza 
strip. The ups and downs of the security and diplomatic situation influence the 
number of these patients.
Financing
The system is financed primarily via a combination of a health-specific 
payroll tax and general taxation. The government distributes funds among the 
HPs according to a capitation formula that takes into account the number of 
members in each plan and their age mix, gender and place of residence (centre/
periphery of the country). While public financing remains the primary source 
of health system resources, the share of private financing has been increasing in 
recent years, rising from 32% of total health expenditure (THE) in 1995 to 39% 
in 2012 (high compared with 27% for the EU, for example), primarily through 
a sharp increase in spending on voluntary health insurance (VHI). 
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Israel’s ability to maintain its relatively low level of spending on health 
is probably in part a reflection of its relatively young age distribution along 
with various structural features and policies that contribute to cost containment. 
Those related to financing include: 
1. The financing of universal health care coverage through a combination 
of earmarked health taxes and general government revenues, with 
high-income and low-risk individuals subsidizing low income and 
high-risk individuals. Moreover, due to the combination of earmarked 
and general government funding, when there are economic slowdowns 
and the health tax revenue decreases, the government can increase its 
share of funding so as not to decrease overall public funding. On the other 
hand, there is always a stable, predictable part of public funding that does 
not depend on year-to-year government decisions and priority settings;
2. There are effective mechanisms for risk sharing between the government 
and the main providers/purchasers of care, through: 
 –  financing of HPs primarily via prospective payments based on a 
capitation formula with simple and objective risk adjusters; and,
 –  supplementary HP funding via retrospective payments based on 
performance and the prevalence of outlier costly diseases;
3. HPs work as managed care organizations with gatekeeping, and some 
cost sharing from patients for visits to specialists and for medications. 
Most of the physicians working with HPs are paid via capitation and/or 
salary arrangements, thereby largely avoiding the cost-promoting effects 
of fee-for-service reimbursement;
4. HPs purchase inpatient care from hospitals through 50 differential daily 
fees and activity-based payments based on procedure-related groups. 
The government publishes maximum-price lists for inpatient care 
and sets hospital revenue caps to contain hospitals’ income increases. 
Moreover, due to their dominance, HPs are further able to obtain 
discounts from hospitals.
Along with the low and decreasing public expenditure on health, there has 
been a constant and marked trend of increases in private spending. The VHI 
market is one of the biggest in OECD countries with about 87% of Israel’s adult 
population covered with health plan VHI, and 53% covered with commercial 
insurance. Household spending on VHI has increased markedly over the past 
decade. Out-of-pocket (OOP) expenditures are also high relative to many 
other countries (26% of total health expenditure, compared to an EU average 
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of 21%), and have increased somewhat over time. There are large differences 
in households’ expenditures on health by income quintile, which indicate the 
existence of inequalities.
On the one hand, the low and stable expenditure on health has been a source 
of pride for the Israeli health care system. On the other hand, the increasing 
growth of private expenditure has raised serious concerns about a shortage of 
resources in the public system and rising inequalities; these, in turn, could pose 
risks to access to services and the population’s health. It is not clear whether 
the Israeli system is an adequately funded system that can provide good care 
through a very high level of efficiency or whether it has steadily been eroding 
its resources up to an unwanted point.
Physical and human resources
Israel’s acute care hospital system is characterized by:
• a low bed-to-population ratio (at 189 beds per 100 000 people, only just 
over half the EU average of 384)
• an extremely low average length of stay (4.3 days, compared with the 
EU average of 6.4) 
• a mid-to-high rate of admissions per 1000 population; and
• a high bed occupancy rate (98%, compared with an EU average of 75.9%). 
The low bed-to-population ratio is the result of deliberate, long-standing 
government policy to shift as much care as possible to community settings and 
to contain costs. However, several years ago the Ministry of Health identified 
a serious need for expansion, particularly in the periphery. As of mid-2015, the 
implementation of a national bed expansion plan is underway including the 
establishment of two new hospitals in the southern periphery.
In 2014, Israel had relatively few computed tomography (CT) and magnetic 
resonance imaging (MRI) units for its size (e.g. three MRI units per million 
people in comparison with an EU average of 10.5), but these devices are 
being used intensively. In 2015, a major government initiative was launched 
to increase the availability of these diagnostic devices. Regardless of the 
potential purchaser, major medical devices require governmental approval 
before purchase.
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In 2014, the Ministry of Health launched a national health information 
exchange for sharing clinical patient data across all of Israel’s general hospitals, 
HPs and additional providers. This provides Israeli clinicians with the world’s 
first national data exchange programme, enabling secure authorization-based 
sharing of clinical data. 
Historically, Israel has had a very high physician-to-population ratio but this 
ratio has seen a marked decline. By 2012, Israel’s rate and the OECD average 
converged at around 3.3 physicians per 1000 people, and at that time the rate 
for Israel was projected to decline even further. Recently, several concrete steps 
have been taken to expand the overall supply of physicians (see below); the 
number of newly licensed physicians has reached a record high, and Israel’s 
ratio of physicians to the population has not fallen below the OECD average. 
The nurse-to-population ratio has been decreasing and at 502 per 
100 000 people is lower than the EU-15 average of 836. Several policy measures 
have also been undertaken recently to increase the supply of nurses, which are 
beginning to prove successful.
Provision of services
The Ministry of Health provides national leadership in a broad range of public 
health domains including food safety, control of communicable diseases, 
screening, health promotion, environmental health and epidemiological 
monitoring. Its key partners include HPs, municipalities and the Ministries of 
Education, Sport and Culture, Finance, and Environment.
One of the principal environmental problems used to be a water shortage, 
exacerbated by the deteriorating quality of water resources under demographic, 
industrial and agricultural pressures. The establishment of large water 
desalination facilities has helped to solve this problem. 
Primary care is provided almost exclusively by salaried physicians (and other 
professionals) employed by the HPs, and independent physicians with whom 
the HPs contract. Primary care doctors play a gatekeeping role for access to 
secondary care, although the exact process depends on the specialist and the HP. 
Nurses also play an extensive role in primary care in areas such as preventive 
health care, counselling, triaging of urgent cases, home care, chronic disease 
management and the handling of clinical paperwork related to the patients’ 
eligibility for various social benefits. 
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Most specialized ambulatory care is provided in community settings, despite 
recent hospital efforts to attract activity to their outpatient departments. In 
contrast, the hospitals are the main source of emergency care, with a relatively 
small but growing role for community-based providers (e.g. evening service 
centres sponsored by HPs and independent urgent care centres). The average 
waiting time for a publicly funded specialist physician in the community is 
3.2 weeks, although there is wide variation by specialty and geographical 
area. Rates of visits to specialist physicians are substantially lower among 
Israeli Arabs than among Israeli Jews, while visit rates to primary care and 
hospitalization rates are higher among Arabs than Jews.
Israelis have access to a secure, safe and stable supply of a wide range 
of pharmaceuticals. The government approves pharmaceuticals for sale, 
establishes a national formulary of pharmaceuticals that all HPs must make 
available to members, sets maximum prices, licenses pharmacists and regulates 
the pharmaceutical market. Israel also has a large, successful and growing 
pharmaceutical industry, with an emphasis on genetic pharmaceuticals. 
Advertising of non-prescription pharmaceuticals is allowed, but direct-to-
consumer advertising of prescription pharmaceuticals is not. However, the 
Ministry of Health has recently established regulations regarding “disease 
awareness campaigns” so that consumers can be empowered with information 
about the availability of new treatments in a manner that does not involve the 
promotion of a particular commercial product.
The system of health and welfare services for the elderly with disabilities in 
Israel has been developed enormously in the past decades. The vast majority 
of elderly people live, or are cared for, at home, with only 3.5% residing in 
any kind of institutional setting (with some 2.5% in a skilled nursing home). 
Even among the disabled elderly, nearly 80% still live in the community. This 
is because of the extensive care provided by families and the development of 
formal services (some quite innovative) intended to reinforce this social support 
and to help families to cope with the burden of care. Institutional care is subject 
to co-payments according to income – children are also required to contribute 
to the cost of institutional care for their parents, depending on their economic 
situation and that of the parents concerned. Informal carers also have special 
rights in Israeli law, for example being entitled to miss workdays because of 
the illness of a parent. 
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Palliative and hospice services are covered as part of the statutory benefits 
package. However, there are no governmental guidelines on when, how and 
to what extent HPs are required to provide these services. Hospital- and 
community-based palliative and hospice services exist, but they are not 
well developed.
As in other countries, over the past two decades Israel has gone through 
a process of de-institutionalization of mental health care. In mid-2015, an 
additional major change was introduced into the mental health care system, 
when responsibility for the provision of publicly financed mental health care 
(not including substance abuse care) was shifted from government to HPs. The 
government continues to operate most of the psychiatric hospitals and a network 
of community clinics as well as a comprehensive programme of rehabilitation 
services for the chronically mentally ill. The private sector is also a major 
provider of community-based mental health services. 
Dental care, particularly for adults, is predominantly provided by the 
private sector – mostly by independent dentists but commercial chains are 
also significant providers – and generally speaking is not part of the statutory 
benefits package. The exception is dental care for children, which (since its 
addition to the benefits package in 2010) is increasingly being provided by 
HPs and financed by government. The government also provides financial 
support for school dental services and limited programmes of dental care for 
poor people.
The use of complementary and alternative medicine (CAM) has grown 
markedly in Israel in recent decades. Moreover, mainstream health providers – 
including hospitals, HPs and physicians – are increasingly involved in provision 
of CAM. In 2010, an experimental programme was started using CAM in some 
pre- and postsurgical settings.
Principal health reforms
In recent years, the intensity of reform efforts in the Israeli health care has been 
greater than at any time since the passage of the NHI Law in 1995. Many of 
these efforts have been, or are in the process of being, implemented. Others 
have not been realized, at least as yet. 
The Ministry of Health and the health care system more broadly are in the 
midst of a major, multipronged effort to reduce health inequalities. The effort 
is based, in part, on the understanding that, as in other countries with universal 
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health insurance programmes, inequalities persist despite universal coverage. 
In Israel, the growth of private insurance and private care provision, and the 
erosion of public funding relative to needs, further underscores the need to 
address health equity issues. Major components of the effort include enhancing 
financial access to services, strengthening the public health system, constraining 
the growth of the private system, enhancing the availability of services and 
key professionals in the periphery, addressing the specific needs of various 
linguistic and cultural minorities, promoting interministerial and intersectoral 
cooperation and providing information about health care disparities. 
In July 2015, mental health services were added to the set of services that the 
HPs must provide to their members, and the government substantially increased 
the level of funding to cover the costs expected to be incurred by them because 
of this new responsibility.
For over a decade, Israel has had an extensive and successful programme for 
monitoring quality of care in the community. In recent years, that programme 
has undergone several important developments, including the first publication 
of performance data by HP. In addition, the Ministry of Health has launched 
an extensive programme to monitor quality in hospitals, including publication 
of comparative data on sensitive issues such as waiting times. 
Since the early 2000s, several significant steps have been taken to increase 
the overall supply of physicians. Key measures include the establishment of a 
new medical school in the Galilee (Israel’s northern region) and the expansion 
of class sizes in all existing medical schools. The number of new medical 
licences issued has doubled in less than 10 years.
Israel’s long-term care (LTC) system is seriously fragmented, with 
consequences for service gaps, duplication, inefficient incentives and 
inadequate investment in prevention and rehabilitation. In 2011, the Ministry 
of Health put forward a detailed plan for a major reform of the LTC system, 
which involved adding it to the statutory benefits package. The plan was not 
adopted at the time, but a variant of it is now being reconsidered.
In June 2014, Israel’s Advisory Committee for Strengthening the Public 
Health System issued a report proposing a comprehensive reform to Israel’s 
health care system, including a substantial increase in financing. However, 
because of a change in government, it is unclear which, if any, of the committee’s 
recommendations will move ahead. 
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Assessment of the health system
Israel’s NHI Law, which established a system of national insurance based on 
the principles of justice, equality and mutual aid, continues to be an inspiration 
and moral compass for Israel’s health care system to this day. However, Israel’s 
record of achievements regarding financial protection and equity in financing 
is complicated and mixed. Israelis have universal health care coverage with a 
broad benefits package. Moreover, the health system is financed predominantly 
via progressive taxation, but approximately 40% of health care expenditure is 
financed privately.
Recent national surveys show that most (75%) patients are satisfied with 
their hospital care and that almost all Israelis are satisfied or very satisfied with 
their HP overall (~90%). Interestingly, only 61% of Israelis felt that way about 
the health system overall. 
Access to primary care physicians is excellent, both in terms of travel times 
and waiting times, and quality has been found to be good from an international 
perspective. Waiting times for community-based specialists are also good 
overall, although waits for advanced specialties are somewhat longer in the 
periphery. However, approximately 10% of Israelis report that someone in the 
family had foregone a medication or health care over the past year. Waiting 
times for publicly financed surgery are highly variable and are problematic for 
some types of operation.
Life expectancy is higher and mortality lower than the OECD average, but 
Israel ranks in the mid-range among European countries for amenable mortality. 
Israel’s standing relative to the OECD average is mixed with regard to avoidable 
hospitalizations and in-hospital mortality, while it outperforms on several key 
safety measures. Despite this, Israel’s rate of hospital-acquired infections is 
higher than in many other developed countries.
Overall, the Israeli health care system appears to be quite efficient. 
Compared with other developed countries, its expenditure on health is relatively 
low, while achievements in population health and the quality of primary care 
are significant. The 2012 OECD report stated “Israel has established one of the 
most enviable health care systems among OECD countries”.
Israeli health care has a history and culture that champion disease prevention 
and primary care, along with tight regulatory controls on the supply of hospital 
beds and advanced medical equipment. Allocative efficiency is promoted by 
having HPs as the main budget holders and organizers of care, as they are 
required to balance cost control and quality/service imperatives. 
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Concurrently, there are several features of the system that appear to limit 
its ability to channel resources where they could have the greatest benefit. 
For example, the growth of public health care financing is much more tightly 
controlled than the growth of private financing, despite the recognition that a 
shekel of public funds is likely to yield more benefit than a shekel of private 
funds. Moreover, the most tightly controlled budgets are those for services 
provided by the Ministry of Health itself, despite the vital nature of those 
services (such as public health and LTC). The lack of clarity regarding who 
is responsible for certain services (e.g. health promotion) also leads to missed 
opportunities. Finally, the multiple roles of the Ministry of Health as regulator, 
provider and funder creates conflicts of interests (or at least perceived conflicts 
of interests) that may be creating various barriers to efficiency. 
Israeli health care also has a number of features that promote its capacity 
to secure high levels of output per unit of input. These include a system of 
regulated competition among HPs, a strong system of health professional 
education and training, a high degree of alignment between the incentives of 
the HPs and those of the professionals whom they employ and a well-developed 
system of electronic health records. In addition, the size and purchasing power 
of the HPs have helped them in price negotiations, particularly with regard 
to pharmaceuticals. 
At the same time, there are some significant barriers to technical efficiency, 
including an outdated hospital pricing system, a capitation formula that does 
not adequately take into account differences in health status, and bureaucratic 
barriers that limit the hours during which operating theatres are in use.
In recent years, the Ministry of Health has made transparency one of its 
main goals and it has made major strides in increasing the public’s access 
to comparative data on quality, finances and patient satisfaction. These 
advances in transparency have also facilitated greater accountability, both to 
the government and to the general public.
Conclusions
The Israeli health care system has demonstrated a remarkable capacity to 
innovate, improve, establish goals, be tenacious and prioritize – all of which 
have enabled it to achieve good health outcomes with limited resources. In the 
years ahead, Israel must find ways to draw on these capacities to address the 
major challenges now facing its health care system.
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1. Introduction
Israel is a small country located at the juncture of three continents (Africa, Asia and Europe). Its population is just over 8 million, and the population density is very high. The largest population groups are Jews (75%) and 
Muslim Arabs (17%). In comparison with other developed countries, Israel’s 
fertility rate is relatively high and its age mix is relatively young.
Israel has a modern market-based economy with a substantial 
high-technology sector. The 2012 gross domestic product (GDP) per capita 
was US$ 32 567, placing Israel among the middle-income countries. At the 
same time, income inequality in Israel is among the highest in Organisation for 
Economic Co-operation and Development (OECD) countries.
Israel is a democratic state with a parliamentary, multiparty system. It is 
an active member in many major international organizations and in 2010 it 
formally joined the OECD as a full member.
Generally speaking, health status in Israel is similar to that of other OECD 
countries, even though the share of GDP allocated to health is relatively low 
(7.6%, compared with 8.7% for the EU average and 8.9% for the OECD average). 
Life expectancy for Israeli males is among the highest for OECD countries and 
that for women is among the top third. As in other countries, Israel’s health 
status has improved significantly in recent decades, even though the share 
of GDP allocated to health has been stable. Gains have been achieved for all 
population subgroups, but disparities persist.
1.1 Geography and sociodemography 
The State of Israel was established in 1948. Israel is a small country at the eastern 
end of the Mediterranean Sea, covering an area of 22 072 km2 (CBS, 2014e). It is 
approximately 470 km in length and 135 km in width at its widest point. It lies 
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in the Middle East at the junction of three continents (Africa, Asia and Europe) 
and is bordered by Lebanon to the north, Syria and Jordan to the east, Egypt to 
the south-west and the Mediterranean Sea to the west. The final status of Judea, 
Samaria and Gaza has not yet been resolved and is the subject of negotiations 
between Israel and the Palestinian Authority.
Israel’s terrain consists of the Negev desert in the south, low coastal plains, 
central mountains and the Jordan Rift Valley. Natural resources include 
copper, phosphates and crude oil. Israel lies on the border of the global desert 
zone, which limits the available supply of water and makes it prone to natural 
environmental problems such as drought and air pollution from natural 
particles. Water, fuel and other natural resources are limited, which increases 
the consequences of environmental degradation. At the same time, Israel’s 
environmental health problems are those of an industrialized country, with 
very high rates of private motor vehicle usage and heavy industry located in 
densely populated areas.
 Israel’s southern and eastern areas are characterized by an arid climate, 
while the rest of the country has a Mediterranean climate. One of the main 
characteristics of this kind of climatic formation is the high variability in 
quantities of precipitation from year to year and between different areas. The 
summer is hot with hardly any rain, and the winter is cool and rainy.
At the end of 2014, Israel had an estimated population of 8.2 million 
(Table 1.1), of whom 75% were Jewish, 17% were Muslim Arabs and the 
remainder other minority groups included Christians (2%) and Druze (2%) 
(CBS, 2014f). Population density is among the highest in the Western world, 
with 353/km2. More than 60% of the population is concentrated in the narrow 
strip along the Mediterranean Sea and the population density in this area is 
several times higher than the national average.
Israel’s three largest cities are Jerusalem (815 300 inhabitants), Tel Aviv 
(414 600) and Haifa (272 200) (CBS, 2013c). Israel recognizes Hebrew 
and Arabic as official languages, and English and Russian are the most 
commonly used foreign languages. The Jewish population is largely urban; 
fewer than 10% live in rural areas, principally in two types of cooperative 
communities: moshavim and kibbutzim. Most of the Arab population lives in 
small- to medium-sized towns.
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Table 1.1
Trends in population/demographic indicators, 1980–2013, selected years
1980 1990 1995 2000 2005 2013
Total population (in thousands) 3 878 4 660 5 545 6 289 6 930 8 060 
Population, female (% of total) 50.1 50.3 50.5 50.7 50.6 50.5
Population, aged 0–14 (% of total) 33.2 31.3 29.6 28.6 28.3 26.2
Population ages 65 and above (% of total) 8.6 9.1 9.5 9.8 9.9 10.5
Population ages 80 and above (% of total) n/a 1.8 2.2 2.2 2.5 2.9
Population growth (average annual growth rate) 2.4 3.1 2.7 2.6 1.8 1.9
Population density (people per km2) 186.7 220.4 247.4 278.7 305.2 359.4
Fertility rate, total (births per woman) 3.2 2.8 2.9 3.0 2.8 3.0
Age-dependency ratioa 71.9 67.7 58.4 62.3 61.9 63.3
Distribution of population (rural/urban) n/a 90.0 89.6 90.6 91.7 n/a
Proportion of single-person households 14.0 15.4 15.9 17.2 16.9 n/a
Proportion with 12 years schooling n/a 53.5 60.5 65.9 70.0 n/a
Source : CBS, 2014e.
Notes : aRatio of population 0–14 and 65+: population 15–64 years; n/a: Not available.
Israel is a relatively young society; 26% of the population is younger than 
15 years and only 11% is older than 64 years. Israel’s general population is still 
significantly younger than that of other industrialized countries. Its relatively 
high total fertility rate (3.0 per woman) has been accompanied by substantial 
growth in the absolute number of elderly people. Since 1955, the elderly 
population (aged 65 years and over) has increased ten-fold, while the general 
population has increased approximately five-fold. The proportion of elderly 
people in the population is expected to reach 12% by 2020 and 14% by 2030. 
Consequently, the age-dependency ratio in Israel is 63%, which is one of the 
highest among OECD countries and which contributes to a heavy burden on 
the working-age population.
Immigration has played a critical role in the demography of Israel. When 
the State of Israel was declared in 1948, its population was 873 000. In its early 
years, the population increased as a result of large waves of Jewish immigration 
from eastern Europe and the Arab countries of the Middle East and North 
Africa in the 1950s. As a result, the population passed the 2 million mark 
within a decade of Israel’s founding. In the 1970s, there was another major 
wave of immigration, this time from the USSR. Immigration rates were lower 
in the 1980s, surged again in the 1990s and then declined gradually during the 
2000–2010 decade.
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The years 1990–2000 saw the arrival of almost 1 million new immigrants, 
including almost 400 000 in 1990–1991 alone. The vast majority of these new 
immigrants arrived from former countries of the USSR. Between 1980 and 
2005, Israel also absorbed approximately 70 000 immigrants from Ethiopia 
(CBS, 2014h). Moreover, Israel has been absorbing Jewish immigrants from 
all over the world since its establishment. In 2013 immigration accounted for 
14% of total population growth (CBS, 2014g).
From 1990 to 1995 – years of particularly high immigration rates – the 
Israeli population grew at an annual average rate of 3.5% per year, while the 
average annual growth was 2.5% from 1995 to 2000, 2.3% from 2000 to 2005 
and 1.9% from 2005–2010.
1.2 Economic context
Throughout its history, armed conflicts with neighbouring Arab countries 
and large-scale immigration have posed heavy burdens on the Israeli 
economy, creating the need for loans and extensive foreign support. Despite 
these challenges, Israel is a developed, industrialized country with a small, 
technologically advanced agricultural sector (less than 2% of the workforce), 
a growing service sector and a substantial high-technology sector. The 2012 
GDP per capita income was US$ 32 567, somewhat lower than the average for 
the OECD countries (37 342). Israel’s economy grew rapidly in the mid-to-
late 1990s and growth slowed in 2000 owing to the worldwide recession, the 
global downturn in the high-technology sector and the upsurge in the Israeli–
Palestinian conflict. In recent years, the Israeli economy has returned to high 
rates of growth.
A total of 63.7% of the population aged 15 years and over was part of the 
civilian labour force in 2013 and the unemployment rate was 6.2% (CBS, 2014e). 
Traditionally there are two population subgroups that intentionally participate 
less in the labour market because of cultural preferences: Arab women and ultra-
Orthodox men. Income inequality in Israel is among the highest in developed 
countries, although it is still lower than in the United States.
Israel’s national currency is the shekel (new Israeli shekel: NIS).1
1 The average exchange rates for 2013 were US$ 1 = NIS 3.61 and €1 = NIS 4.80. The Bank of Israel (2015) quotes an 
average exchange rate for 2014 of €1 = NIS 5.0.
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Table 1.2
Macroeconomic indicators, 1990, 2000 and 2013
1990 2000 2013
GDP (current US$, billions) 52.49 131.45 290.55
GDP growth (annual %) 6.8 8.9 3.2
Inflation, GDP deflator (annual %) 15.9 2.2 2.5
Exports of goods and services (% of GDP) 35 36 33
Imports of goods and services (% of GDP) 45 36 32
Gross capital formation (% of GDP) 25 22 20
Revenue, excluding grants (% of GDP) n/a 38.6 31.7
Cash surplus/deficit (% of GDP) n/a −3.4 −5.4
Time required to start a business (days) n/a 19 13
Domestic credit provided by financial sector (% of GDP) 106.2 72.7 n/a
Tax revenue (% of GDP) n/a 27.3 22.1
Military expenditure (% of GDP) 14.8 7.1 5.8
Mobile cellular subscriptions (per 100 people) 0.3 73.2 122.8
Internet users (per 100 people) 0.1 20.9 70.8
High-technology exports (% of manufactured exports) 11 19 16
Source : World Bank, 2015.
Note : n/a: Not available.
The CIA World Factbook (2015) lists the following key points about the 
Israeli economy.
• Between 2004 and 2011, growth averaged nearly 5% per year, led by 
exports. The global financial crisis of 2008–2009 spurred a brief recession 
in Israel, but the country entered the crisis with solid fundamentals, 
following years of prudent fiscal policy and a resilient banking sector… 
The economy has recovered better than most advanced, comparably sized 
economies, but slowing demand domestically and internationally, and a 
strong shekel, have reduced forecasts for the next decade to the 3% level.
• Natural gas fields discovered off Israel’s coast since 2009 have brightened 
Israel’s energy security outlook. The Tamar and Leviathan fields were 
some of the world’s largest offshore natural gas finds this past decade.
• In mid-2011, public protests arose around income inequality and rising 
housing and commodity prices. Israel’s income inequality and poverty 
rates are among the highest of OECD countries and there is a broad 
perception among the public that a small number of “tycoons” have 
a cartel-like grip over the major parts of the economy.
• Over the long term, Israel faces structural issues, including low labour 
participation rates for its fastest growing social segments – the ultra-
Orthodox and Arab-Israeli communities. Also, Israel’s progressive, 
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globally competitive, knowledge-based technology sector employs 
only 9% of the workforce, with the rest employed in manufacturing 
and services sectors, which face downward wage pressures from 
global competition.
1.3 Political context
Israel is a democratic state with a parliamentary multiparty system. All citizens 
aged 18 years and over have the right to vote. The head of state is the president, 
who has largely ceremonial duties. The state’s legislative branch is the Knesset 
(parliament), which has 120 members. Elections are held every four years by 
a system of proportional representation. A prime minister heads the executive 
branch. The prime minister is the head of the party (usually the largest party) 
chosen by the president to form a government.
There are many political parties, so all governments have been formed 
from coalitions. At no time in Knesset history has any one political party held 
an absolute majority. The cabinet (referred to in Israel as “the government”) 
is assembled by the prime minister, but it must receive a collective vote of 
confidence from the Knesset. As a result, the cabinet usually comprises political 
leaders from a number of different parties. The judicial branch, headed by the 
Supreme Court, has the authority to supervise the legal system throughout the 
various localities.
The most recent parliamentary elections were held in March 2015, and they 
resulted in a Knesset comprising representatives of 10 political parties. The 
current government is a right-of-centre/ultra-Orthodox coalition government 
made up of five political parties. Together, these parties have 61 of the Knesset’s 
120 seats; this is the minimum needed to form a government. The dominant 
party, Likud, has 30 seats.
Local governments are elected every five years and operate as independent 
authorities providing local services such as water, sanitation, education and 
social welfare services. There has been a continuing process of transfer of 
responsibilities and decentralization to these local authorities, which nonetheless 
remain dependent on central government for much of their financing.
Israel is an active member of several major international organizations, 
including the United Nations and the World Health Organization (WHO) 
European Region. In 2010, Israel formally joined the OECD as a full member. 
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It is a signatory to many significant international agreements, including the 
General Agreement on Tariffs and Trade, the Framework Convention on 
Tobacco Control and the Convention on the Rights of the Child.
1.4 Health status
1.4.1 Health indicators
In 2013, life expectancy at birth was 80.3 for males and 83.9 for females 
(CBS, 2013a, 2014b) (Fig. 1.1 and Table 1.3).2 Life expectancy for Israeli males 
is among the highest for OECD countries and that for women is in the top 
third of OECD countries (OECD, 2012b). From 1990 to 2013, life expectancy 
increased by 5.4 years for males and by 5.5 years for females (CBS, 2014b). The 
most recent estimates of health-adjusted life expectancy at birth are for 2013, 
with 69.5 years for males and 71.7 for females (Murray et al., 2015).
Fig. 1.1
Life expectancy at birth in Israel, by gender, 1975–2013 
Source : CBS, 2013a.
2 This section is based on data collated by the Israel Centre for Disease Control and was prepared by Anneke Ifrah.
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Table 1.3
Mortality indicators, 1980–2013, selected years
1980 1990 1995 2000 2005 2013
Life expectancy at birth (total, years) 73.9 76.7 77.5 78.8 80.2 82.1
Life expectancy at birth, male (years) 72.1 74.9 75.5 76.7 78.2 80.3
Life expectancy at birth, female (years) 75.7 78.4 79.5 80.9 82.2 83.9
Mortality rate, males aged 15–59 (per 1000)a 2.5 1.8 1.9 1.9 1.8 1.4
Mortality rate, females aged 15–59 (per 1000)a 1.5 1.2 1.1 1.0 1.0 0.8
Sources : World Bank, 2015; aCBS, 2014b.
In 2013, the infant mortality rate was 3.1 per 1000 live births (CBS, 2014b) 
(Fig. 1.2); it has declined by 39% since 2000. The infant mortality rate for 
the Arab population has shown an even more rapid decline than that for the 
Jewish population, but it still remains approximately double that of the latter, 
reflecting the influence of high rates of consanguineous marriages and various 
socioeconomic factors. The main immediate causes of infant mortality are 
prematurity in the Jewish-Israeli population and congenital anomalies in 
the Arab-Israeli population (Ministry of Health, 2014f). The rate of under-5 
mortality in 2015 was estimated at 4.0 per 1000 live births (UNICEF, 2015).
Fig. 1.2
Trends in infant mortality in Israel (infant deaths per 1000 live births), 1977–2013 
Source : CBS, 2013a.
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The crude mortality rate in 2013 was 5.3 per 1000 population, down from 
6.0 per 1000 population in 2000. The leading causes of death were malignant 
neoplasms, heart disease, diabetes, cerebrovascular disease, chronic lower 
respiratory diseases, infectious diseases and injuries, accounting for two thirds 
of all deaths in 2012 (CBS, 2014b,i).
Mortality from stroke and coronary heart disease has been declining 
steadily since the mid-1970s. The decline is attributed to improved treatment 
(medication and surgical intervention) and to greater awareness and prevention. 
The decline was generally more marked in the Jewish-Israeli than in the 
Arab-Israeli population. Notwithstanding this decline, heart disease remains 
a major health problem in Israel, among both men and women. From 1985 to 
2015, rates of cancer mortality have declined in the Jewish-Israeli population 
and increased in the Arab-Israeli population (and less markedly in women than 
in men for the former).
Interestingly, while the crude death rates for both men and women 
(over age 20) have declined in recent decades, the decline has been greater for 
men, so that now the crude death rates for the two genders are very similar 
(Fig. 1.3). With regard to the crude death rate for the under-65 population 
(Fig. 1.4), the male rate remains higher than the female rate, although here, too, 
the gap has narrowed somewhat over time.
Fig. 1.3
Mortality rates for adults (≥20 years), by gender (per 1000 adults), 1970–2012 
Source : CBS, 2013a.
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Fig. 1.4
Under-65 mortality rates, by gender (per 1000 adults, aged 20–65 years), 1970–2012 
Source : CBS, 2013a.
Among women, breast cancer is the leading cancer, accounting for 
approximately 30% of all cancer morbidity and 20% of cancer mortality. 
Among men, the leading cancers are prostate cancer (in Jewish men) and lung 
cancer (in Arab men). The cancer with the highest mortality rate is lung cancer 
(for both Jewish and Arab men) (CBS, 2014i).
Data on the incidence of cancer are drawn from the National Cancer Registry, 
while other morbidity data are generally self-reported, based on large population 
surveys such as the 2009 National Health Survey (CBS, 2010) and the Israel 
National Health Interview Survey (ICDC, 2012). In addition, national hospital-
based surveys of coronary heart disease and stroke have been established: the 
Acute Coronary Syndromes in Israel Survey has been carried out in 2000, 2002, 
2004, 2006, 2008, 2010 and 2013 (Goldenburg, 2014) and the National Acute 
Stroke Israeli Survey in 2004, 2007, 2010 and 2013 (Bornstein, 2014).
Among the Arab-Israeli population, the leading causes of morbidity and 
mortality are cancer, heart disease, injuries, diabetes and stroke. Risk factors 
for cardiovascular diseases, such as obesity, diabetes and physical inactivity, are 
particularly prevalent among Arab men and women over the age of 45. Lung 
cancer, which is the leading cancer among Arab men, carries a 50% higher 
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mortality rate among Arab men than among Jewish men; this has been linked 
to the higher rates of smoking among Arab men (approximately 39%) compared 
with Jewish men (approximately 21%) (Ministry of Health, 2014e).
With regard to lifestyle factors, alcohol consumption is appreciably lower 
in Israel than in other OECD countries, while rates of cigarette smoking are 
similar in men and slightly lower in women (OECD, 2012b). Rates of smoking 
have shown a decline since the mid-1990s; in 2013 approximately 19% of the 
population aged 21 years and older reported that they were smokers (compared 
with approximately 27% in 2000) (Ministry of Health, 2014e). The prevalence 
of cigarette smoking has also declined somewhat in teenagers. In 18-year-old 
army inductees, there has been no decline in smoking rates in men since 
the mid-1990s. In women inductees, however, smoking rates have declined 
somewhat since 2008 (Ministry of Health, 2014e).
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2. Organization and governance
The Israeli health care system is, in its basic structure, a universal statutory health insurance system. Health care service provision is the responsibility of four nationwide non-profit-making health plans (HPs): Clalit, Maccabi, 
Meuhedet and Leumit.3 Health care services in Israel were developed over the 
past century, with all four HPs established between 1920 and the early 1940s. 
The modern era of Israeli health care began in 1988 when the government 
established the Netanyahu Commission. The recommendations of this 
Commission constituted a major watershed in the history of Israeli health policy 
and laid the groundwork for the passage of the 1995 National Health Insurance 
(NHI) Law. From 1995 to the late 2000s, there were almost no major structural 
reforms, but there was a good deal of positive evolutionary change in health 
system organization and service delivery. Since 2010, there has been a resurgence 
of large-scale health system changes, including an expansion of the NHI 
benefits package to include dental care for children and mental health services.
In the early 1990s, a major effort to transform government hospitals into 
independent, non-profit-making trusts did not succeed. Instead, government 
hospitals have been gradually given increasing autonomy.
The NHI Law called for the government’s role in service provision to be 
reduced, specifically in personal preventive care, long-term care (LTC) and 
mental health care, and these responsibilities were to be transferred to the HPs 
over three years. To date the transfer has only been successful for mental health 
care, although efforts have been made in the other two areas as well.
Most analysts interpret the NHI Law as increasing government control 
of the main elements of the health care system. Previously, HPs were largely 
unregulated, but under the Law the government has substantial powers regarding 
3 HPs are insurers that also provide services. In the United States, they are sometimes referred to as health maintenance 
organizations or managed care organizations. In some European countries, they are referred to as “sickness funds”.
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the benefits to be provided and to the level of HP revenues. Nevertheless, the 
HPs remain separate legal entities with considerable latitude for strategic and 
managerial discretion.
Since 2013, the Ministry of Health has initiated moves towards addressing 
Israel’s growing health challenges, with the establishment of a Planning 
Directorate to lead and coordinate long-term planning, appointing ad hoc 
commissions or expert committees to support development of new policies 
on sensitive subjects and increasingly collaborating with other organizations.
There are sophisticated information systems within all the HPs and hospitals 
that aggregate data on services and quality of care; data are also combined from 
across providers to support broad policy decisions and to monitor and analyse 
overall national developments.
Israel has a formal, highly sophisticated process for setting priorities for 
the adoption of new technologies. The prioritization process draws upon both 
technical information on costs and health benefits and an intuitive sense of 
public preferences and aspirations.
The government uses regulation to promote access to care, quality of care, 
financial stability and equity. This is mainly done through regulation directed at 
the HPs, but hospitals, private insurers, manufacturers, and health professionals 
are also highly regulated.
In recent years, Israel had made great strides in making more information 
available to consumers regarding health care services, health insurance options 
and health rights.
2.1 Overview of the health system
Israel has an NHI system that provides for universal coverage. Every citizen or 
permanent resident of Israel is free to choose from among the four competing, 
non-profit-making HPs. The HPs must provide their members with access to 
a benefits package that is specified in the NHI Law. The system is financed 
primarily via progressive taxation, and the government distributes the NHI 
funds among the HPs according to a capitation formula that takes into account 
the number of members in each plan and their age mix, gender and place of 
residence (centre/periphery). While public financing remains the primary 
source of health system resources, the share of private financing has been 
increasing in recent years.
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In addition to its planning and policy-making roles, the Ministry of Health 
also owns and operates about half of the nation’s acute care hospital beds. The 
largest HP operates another third of the beds, and the remainder are operated 
through a mix of non-profit-making and profit-making organizations.
The organization of the Israeli health system is shown in Fig. 2.1.
Fig. 2.1
Overview of the health system  
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2.2 Historical background
Health care services in Israel have been developed over the past century by 
voluntary (nongovernmental) HPs, originally called “sickness funds”, as well 
as by non-profit-making institutions, the government and the British Mandatory 
regime that existed prior to the establishment of the State of Israel in 1948. 
All four of Israel’s HPs were formally established in the period between 1920 
and the early 1940s; some of them emerged from mergers of HPs established 
even earlier. Another important actor in the early years of the Israeli health 
care system was the Hadassah Medical Organization, which began in 1913 
and started with well-baby clinics. Government hospitals, which provide more 
than half of all acute beds in the country at the time of writing, along with most 
psychiatric facilities, consist primarily of hospitals established by the State 
of Israel in British Mandate hospitals and some in buildings of British Army 
camps left over from the War of Independence in 1947–1948. (The 2009 Israel 
HiT covers the historical background of the health system; Rosen, Samuel & 
Merkur, 2009.)
The nature and the achievement of the health care system in Israel stem, to 
a large extent, from its foundation in organized social arrangements, as well 
as a general consensus that society as a whole is responsible for the health of 
its citizens. This guiding principle has been reflected in the structure of health 
services in Israel, combining state activities with those of the voluntary HPs 
(non-profit-making mutual organizations).
As of 2014, four non-profit-making HPs operate in Israel: Clalit, Maccabi, 
Meuhedet and Leumit (Rosen, Samuel & Merkur, 2009).
The State is responsible for supervising, licensing and overall planning of 
health services. It also subsidizes some of the voluntary HPs and other bodies, 
as well as directly funding or providing some services not offered by the HPs, 
such as long-term hospitalization.
General hospitals, together with hospitals built by Clalit and voluntary and 
religion-based hospitals, provide services to the members of all the HPs on the 
basis of reimbursement rules established by the state.
Since the late 1970s, the Israeli health care system, like those of other 
countries, has had to confront population ageing, resulting in a steadily 
increasing demand for geriatric services and care of chronically ill people, along 
with the need for the latest technology for diagnosis and treatment. The Israeli 
public have expected and demanded the provision of modern and progressive 
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services to meet their needs, requiring investment in sophisticated equipment 
as well as research and professional expertise, in order to remain current in 
terms of leading international standards. The result has been an ever-widening 
gap between the demand for care and the available resources of the health 
care system. Due to a number of other challenges since the 1980s, the Cabinet 
of the State of Israel in June 1988 established a State Commission of Inquiry 
into the functioning and efficiency of the health care system – the Netanyahu 
Commission. The recommendations of this Commission constituted a major 
watershed in the history of Israeli health policy. The Commission emphasized 
a large number of problems and proposed recommendations in a report 
(see Chapter 7 and Rosen, Samuel & Merkur, 2009).
In the years immediately following the submission of the Commission’s 
recommendations (1990–1993), reform efforts focused on an attempt to 
transform the government hospitals into stand-alone hospital trusts. This effort, 
discussed in greater detail in Chapter 7, failed because of opposition from health 
care workers’ unions and the Histadrut (the national labour federation). The 
focus then turned to the development of the NHI Law, which proved to be more 
successful; the Law was passed in 1994 and came into effect in January 1995.
The NHI Law ensures that all Israelis are covered by health insurance and 
spells out the list of benefits to which they are entitled. Coverage is provided 
via competing non-profit-making HPs, and there is full freedom of choice 
among HPs. The system is financed primarily via progressive taxation and 
the government distributes these funds among the HPs based on the size and 
age mix of their members. Further information on the problems that led to the 
adoption of NHI, its main components, and its implementation is provided in 
Chapters 3 and 7.
In the decade or so following the introduction of NHI in 1995, there were 
few if any major top-down structural reforms in Israeli health care. Plans were 
developed to transfer several key services (mental health services, preventive 
maternal and child health services, and institutional LTC services) from the 
government to the HPs, but these were not implemented. As a result, some 
observers suggested that the NHI reform was followed by a period of policy 
stagnation and even regression. They argued that the equity-related advances 
introduced by NHI were eroded by the introduction of co-payments for 
pharmaceuticals and physician visits, as well as by the growth of supplemental 
insurance programmes. They noted that since the mid-1990s there has been 
an increase in the extent to which national health care expenditure is being 
financed privately – from 26% in 1995 to 39% in 2012 – and the concomitant 
decline in the role of government financing.
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Others note that in the 1995–2010 period the health system went through some 
very positive evolutionary changes in terms of organization and service delivery, 
with both governmental and nongovernmental actors playing a role in their 
initiation. For example, the Ministry of Health created several significant new 
planning and regulatory units staffed by highly trained professionals, including 
units for health economics, supervision of HPs and regulation of the adoption 
of new technologies. Moreover, even though the Ministry of Health continued 
to own the government hospitals, the latter became far more autonomous than 
they had been previously. In parallel, the HPs invested heavily in information 
systems and quality improvement efforts, as discussed elsewhere in this report.
Since 2010, there has been a resurgence of large-scale health system changes 
driven, in large part, by the Ministry of Health. The NHI benefits package has 
been expanded to include dental care for children (section 5.12) and mental 
health services (section 6.1.2). The Ministry of Health has initiated a major 
national effort to monitor the quality of hospital care, and it has also mandated 
that the data on HP quality be disseminated on a comparative, plan-specific 
basis. As detailed in section 4.2, a series of major policy measures have been 
adopted to address Israel’s serious nursing shortage and its impending physician 
shortage. Similarly, a multifaceted national programme for reducing health 
care disparities has been implemented (section 6.1.1). Finally, as described 
in section 6.2, in 2013 the Ministry of Health formed a blue ribbon panel 
(the Advisory Committee for Strengthening the Public Health, known as the 
“German Committee”) to consider how the publicly financed system could best 
be strengthened in light of various threats posed by the growing private sector. 
In mid-2014 the panel released its recommendations and some of these are 
already being implemented.
2.3 Organization
This section begins with an introduction to the overall framework of the Israeli 
Government in terms of health care in the country, and continues with a description 
of the organization of the Ministry of Health and the health care system.
2.3.1 The Knesset
Israel is a parliamentary democracy and it is the Knesset that ultimately 
determines laws and budgets. Since the mid-1990s, the Knesset has been very 
active in health-related legislation, passing such laws as the NHI Law of 1995 
and the Patients’ Rights Law of 1996. The key Knesset committees relating to 
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health are the Finance Committee, which prepares the annual budget for votes 
in the plenum, and the Labour, Social Affairs and Health Committee, which is 
formally charged with the leading role on health issues.
It is important to note that since the mid-1990s much use has been made of 
the annual Budget Arrangements Bill, which accompanies the national budget, 
to move health and other social policy matters quickly through the Knesset in 
late December as part of the annual budgeting process. This Bill is handled by 
the Finance Committee rather than by the Labour, Social Affairs and Health 
Committee, and its use for substantive issues has come under increasing 
criticism on the part of Israel’s social lobby (a loose network of Knesset 
members and nongovernmental organizations (NGOs) that seeks to advance 
legislation to promote equality and the well-being of low-income groups).
2.3.2 The government
Executive power is in the hands of the government. After each round of 
parliamentary elections, the president (whose role is primarily ceremonial) asks 
the leader of the largest party to try to assemble a government (cabinet), which 
must secure and maintain majority support in the Knesset. This is done through 
the distribution of cabinet portfolios among the various coalition parties. Until 
the 1990s, the health portfolio was given to one of the smaller, less powerful 
parties, with the major parties preferring the more visible and powerful 
portfolios such as Foreign Affairs, Finance, Defence and Education. The period 
from 1990 to 1994 was unique, as the Ministry of Health was held by major 
players: first by one of the rising stars of the Likud Party and then by a rising star 
of the Labor Party. This was a reflection of the growing salience of health care 
issues in Israel. Between 1995 and 2013, there were 12 ministers of health, some 
from the smaller parties and some second-tier figures from the dominant parties.
The government plays a role in health care at several critical junctures. 
First, while the Knesset ultimately must vote on the annual budget, it is the 
government that prepares and submits the budget. The Ministry of Finance and 
its powerful Budget Division play a critical role in drafting the budget. However, 
the government ultimately determines what is proposed in the budget sent to 
the Knesset, and the political balance of power, as well as the policy priorities 
of the government as a whole, invariably affect allocations to health care.
Similarly, the government plays an important role in the legislative process. 
While the Knesset will entertain private members’ bills, in practice most 
legislation – and almost all major legislation – is submitted by the government. 
While the relevant ministry prepares the bill concerned, the government’s 
Ministerial Committee on Legislation plays an important role. For example, 
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in the case of the NHI Law, this was the place where a crucial compromise 
was reached whereby the Minister of Finance agreed to support the bill on the 
condition that the Minister of Health would agree to various measures that 
would serve to control NHI expenditure.
In some cases, elected officials need to decide whether to introduce major 
health reforms via legislation (which can only be enacted by the Knesset) or via 
governmental administrative decrees. This was illustrated by the mental health 
insurance reform (see section 6.1.2), where, after numerous failed attempts to 
pass legislation enacting the reform, in 2012 the government gave up on the 
legislative route and introduced the reform via administrative decree.
2.3.3 The Ministry of Health
The Ministry of Health has overall responsibility for the health of the population 
and the effective functioning of the health care system. The Ministry is headed by 
the Minister of Health, who is a member of the government (cabinet) and appoints 
a physician as Director-General, the Ministry’s senior health care professional.
Key functions of the Ministry of Health include:
• planning and determining health priorities;
• drafting health care laws to be put before the Knesset and enacting 
regulations subsequent to primary legislation;
• providing adequate resources for the NHI system and for other 
components of the health care system; promoting the effective use 
of resources within the health care system, including proposing the 
Ministry’s annual budget for the Ministry of Finance and the government;
• monitoring and promoting population health (see section 5.1);
• overseeing the operation of the government’s 11 acute care hospitals, 
8 psychiatric hospitals and 5 chronic disease hospitals;
• monitoring and regulating the activities of nongovernmental actors in 
the health care system, including hospitals, HPs,4 various stand-alone 
diagnostic facilities and so on;
• regulating the health care professions, with part of this function delegated 
to the Scientific Council of the Israel Medical Association (IMA), which 
works closely with the Ministry on issues surrounding physician licensing 
and other key matters; and
4 The Ministry of Health is involved in primary care in part through its regulation of the HPs and in part through a 
small unit involved in developing policy and strategic initiatives in primary care. However, primary care has not 
traditionally been a major focus of Ministry attention.
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• preparing the health care system for various emergency situations, 
including terror attacks or military attacks with both conventional and 
non-conventional weapons.
In addition to all the usual planning, public health, regulatory and 
stewardship functions, Israel’s Ministry of Health also plays a major role in 
the direct provision of care. It owns and operates almost half of the nation’s 
acute hospital beds, approximately two thirds of the psychiatric hospital beds 
and less than 10% of the chronic disease beds. In addition, it operates many 
of the nation’s mother and child preventive health centres. This multiplicity of 
Ministry roles has long been recognized5 as one of the problems of the Israeli 
health care system, and it is an issue that is discussed further in section 5.1.
The Ministry of Health receives important input from various advisory 
bodies. These include the National Health Council, a statutory body established 
to advise the Minister of Health on implementation of the NHI Law, and a series 
of standing national councils on, for example, community medicine, oncology, 
cardiovascular diseases and women’s health; these are appointed to advise 
the Director-General on both long-term goals and pressing issues requiring 
immediate policy response.
In the wake of the 2014 report of the German Committee (see section 6.2), steps 
were initiated to establish a government hospital authority, which would be separate 
from the Ministry of Health (although still reporting to the Minister of Health).
2.3.4 Other key government bodies involved in health
The Ministry of Finance. As noted above, this is the agency of the executive 
branch that prepares the budget for approval by the cabinet and Knesset, and 
monitors its implementation. Historically, its budget division has also been 
a catalyst for major structural reforms in Israeli health care. In addition, the 
Ministry’s Wages and Collective Bargaining Division is the lead government 
actor in negotiations with the health care labour unions. Its Finance and 
Capital Markets Division plays an important role in regulating the commercial 
insurance sector. Consequently, the Ministry of Finance has multiple, powerful 
points of influence over Israeli health care. As in other countries, the Ministry 
of Finance is the key governmental actor that consistently seeks to limit public 
spending on health care, to constrain the construction of new health care 
facilities and to limit the number of employed physicians.
5 This problem was discussed thoroughly by the Netanyahu Commission, as well as by various other commissions 
prior to the setup of the Netanyahu Commission. Most senior managers within the government and the HPs concur 
with this assessment.
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The National Insurance Institute (NII). This collects the health tax that plays a 
major role in the financing of the NHI system (see Chapter 3 for further details).
The Israel Defence Force (IDF). The Medical Corps of the IDF provides basic 
and emergency care for military personnel directly and purchases tertiary 
services from the civilian sector.
The Israel Prison Service. This has its own system for providing medical 
services to prisoners.
2.3.5 Key nongovernmental actors
HPs. HPs are voluntary, non-profit-making organizations, obliged to ensure 
that their members have access to a benefits package, as specified in the NHI 
Law. In return, the HPs receive an annual capitation fee per member from the 
government. At the time of writing, there are four HPs and their market shares 
at the end of 2013 were as follows: Clalit, 52%; Maccabi, 25%; Meuhedet, 14%; 
and Leumit, 9%. The HPs are governed by boards of directors. In some HPs 
the members are chosen by parent organizations (labour federations), while in 
other cases they are indirectly elected by the members of the plan.
Hospitals. While the government owns approximately half of the acute beds, 
Clalit owns one third of the acute beds and the remaining beds are owned by 
various non-profit-making and profit-making entities.
Magen David Adom (“Red Star of David”). Israel’s equivalent of the Red Cross 
operates ambulances and other emergency services.
Pharmaceutical companies. The major international pharmaceutical 
companies are active in Israel, both in terms of marketing their products and 
in trying to influence public policy through their industry association Pharma.
Health care unions. Most notable in this regard are the IMA and the Israel 
Nurses Association (see section 3.7.2).
Universities. Israel has seven research universities and numerous colleges, and 
they play a pivotal role in training health care professionals.
Research centres. Centres such as the Myers-JDC-Brookdale (MJB) Institute 
and the Gertner Center, along with various university-based research units, 
play a pivotal role in the monitoring and evaluation of health care services. In 
the past decade, the two largest HPs have also established research institutes. 
The National Institute for Health Policy and Health Services Research plays an 
important coordinating role.
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Advocacy groups and patient organizations. Many of these are organized 
around specific diseases, health risks (such as accidents) or health care services.
It is worth noting that the category “employers” does not appear on this list. 
Employers used to play an important role in health care financing, but they no 
longer do so (see Chapter 3 for further details).
2.3.6 Political parties
In theory, citizens can influence Israeli health policy through several major 
channels. The first is the political parties’ primary elections and the Knesset 
elections themselves (for other methods of citizen participation, see section 2.9.5). 
However, throughout the history of the State of Israel, domestic issues in 
general and health care in particular have not figured prominently in election 
campaigns. One important exception was the 1992 general election campaign 
in which the introduction of NHI and, to an even greater extent, reduction of 
corruption in the Histadrut and its separation from Clalit constituted central 
campaign issues for both main parties.
It should be noted that the political parties had a substantial impact on health 
policy even during periods when health policy was not a central campaign 
issue.6 For many years, the Labor Party resisted efforts to eliminate the HP 
system in favour of a unitary, government-run NHI system. It also successfully 
fought for government subsidies of the Histadrut-affiliated HP. Conversely, for 
decades the revisionist parties, predecessors of the current Likud, used their 
political power to block any NHI legislation that would preserve the dominance 
of the Histadrut-affiliated HP. The religious parties used their pivotal role in the 
political balance of power both to influence NHI legislation and to influence 
legislation on sensitive issues such as abortion and autopsies.
In recent years, while the political parties per se have not sought to advance 
particular health policy issues, the policy agendas of the ministers of health 
appear to have been influenced, at least in part, by their party affiliations. For 
example, the minister who served from 2013 to 2014 was particularly attuned 
to middle class concerns, which is not surprising as the middle class is the 
core constituency of her party. Similarly, the current minister appeared to be 
particularly attuned to the needs of his party’s core constituency – low income 
ultra-Orthodox Jews.
6 Since they are voluntary associations of citizens, political parties can be considered a form of citizen participation.
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2.4 Decentralization and centralization
Israel has a unitary, as opposed to a federal, system of government. While the 
government has administrative divisions at the regional level, these do not have 
independent authority in the same way as the states in the United States or the 
länder in Germany.
Although the Ministry of Health’s Public Health Division operates through 
regional and district offices, which have some leeway in responding to local 
conditions, the ultimate source of authority is the national office. The regional 
and district offices serve primarily to implement the policies and strategies 
developed at the national level, both in the public health field and in terms of 
the regulation of LTC and psychiatric care.
The same is true of the HPs; all have regional administrations but authority 
rests with their national headquarters. In recent years, the HPs have been 
undergoing a process of decentralizing authority and responsibility to the 
regions and branches. This was particularly true of Clalit, which underwent an 
ambitious programme of decentralization down to the clinic level.
The Ministry of Health and its institutions have one set of regional structures 
and the HPs each have their own. There is little coordination between these 
bodies at regional level.
The NHI Law called for the role of government to be reduced in terms 
of service provision in three key areas of activity: personal preventive care, 
LTC and mental health care. The Law stated that within a three-year transition 
period, these responsibilities would be transferred to the HPs. The original 
decision to transfer responsibility for personal preventive care (discussed in 
greater detail in section 5.1) was reversed by the Knesset in 1998 and it is 
only recently that the transfer of responsibility for mental health care has been 
implemented (section 6.1.2). A relatively recent effort by a health minister to 
similarly transfer responsibility for LTC did not succeed because of a mix of 
budgetary concerns and jurisdictional disputes (section 6.1.5).
A major effort was undertaken in the early 1990s to transform the 
government hospitals into independent, non-profit-making trusts. This was a 
top priority of the Minister of Health at the time. However, the effort failed, 
primarily because of opposition from the health care unions (see section 5.1). 
Instead, the government hospitals have been gradually given far more autonomy 
than they had in the past.
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Until recently, efforts were under way to establish a government hospital 
authority, which would supervise all of the government’s hospitals; the current 
plan calls for the authority to report to the Minister of Health but not to be part 
of the Ministry of Health, per se. However, this process has been halted in the 
wake of the change in government.
Most analysts interpret the NHI Law as increasing government control of 
the health care system. Previously, the HPs were largely unregulated. Now, 
the government has substantial regulatory powers regarding the benefits to 
be provided and to what extent to finance HP activity. Nevertheless, the HPs 
remain separate legal entities with considerable latitude for strategic and 
managerial discretion. The change is less radical than that which was envisaged 
by competing approaches to NHI, such as abolition of the HPs and institution 
of a unitary health insurance system run by the government. It is also evident 
that HPs have significantly less independence than they had prior to 1995.
The change in law enhanced the public’s right to a defined benefits 
package and increased equity in the health care system. What is less clear 
is the magnitude of the costs of the change in terms of reduced innovation, 
responsiveness and diversity.
In summary, since the mid-1990s the Israeli health care system has undergone:
• some deconcentration of central government authority to lower 
administrative levels of central government, particularly in the case 
of the government hospitals;
• no significant devolution of authority to regional or local governments;
• no significant delegation of responsibilities to quasi-public organizations 
(on the contrary: NHI constitutes a process of transfer of authority from 
the HPs to the government); and
• some privatization, in the sense of transferring responsibilities for service 
provision (e.g. mental health care) from the government to the voluntary 
sector, as well as some expansion of government responsibility (e.g. dental 
care for children).
Questions remain as to the desirable extent of deconcentration, devolution, 
delegation and privatization in Israeli health care. There continue to be vigorous 
debate as to the desirability of the changes that took place in the 1990s. Similarly, 
there is no clear consensus as to how Israeli health care should evolve with 
regard to these issues in the decade ahead.
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2.5 Planning
In 2013, the Ministry of Health established a new Planning Directorate to lead 
and coordinate long-term planning of the health care workforce as well as 
hospital beds, medical equipment and other vital inputs. In these efforts, it 
works closely with other Ministry of Health divisions, as well as the Ministry 
of Finance, the Prime Minister’s Office, the Council on Higher Education and 
all the major HPs and health care providers. Recent innovative efforts led by 
the new directorate include:
• creating sophisticated databases for workforce planning and policy 
analysis that integrate data from a wide variety of sources;
• developing a national plan for hospital beds through 2035, which is now 
being used as a basis for regional and hospital-specific plans;
• developing national strategies for reducing health disparities, including 
those related to problems faced by the geographic periphery;
• developing a plan for health insurance coverage and health care for 
migrant workers, and others who are not permanent residents; and
• approaching workforce issues in a comprehensive manner that takes 
into account the roles of Israeli universities in professional training, the 
availability of clinical training placements in field organizations and the 
expected influx of professionals from other countries.
Other planning efforts are led by other divisions of the Ministry of Health. 
For example, the Ministry of Health’s Public Health Division takes the lead on 
setting national health targets and developing strategies for achieving them. Yet 
another Ministry of Health unit is responsible for preparedness for large-scale 
health emergencies or disasters (such as wars, epidemics); it works closely with 
the Ministry of Defence and the IDF.
In many areas that require the development of new policies on sensitive 
subjects, the Ministry of Health has appointed ad hoc commissions or 
committees of prestigious experts (from within as well as outside government) 
to advise on the matters concerned.
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2.6 Intersectorality7
The Ministry of Health increasingly collaborates with other governmental and 
nongovernmental actors in order to address Israel’s growing health challenges. 
In addition to other government ministries, this includes nongovernmental 
sectors from within health and beyond, such as academia, NGOs, industry 
and civil society. The following are examples of how the Ministry’s 
intersectoral approach is manifest, as well as additional steps to increase 
intersectoral potential.
The National Programme to Promote Active, Healthy Lifestyle and its 
linked initiatives
The National Programme to Promote Active, Healthy Lifestyle was launched in 
December 2011 by the government’s Social and Economic Affairs Committee. 
The programme is led by the Ministries of Health, Education and Culture and 
Sport, and includes partnerships across government and within municipalities 
and civil society. Aims include improving eating habits and increasing physical 
activity in order to address obesity and chronic disease. The programme’s 
primary strategies are fostering health-promoting environments in the settings 
that make up Israeli life, increasing access to information and providing 
incentives for organizations and municipalities to promote health.
Legislative initiatives, such as removing junk foods from schools, tax breaks 
for workplace purchases of healthy refreshments, easing of access to fitness 
clubs, banning junk food advertisements during children’s TV and mandating 
front of package and restaurant calorie-labelling are all contingent upon joint 
leadership between the Ministry of Health and other ministries. Additional 
critical stakeholders who took part in the legislative process include the Israeli 
Union of Restaurateurs, national councils of family physicians and paediatricians 
and television networks. The Ministries of Health, Finance, Economy and 
Agriculture are currently working together to identify economic interventions 
to lower the cost of healthy foods and/or increase the cost of unhealthy foods.
Following decades of collaborative work with the Ministry of Health, the 
Ministry of Education has added health promotion of students to its permanent 
list of ministerial objectives, declaring that 2011–20 was “The Year of Active, 
Healthy Lifestyle.” Schools appointed councils of health-promoting students. 
Since then, 250 schools have gained accreditation as health-promoting schools. 
Also in 2013, the Ministry of Education launched a programme to distribute 
fresh fruits and vegetables in schools, in partnership with the Ministries of 
Agriculture and Health.
7 This section was prepared in collaboration with Yannai Kranzler.
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Fifteen municipalities are participating in the “Municipalities Promoting 
Active, Healthy Lifestyle” programme. In addition to creating opportunities for 
all to engage in active, healthy lifestyle, each municipality must create policy 
change at public institutions, community centres and schools. In parallel, the 
National Programme is strengthening Israel’s Healthy Cities Network, the 
foundation of which is an intersectoral approach to municipal health governance.
Also part of the National Programme to Promote Active, Healthy Lifestyle 
framework, NGO-led programmes include active transportation to school, edible 
gardens in nursery schools and providing bicycles and training to disadvantaged 
youth. The Ministry of Health is also (cautiously) working with the food industry 
to reduce salt content in processed foods and fortify flour for the Bedouin 
community, which suffers from malnutrition and high infant mortality. A joint 
effort with the National Programme for At-Risk Children, the Ministries of 
Health and Welfare as well as NGOs launched the “Health and Parenting for Small 
Children” initiative. Working together with nurses, teachers and parents, the 
programme utilizes nutrition as a platform for teaching healthy parenting skills.
The National Programme includes several examples of budget-sharing 
between ministries. Governance structures include an intergovernmental 
steering committee, and committees charged with workplace health promotion 
and identifying regulatory measures to encourage healthy eating. Budget 
commitments, mostly by the Ministry of Health, but with sums committed by 
the Ministries of Education, Culture and Sport, Finance and Agriculture, bind 
these ministries to work together to achieve the shared goal of active, healthy 
lifestyle. An evaluation committee, with representation from government and 
academia, ensures that evaluation meets current research standards and utilizes 
Israel’s leading health researchers, their students and the international networks 
of which they are a part.
The National Programme is increasingly driven by public engagement, and in 
2013, launched its social marketing programme, primarily via social media and 
community-based social marketers. Their role is to coordinate programming 
with local stakeholders such as parents’ associations, city councils, religious 
leaders and other local organizations in order to boost programme effectiveness 
as well as to guide policy, catalyse advocacy, facilitate smoother implementation 
and management and deepen both monitoring and evaluation.
Other intersectoral initiatives
While the National Programme represents the Ministry of Health’s most 
comprehensive intersectoral initiative, several additional examples of the 
Ministry’s work reflect the understanding of the interdependency between 
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sectors in ensuring population-wide health. One such effort is the focus 
on incorporating health impact assessment in urban planning and project 
development. So far, health impact assessment and similar reviews have been 
conducted in conjunction with the planning of the coal-fired power plant in 
Ashkelon, phosphate mining, industrial waste management in Ramat Chovav, 
railway expansion, wireless Internet in schools, water desalinization, and 
pesticide use. Together with the Environment and Health Fund, an international 
workshop on health impact assessment was conducted in 2011 with participants 
from a variety of sectors (health, environment, planning, economy). The case 
studies analysed included issues such transportation, industry and air pollution, 
urban planning and more.
A further example of intersectorality in the Ministry of Health is the 
development of national sustainability and well-being indicators, to complement 
GDP and gross national product as expressions of national success. In 
collaboration with the Ministry of Environmental Protection and the National 
Economic Council, the Ministry of Health is providing the health components 
of these indicators, with special emphasis on the social determinants of 
health. The Ministries of Health and Environmental Protection are also in the 
process of drafting a National Programme on Health and the Environment in 
order to address the health effects of environmental hazards, with a focus on 
vulnerable populations.
The High Food Council, a government-nominated structure led by the 
Ministries of Agriculture and Health, facilitates policy coherence between both 
ministries on matters related to the food chain.
Finally, one of the more innovative projects in the Ministry is the creation 
of a “Health impact bond”, a collaborative experiment with the Ministry of 
Finance aimed at enabling increased funding and outcome-oriented diabetes 
prevention among at-risk populations.
Ministry work is routinely informed by and alongside academia and 
NGOs. In recent years, the Ministry has set up formal structures to anchor 
the consultation process. “National Councils” now advise decision-making 
on Israel’s most pressing health challenges. The National Council on Health 
Promotion, for example, includes representatives from government ministries, 
academia, health maintenance organizations, and health, human rights and 
social justice organizations. The Ministry of Health recently launched an 
additional “roundtables” project to formalize ongoing communication with 
civil society and NGOs on issues including child safety, sustainability and 
sexual health.
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While intersectorality has gained prominence as a vital policy-making 
strategy, the following steps have been identified in order to strengthen the 
Ministry of Health’s intersectoral potential and to foster a cross-governmental 
policy-making system conducive to health.
Cross-ministry committees. Ministry of Health representatives play highly 
technical roles in committees that address food imports, agriculture, urban 
planning and other policy challenges not explicitly defined as “health issues”. 
These memberships can be leveraged to promote health on broader level and 
to address determinants that enable health and health equity, such as access to 
services, community, environmental justice and fair housing.
Knowledge translation. The Ministry could increase its focus on knowledge 
translation to ensure that health information is accessible to and disseminated 
to non-health sectors, and synthesized and framed according to their language 
and policy-making needs. In the opposite direction, members of the Ministry of 
Health must continue to step out of the “health box” to become acquainted with 
other policy-making environments in order to identify additional “win–win” 
situations between sectors and strengthen the networks that anchor intersectoral 
action for health.
The Ministry of Health continues its intersectoral path and is also researching 
both enablers of and barriers to intersectorality in order to maximize its ability 
to utilize the strengths of partners in and beyond government to foster equitable, 
population-wide health in Israel.
2.7 Health information management
2.7.1 Information systems
All HPs and the hospitals have sophisticated information systems that include 
electronic medical records, data on activity levels, services provided and quality 
of care (see section 4.1.4). Each of these organizations makes extensive use of 
their own data systems at both the individual care level, and to make broader 
policy decisions.
In addition, there are several systems for aggregating data across providers so that 
the data can be used to monitor and analyse overall national developments, including:
Infectious disease surveillance system. By law, any provider coming into 
contact with a patient who has any one of a long list of infectious diseases 
must report this information to the Ministry of Health.
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Disease registries. These are maintained by the Israel Centre for Disease 
Control (ICDC) and other units of the Ministry of Health and cover such topics 
as cancer, trauma, low birth weight, diabetes and heart disease.
National Hospitalization Database. This Ministry of Health database 
includes micro-level demographic, diagnostic and treatment data for almost 
all hospitalizations.
Hospital activity data. The Ministry of Health has a system of monitoring and 
disseminating aggregate hospital activity data (at the level of the hospital and 
the department).
Specific information systems on areas that benefit from government financial 
support. The Ministry of Health collects data on psychiatric hospitalizations, 
visits to emergency departments (EDs) and institutional LTC.
Cause of death statistics. The Central Bureau of Statistics (CBS)/Ministry of 
Health have a system for monitoring and reporting causes of death.
The National Quality Measures Programme. This collects information 
from the HPs on over 50 measures of the quality of community-based care 
(section 6.1.3).
Deaths and other adverse events in hospitals. Data are collected by the 
Ministry of Health for reporting and investigation.
Hospital-acquired infections. The Ministry of Health has an information 
system for monitoring and analysing infections in hospitals.
Disease registry systems. The Ministry of Health has registries for a number 
of diseases including for cancer, tuberculosis and human immunodeficiency 
virus/acquired immunodeficiency syndrome (HIV/AIDS).
Workforce registry systems. These cover physicians, nurses, dentists, 
pharmacists and others.
In addition, there are several important national population surveys that 
periodically collect nationwide data:
The Health Survey. This is carried out by the CBS and the Ministry of Health 
and collect information on self-perceived health status, health behaviours, 
utilization of services and so on. The most recent survey in the series was 
carried out in 2009.
The CBS Family Expenditure Survey. This annual survey provides information 
on spending for many different categories of health care.
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The CBS Labor Force Survey. This ongoing survey always includes a set of 
questions regarding health and health care.
The MJB’s biannual survey into the public’s perceptions of the level of 
services provided by the HPs. The topics covered include satisfaction with 
various dimensions of care, access/barriers to care, waiting times, and the 
nature of the interactions with providers of care.
ICDC surveys. Various surveys are carried out by the ICDC, including the 
KAP surveys, which look at knowledge, attitudes and practices related to health 
behaviours (ICDC, 2015); the MABAT series, which look at nutritional patterns 
in various age groups (ICDC, 2014); and the European Health Interview 
Surveys (ICDC, 2012), which collect information on health status and service 
utilization in a manner that is comparable to similar surveys carried out in 
various European countries.
2.7.2 Health technology assessment
In 1998, Israel established a formal process for setting priorities for adding new 
services to the benefits package. Each year, the government decides how much 
money it will allocate for these additions. In parallel, the Ministry of Health 
solicits recommendations for which new technologies/medications (henceforth 
referred to as technologies) should be prioritized for inclusion in the benefits 
package. HPs, pharmaceutical companies, the IMA, patient organizations and 
other groups submit recommendations, along with supporting analytic material. 
These proposals are reviewed by a staff unit within the Ministry of Health, 
which analyses the likely costs and benefits of each proposal. This background 
material is brought before a public commission that recommends to the 
Ministry and the government which new technologies should be adopted, given 
the previously determined budget constraints (Chinitz et al., 1998; Shani et al., 
2000; Shemer, Abadi-Korek & Seifan, 2005).
In 2005, a subcommittee was established, consisting of representatives of 
the HPs, the Ministry of Health and the Ministry of Finance, to review and 
refine the more technical components of the background information (such as 
the price and volume projections), thereby allowing the full committee to focus 
its efforts more on values and priorities. While this explicit priority-setting 
process does have various problems and limitations, it has been considered by 
many health policy analysts in both Israel and abroad to be ground breaking 
on an international scale (Chinitz & Israeli, 1999).
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In analysing the costs and benefits of proposed new technologies, the 
professional staff of the Ministry of Health examine various factors:
• health problems and conditions that the new technology would address;
• extent to which the benefits package already includes treatments for 
those problems and conditions, and the efficacy of those treatments;
• number of patients whose care would be improved;
• extent of the improvement in terms of duration and quality of life;
• health risks associated with the new technology;
• number of units of the new technology that would be likely to be 
consumed if the new technology were to be adopted;
• projected unit price of the new technology;
• total cost to the system of adopting the new technology; and
• potential savings from reduced consumption of existing technologies, 
for which the new one serves as a substitute.
In carrying out these analyses, the Ministry of Health staff rely on a number 
of sources, including:
• background materials submitted by the person/organization that proposed 
the adoption of the new technology;
• recent scientific evidence from published articles, testimony and 
correspondence;
• analyses carried out by health technology assessment units in other 
countries;
• assessments of panels of clinical experts, such as the various national 
medical councils, regarding the expected clinical benefit and the number 
of affected patients;
• epidemiological data available from government sources, such as the 
ICDC and various disease registries; and
• relevant data on consumption and pricing from the HPs, hospitals and 
other provider organizations.
The Ministry of Health staff employ a two-stage annual funding cycle. First, 
from a preliminary assessment of the added medical value, costs and benefits, 
and in light of the amount of new money available that year, they weed out those 
technologies that are not of sufficient promise to be discussed in the public 
commission. Second, they carry out in-depth analyses for those technologies 
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that have made it through the first phase. For each technology, a detailed 
analysis (typically 10–20 pages) is prepared. The analyses for all candidate 
technologies are published in a book prepared for the public commission. 
This book is not distributed to the general public but is distributed to the key 
interested parties and is also made available to academic researchers studying 
relevant issues. Table 2.1 indicates the number of new technologies considered 
and added to the benefits package in each funding cycle since 1999 (mostly new 
medications for cancer, heart disease, etc.).
Table 2.1
Number of technologies submitted and adopted, 2003–2015
Year Submitted Accepted
2015 >800 73
2014 >650 83
2013 >680 90
2012 613 77
2011 430 61
2010 420 80
2009 >400 87
2008 >500 93
2006–2007 400 75
2005 429 69
2004 – 0
2003 369 35
There is general consensus that the Ministry unit dealing with this process 
is understaffed relative to the number of health technology assessments they 
need to prepare (650–700 annually in recent years), the tight annual time-frame 
in which they must prepare them, and the sought-after levels of analytic depth. 
Additional professionals with the relevant skills do exist in Israel, but budget 
constraints prevent the Ministry of Health from hiring them for this purpose.
In evaluating the new technologies, the unit makes use of relevant clinical 
trials, systematic reviews, and submissions from those proposing that the 
technology should be added to the benefits package, plus additional information 
on expected volume and/or price from national disease registries, HPs, hospitals 
and pharmaceutical companies.
In its 15 years of operation, the items approved by the public committee 
include both preventive as well as curative services, as well as those intended 
to extend life along with those intended primarily to improve the quality of life. 
The relative emphases given to these has varied over time.
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The system has proven to be an effective one for national decision-making 
and has earned the support of the public, the relevant government ministries, 
the courts, and the key health care providers.
2.8 Regulation
2.8.1 Regulation and governance of third-party payers
HPs
The government regulates several aspects of the HPs and their operation. First, 
the total amount of government financing to be allocated to the NHI system 
is regulated, with separate decisions regarding the amount to be paid for the 
existing benefits package (to reflect population growth, inflation of key inputs 
and so on) and the amount to be made available for expansions of the benefits 
package. Second, the government provides the authorization necessary to 
operate an HP.
Furthermore, the capitation system that governs how the bulk of NHI funds 
are distributed among the HPs is set by the government. In part, this involves 
determining what parameters will be included in the capitation formula, for 
example determining whether health status, socioeconomic status and/or quality 
measures should be added, alongside age and sex. In addition, the coefficients 
of the existing parameters – age and sex – need to be updated periodically. 
A related decision is the extent and nature of payments to the HPs outside the 
capitation formula, such as the payments for “serious illnesses” and various 
safety net payments (see section 3.2).
The government also specifies the HPs’ financial reporting requirements 
and ensures that the HPs’ financial and operational activities are consistent with 
various legal requirements (e.g. limits on advertising expenditure).
With regard to the HP–consumer interface, regulation involves determining 
the extent and nature of the co-payments that HPs and others can charge 
their members. The content and pricing of supplemental insurance packages 
offered by the HPs are also regulated. This includes such issues as whether the 
voluntary health insurance (VHI) packages can include coverage for life-saving 
pharmaceuticals and choice of hospital-based physician. A related issue that 
is also regulated is whether the HPs can use their VHI programmes to cross-
subsidize their core activities (i.e. those related to the basic benefits package), 
or vice versa.
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Israel has a well-developed and highly effective national programme for 
monitoring the quality of care provided by the HPs in the community. The 
programme is run by an academic directorate, with funding coming from 
the Ministry of Health’s National Health Council and the Israel National 
Institute of Health Policy and Research. All four HPs participate voluntarily 
in the programme and play an active role in all decisions related to indicator 
selection and specification, data collection, and dissemination of the findings. 
Approximately 50 primary care quality indicators are used and are related to 
process of care and intermediate outcomes. Detailed results for the country 
as a whole, as well as by HP, are made available to the general public on an 
annual basis.
The Ministry of Health also involves the general public as partners in the 
regulation of the HPs. As described in section 2.9.4, the Ministry of Health 
has an ombudsman’s office which handles consumer complaints about the 
HPs; the complaints are addressed at both the individual and the systemic 
levels (Ministry of Health, 2013b). Moreover, as described in section 7.6, the 
Ministry of Health has recently set up a web site with extensive information on 
consumer rights related to both the NHI system and the supplemental insurance 
programmes (Brammli-Greenberg et al., 2014). This web site facilitates the 
capacity of consumers to demand that the HPs provide them with their rights.
In cases of financial irregularities or major deficits, the Ministry of Health 
can appoint an external comptroller for an HP. In extreme circumstances of 
financial or other irregularities, the Ministry of Health can even dismiss the 
chief executive officer of an HP and appoint a new one.
Commercial insurers
The private health insurance packages offered by commercial insurance 
companies are regulated by the Ministry of Finance’s Commissioner 
of Insurance, rather than by the Ministry of Health. Historically, the 
Commissioner’s regulatory efforts have focused on the actuarial soundness 
of the policies, with relatively little attention to the broader implications of 
the policies for the health care system. Recently, the Commissioner has begun 
to involve the Ministry of Health more in its regulatory decisions and this is 
leading to consideration of a broader set of health system factors.
2.8.2 Regulation and governance of providers
In terms of hospitals, the government regulates hospital licensure and oversees 
the authorization process for opening a new hospital or department. Furthermore, 
the number of hospital beds is regulated, along with their distribution in terms 
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of ownership, specialty and location, as is major capital expenditure, such as the 
acquisition of magnetic resonance imaging (MRI) scanners and other expensive 
equipment. In Israel, monitoring of nonmedical components of quality takes 
place through a system of inspections and other types of review. The Ministry 
of Health also issues periodic directives that address various dimensions of the 
quality of care in hospitals and HPs.
2.8.3 Regulation and planning of human resources
The Ministry of Health sets the requirements for licensure as a physician, nurse 
or other health care profession and assesses whether individual applicants meet 
those requirements.
There are also requirements for physician specialty recognition (together 
with the IMA) through the jointly operated Scientific Council. There are no 
legal requirements for physicians to participate in continuing medical education 
courses. However, many of the organizations encourage such participation 
through mechanisms such as funding the time for participation.
The Ministry of Health has recently set up a new department dedicated to 
long-term human resource planning.
2.8.4 Regulation and governance of pharmaceuticals
In the pharmaceutical sector, the maximum prices that pharmacies are allowed 
to charge consumers in direct sales to them are centrally set. Also regulated 
are the types of pharmaceutical that can be sold in Israel, from a safety and 
efficacy perspective. Further controls include which pharmaceuticals and other 
technologies will be covered via the NHI basic benefits package (see also 
section 5.6).
Quality monitoring
The Ministry of Health licenses and monitors the quality of Israel’s hospitals, 
outpatient surgery centres, dialysis centres, clinical laboratories and other key 
health care facilities. The licences granted to hospitals are valid for one to three 
years, depending on the results of the latest inspection. The licences are very 
detailed. They refer to a specific number of beds by department, as well as 
specifying the types of outpatient clinic the hospital is authorized to operate.
The Ministry of Health carries out periodic site inspections of hospitals and 
other health care facilities (irrespective of whether the facility is run by the 
Ministry or another provider).
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The Ministry of Health has developed several quality-monitoring tools 
with an emphasis on outcomes. Major in-depth studies have been carried 
out regarding such topics as hospital-acquired infections, coronary bypass 
operations, intensive care and transplants.
A few years ago, the Ministry of Health also embarked on a major initiative 
to monitor the quality of key processes of care within hospitals, with all 
hospitals required to report on five key indicators by the end of 2014. In 
mid-2015, the Ministry of Health released to the public a report with hospital-
specific performance data.
A large and growing number of Israeli hospitals have been accredited by 
the Joint Commission International, with many additional hospitals currently 
under review.
2.9 Patient empowerment
This section covers such issues as patients’ choices and rights and information 
on navigating the system.8
2.9.1 Patient information
When choosing among HPs, Israelis have available to them information on 
availability and accessibility of HP services, and patient satisfaction. More 
recently, comparative data on clinical dimensions of care have become publicly 
available. Additionally, a Ministry of Health web site provides detailed 
comparative data on what health care services are covered by the various 
commercial, supplemental and basic insurance programmes. A Ministry of 
Health-operated multilingual call centre is available to answer questions about 
insurance coverage and other aspects of health care.
All of the HPs operate both call centres (e.g. for scheduling appointments, 
providing coverage details) and extensive web sites (with searchable directories, 
coverage details, forms, etc.) to help guide their members through the health system.
Web sites established by various consumer organizations also provide 
important health care information, as well as web-based access to medical 
specialists and various peer-to-peer social networking opportunities. The 
largest, Camoni (“like me”), has over 100 000 unique visitors per month. Israel 
also has a Freedom of Information Act.
8 Ephraim Shapiro played the leading role in the preparation of this section.
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There is a growing recognition in Israel of the need to make services more 
accessible to cultural and linguistic minorities and several initiatives have been 
instigated in this regard. For example, Ethiopian immigrants having access 
in some clinics and hospitals to employed facilitators/liaisons, and there are 
Arab primary care providers (PCPs) in Arab villages. However, when it comes 
to specialty outpatient care and hospitals, significant cultural and linguistic 
barriers remain. The lack of professional translators results in an overreliance on 
family members or hospital employees who have not been trained in translation.
2.9.2 Patient choice
All Israelis are free to choose their HP and HPs must accept all applicants. 
In the past, transfers were limited to specific periods of the year, but anyone 
who has been in a plan for at least six months may transfer at any time. In 
practice, each year approximately 1.0–1.5% of the population switches 
plans and, interestingly, switching behaviour is relatively more common 
among lower-income individuals. New immigrants must choose a plan for 
the first time.
Interestingly, in a 2014 MJB Institute survey with 1540 participants 
(Brammli-Greenberg & Medina-Artom, 2015), 20% of adult respondents 
indicated that they had considered switching plans in the past year. Reasons 
for ultimately remaining in the plan were personal reasons (laziness/lack of 
time), 38%; realization that they were satisfied with their own plan, 32%; 
concerns regarding whether it was worthwhile to switch, 20%; and bureaucratic 
reasons, 18% (respondents were allowed to cite more than one reason). Another 
category included concerns about continuity of benefits/eligibilities and the 
price of supplemental insurance in the new plan. It is also important to keep in 
mind that the survey shows that the vast majority of the population (over 85%) 
are either satisfied or very satisfied with their plan.
Within plans, patients have a great deal of freedom in choosing their 
community-based physicians – both primary and specialist – from among those 
physicians affiliated with the plan. In most specialties, and in most areas of the 
country, each plan is affiliated with numerous physicians so that there is real 
choice in practice. Nevertheless, there are some specialties (e.g. child psychiatry) 
and regions (e.g. the Negev) where choice is more limited. If a member wants to 
see a physician not affiliated with the plan, access is not guaranteed through the 
basic benefits package, but in many circumstances partial coverage is available 
for those who have enrolled in supplemental insurance programmes.
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HPs have the right to direct their patients to particular hospitals. With 
the growth of selective contracting between HPs and hospitals, the plans 
have become much more active in directing patients. This has led to strong 
objections from many patients, and even more so from certain hospitals. The 
German Commission (see section 6.2) has recently recommended that HPs be 
required to provide their members in need of hospitalization with a choice of 
at least three hospitals.
In general, patients in non-profit-making hospitals are not free to choose 
which hospital-based physician will treat them.9 Instead, department heads 
assign physicians to particular rotations and/or patients. However, in Jerusalem’s 
non-profit-making hospitals, there is a private medical service option (SHARAP), 
in which the patient can choose their physician for an additional fee (i.e. beyond 
the fee paid by the HP for the basic hospitalization). All of the supplemental and 
commercial insurance packages offer partial or total coverage for this additional 
fee and the private medical service programme has grown markedly since the 
mid-2000s. Similarly, in Israel’s rapidly growing profit-making hospital sector, 
patients can choose their doctor, and with most of these fees being covered by 
supplemental and commercial insurers, more and more patients are electing to do so.
Although informed consent and a patient’s right to information are regulated 
by Israeli law, little provision is made for shared decision-making and few 
organizations formally promote it; as a result, there are those who see potential 
for increased shared decision-making because of Israel’s universal coverage and 
limited number of HPs (Miron-Shatz et al., 2012). However, others note that, 
when choosing among treatment options, responsibility for the final decision 
typically lies with patients, with doctors being responsible for providing 
information to inform patient choice; some doctors find fault with this policy 
since not all patients may be fully capable of making such choices.
2.9.3 Patient rights
The Patients’ Rights Law, enacted in 1996, emphasizes that patients have rights 
above and beyond the right to health care alone. Also enshrined in the Law is the 
patient’s right to review and transfer the information in her/his medical record.
The Law was the product of cooperation between Knesset members, 
government offices, the Association for Civil Rights, religious and legal 
representatives, women’s organizations and patient and professional associations. 
It defined the rights and obligations of patient–provider relationships, moving 
9 The German Committee considered recommending that SHARAP (private medical service) be allowed within all 
of Israel’s non-profit-making hospitals, but ultimately decided not to do so.
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from a paternalistic model of care to a patient-centred model emphasizing patient 
autonomy. The main goals of the Law were to ensure caregiver professionalism 
and quality and to protect the dignity and privacy of patients. In addition, the 
Law included rights that were previously granted in lawsuit verdicts within 
the realm of medical ethics and social norms, for example prohibition against 
discrimination and promotion of informed consent.
In 2008, the Law on Equal Rights for People with Disabilities (2005) was 
amended to require that, within 12 years, all public buildings will be accessible 
to the disabled and that all new buildings must provide such access from their 
inception. Although no comprehensive data regarding accessibility in health 
care facilities exist, a study finding that the vast majority of gynaecological 
clinics were not accessible for the disabled sparked an awareness campaign by 
several voluntary organizations. There are some preliminary indications that 
these efforts have worked to increase awareness of needs and to persuade the 
HPs to increase access.
2.9.4 Complaints procedures
All major Israeli health care institutions (such as HPs and hospitals) are required 
to assign a designated person as responsible for handling patient complaints. 
In addition, the Ministry of Health itself operates several units to which 
patients can send complaints regarding problems they encounter anywhere in 
the health system, both clinical and administrative. Both the Ministry and the 
providers try to respond to the complaints at two levels: by trying to better 
meet the specific needs of the individual who submitted the complaint, and by 
analysing aggregate complaint data to identify and then address problems that 
are prevalent and systemic in nature. The Ministry of Health also publishes an 
annual report that includes detailed information on the prevalence of complaints 
by provider and type of problem, as well as documenting the types of action 
carried out to address those complaints.
While all health care organizations have staff to handle complaints, people 
can still get lost in the system. Consequently, a national ombudsman has been 
appointed to address this issue and serve as a liaison between the individual 
and the system. The ombudsman can address both clinical/malpractice issues 
and patient financial rights/administrative issues; the ombudsman can enforce 
the withholding of funds from noncompliant HPs.
The Director-General of the Ministry of Health has recently encouraged the 
public to file complaints for any service that does not meet the standards of the 
NHI Law. In 2012, almost 4000 complaints were filed, of which approximately 
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25% were found to be justified (Ministry of Health, 2013b). It is unclear to what 
extent complaints are not filed even when patients have a right to do so. For 
example, advocates for those with mental health issues say that, as a practical 
matter, patients cannot complain while in psychiatric hospitals because the staff 
has de facto power over them.
With specific regard to hospital care, all Israeli hospitals are authorized by 
law to maintain two types of quality committee: a quality control committee 
to monitor and promote quality on an ongoing basis and a quality examination 
committee charged with examining specific untoward events. A 1995 Supreme 
Court ruling (Civil Appeal Request 1412/94) determined that patients and their 
families should be guaranteed access to the findings of the quality examination 
committees regarding their specific cases, but the IMA objected strongly to 
this and encouraged physicians to not cooperate. Over time, the extent of 
the IMA opposition has abated and the extent of physician cooperation has 
increased. The IMA continues to encourage physicians appearing before quality 
examination committees to bring a lawyer with them.
Hospitals are required to send reports to the Ministry of Health concerning 
all hospital deaths and unusual events in hospitals. The Unit for the Assessment 
of Reportable Deaths and Events reviews these reports and determines which 
cases require more in-depth investigation (which, in turn, could lead to 
disciplinary measures) and maintains a database encompassing all reports to 
identify systemic problems as a basis for system-wide interventions.
With regard to adverse drug reactions, the public is encouraged to report 
these directly to the Ministry of Health, although usually they discuss these 
with their physician, who then reports the event to the Ministry.
Direct-to-consumer advertising of pharmaceuticals is illegal, while the 
situation with regard to medical devices is ambiguous. Advertisements by 
doctors are strictly regulated.
2.9.5 Public participation/involvement
In addition to their influence via political parties, citizens also influence 
the health care system through their involvement in the boards of directors 
of key organizations, such as Hadassah, the HPs, and Magen David Adom, 
and through participation on various government advisory bodies, such as the 
National Health Council.
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Citizens, as consumers, also have influence over the system through the 
mechanisms of “voice” and “exit”. Increasingly, researchers are using surveys 
and in-depth interviews to help consumers to articulate their needs and wants 
with regard to an ever-widening set of health care services and issues. Moreover, 
in those areas of health care characterized by competition, such as the HP sector, 
shifts and potential shifts in market shares have led providers to be much more 
responsive to consumer demands and wants than they were in the past.
The MJB carries out a biannual survey of the general population regarding 
health system performance. In the 2007 survey, 88% of respondents indicated 
that they were “satisfied” or “very satisfied” with their HPs. In the first round 
of the survey, the comparable figure was 83% (1995); by the second round, 
it had risen to 91% (1997) (probably as a result of the introduction of NHI), 
and has remained high since then (89% in 2014). The survey also enquires 
about satisfaction with the health system as a whole, and here the percentage 
of “satisfied” or “very satisfied” individuals was 62% in 2014, which was down 
from 70% in 2012, but still slightly higher than the 58% level found in the 
2003 survey.
In 2003, a unique initiative was launched – the Health Parliament. Groups 
of ordinary citizens from around the country were given an opportunity to 
voice their views on pressing health policy issues after being given extensive 
background information on those issues in a series of regional meetings with 
leading health policy experts (Guttman et al., 2008). The initiative succeeded 
in providing policy-makers with valuable input on citizens’ preferences but was 
discontinued the following year because of funding problems.
A variety of entities have undertaken initiatives to improve the patient 
experience. The government is working specifically to improve communication 
between geriatric patients and providers, with future projects directed 
at including patient experience in medical school curricula as well as at 
further surveys on patient satisfaction in hospitals and the community. An 
emphasis has also been placed on collecting data for measures that other 
OECD countries collect, such as re-admission rates, in order to facilitate 
cross-country comparisons.
Innovative nongovernmental initiatives include, for example, the Askme3 
programme – an American patient education programme that has been 
implemented in Israel and encourages patients to ask doctors what is the 
medical problem, what do they need to do and why is it important.
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Advanced technology call centres have also been developed for specific 
purposes such as patients with complex needs. For example, one HP and research 
institute have together created the first call centre in Israel for people with chronic 
diseases (and their caregivers), coordinating clinical and community support.
2.9.6 Patients and cross-border health care
The detection and control of infectious diseases is a major focus of cross-
border cooperation and is pursued through the Middle East Consortium for 
Infectious Disease Surveillance. Established in 2003, it was set up to improve 
detection and control of foodborne infectious diseases and facilitating data 
sharing and cross-border communication, but this infrastructure has proved 
invaluable for broaden surveillance of other serious emerging infections, such 
as avian influenza.
Hospital care is another focus of cross-border cooperation. Israel’s tertiary 
hospitals attract patients in need of highly specialized care from various 
Mediterranean and Middle Eastern countries. Israeli hospitals also treat 
patients from the Palestinian Authority in the West Bank and the Gaza strip. 
The vagaries of the security and diplomatic situation influence the number of 
these types of patient.
In recent years, Israel has emerged as a major medical tourism destination 
for patients from beyond the region. This is because Israel can offer many 
advantages, including first-rate quality of care at reasonable prices. Israel’s 
facilities are recognized throughout the world, with regular contacts maintained 
on a reciprocal basis with major medical and scientific research centres abroad. 
Israel is frequently the host venue for international conferences on a wide 
variety of medical topics. Patients come to Israel for procedures such as in 
vitro fertilization, bone marrow transplants, heart surgery and catheterization, 
oncological and neurological treatments, car accident rehabilitation and more. A 
growing number of private companies are engaged in marketing Israeli hospital 
care abroad. The growth in medical tourism to Israel has sparked a major debate 
about its appropriate scope and how it should be regulated.
In parallel, a number of Israeli patients go to other countries voluntarily to 
seek care. This is especially true in the area of reproductive care.
Many migrant workers, who make up to 14% of the Israeli workforce, are not 
eligible to receive NHI, but employers are obliged by law to purchase private 
health coverage for non-resident workers. Undocumented migrants in particular 
may face individual, social and structural obstacles, leading them to avoid 
seeking medical care.
3. Financing
Israel has had a low and stable level of total expenditure on health (THE), both as a percentage of GDP and per capita in purchasing power parity (PPP). Israel’s ability to maintain this relatively low level of total spending 
on health probably in part reflects its relatively young age distribution together 
with various structural features and policies that contribute to cost-containment. 
Those related to financing include the following.
1. Health care works within an NHI framework that is compulsory and 
universal. It is financed by a combination of earmarked health taxes 
and general government revenues. Both are progressive, in a way that 
high income and low-risk individuals subsidize low income and high-risk 
individuals. Moreover, due to the combination of earmarked and general 
government funding, when there are economic slowdowns and the health 
tax revenue decreases, the government can increase its share of funding 
so as not to decrease the NHI funding. On the other hand, there is 
always a constant predictable part of NHI funding that does not depend 
on year-to-year government decisions and priority settings. 
2. There are effective mechanisms of risk sharing between the government 
and the main providers/purchasers of care, the four HPs, through: 
(1) financing of HPs primarily via prospective payments based 
on a capitation formula with simple and objective risk adjusters; 
(2) supplementary HP funding via retrospective payments based 
on performance and outlier costly diseases. 
3. HPs work as managed care organizations with gatekeeping, and some 
cost sharing from insurees for visits to specialists and for medications. 
Most of the physicians working with HPs are paid via capitation and/or 
salary arrangements, thereby largely avoiding the cost-promoting effects 
of fee-for-service reimbursement.
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4. HPs purchase inpatient care from hospitals through 50 differential per 
diem fees, and activity-based payments based on procedure-related 
groups (PRGs). The government publishes maximum-price lists for 
inpatient care and sets hospital revenue caps to contain hospitals’ income 
increases. Moreover, due to their dominance, HPs are further able to 
obtain discounts from hospitals.
Along with the low and decreasing public expenditure on health (Table 3.1), 
there has been a constant and marked trend of increases in private spending. 
The VHI market is one of the biggest in OECD countries, with about 87% of 
Israel’s adult population covered with VHI offered by the HPs (HP-VHI; called 
in Hebrew “supplemental insurance”, see section 3.5.3) and 53% covered with 
commercial insurance. Household spending on VHI has increased markedly 
since the early 2000s. Out-of-pocket (OOP) expenditure is also high relative 
to other countries and has increased somewhat over time. There are large 
differences in household expenditure on health by income quintile, which 
indicate the existence of inequalities.
Table 3.1
Trends in health expenditure in country, 1995–2012, selected years
Expenditure 1995 2000 2005 2012
THE per capita (US$ PPP) 1 435 1 765 1 829 2 304
THE (% of GDP) 7.7 7.6 7.9 7.3
THE, mean annual real growth ratea 5 4 3 4
THE, annual growth rate in real terms n/a 6.7 2.2 4.1b
Mean annual real growth rate in GDPc 6.5 8.7 4.9 3.4
Public expenditure on health (% of THE) 68.3 64.1 63.1 60.8
Private expenditure on health (% of THE) 31.7 35.9 36.9 39.2
Government health spending (% of total government 
spending)
2.0 2.0 0.6 0.5
Government health spending (% of GDP) 1.7 1.6 0.5 0.4
OOP payments (% of THE) 27.6 27.4 25.7 25.6d
OOP payments (% of private expenditure on health) 87 76 70 65d
VHI (% of THE) 4.1 8.5 11.2 13.6d
VHI (% of private expenditure on health) 13 24 30 35d
Sources : CBS, 2014d; OECD, 2015.
Notes : aCalculated as the mean of the annual growth rates in national currency units at 1995 GDP prices; b2011–2012; cPercentage of 
volume change each year compared with the previous one; d2013; n/a: Not available.
On the one hand, the low and stable THE has been a source of pride for the 
Israeli health care system. On the other hand, the increasing growth of private 
expenditure has raised serious concerns about a shortage of resources in the 
public system and rising inequalities; these, in turn, could pose risks to access 
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to services and the population’s health. It is not clear whether the Israeli system 
is an adequately funded system that can provide good care through a very high 
level of efficiency or whether it has steadily been eroding its resources up to 
an unwanted point.
3.1 Health expenditure
In 2013, Israel spent around NIS 70 billion (€14 billion in 2014 prices10) on 
health care, amounting to 7.6% of GDP (CBS, 2014a,d). As shown in Figs. 3.1 
and 3.2, the proportion of Israel’s GDP devoted to health is low, relative to the 
OECD and EU averages. In 2012, Israel spent US$ 2334 (PPP) per capita on 
health care, and this too is low compared with countries in the WHO European 
Region countries (Fig. 3.3).
Fig. 3.1
Health expenditure as a percentage of GDP in OECD countries, 2012 (or nearest year) 
Source : OECD, 2015.
10 The average exchange rate for 2014 used is 1 NIS = €0.20 (Bank of Israel, 2015).
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Fig. 3.2
Trends in health expenditure as a percentage of GDP in Israel and as the EU and OECD 
averages, 1995–2012 
Sources : OECD, 2015; WHO Regional Office for Europe, 2015.
Israel’s relatively low levels of health care spending may be partly because 
of the country’s relatively young population. Yet, even after adjusting for age, 
the proportion of GDP allocated to health in Israel is still less than the OECD 
average (93% of the OECD average, compared with 81% before the adjustment). 
Similarly, age-adjustment increases Israel’s per capita expenditure in PPP 
from 63% to 73% of the OECD average. Other factors contributing to Israel’s 
relatively low levels of spending on health include its relatively high level of 
defence spending and interest payments for the public debt (Shmueli & Israeli, 
2013; Ministry of Health, 2014a).
The public share of health care financing in Israel has declined steadily 
since the early 2000s. At 60%, it is currently one of the lowest among OECD 
countries (where the average is 72%) (Fig. 3.4). The Israel–OECD gap in 
public expenditure on health, both in share and per capita terms, is even bigger 
than the gap for THE (Bank of Israel, 2013). Here, too, high levels of defence 
spending and interest payments are playing an important role (Shmueli & 
Israeli, 2013).
0
2
4
6
8
10
12
EU
OECD 
average
Israel
201220112010200920082007200620052004200320022001200019991998199719961995
Pe
rc
en
ta
ge
 o
f G
DP
Health systems in transition  Israel 49
Fig. 3.3
Health expenditure per capita (US$ PPP) in the WHO European Region, 2012 
Source: WHO Regional Office for Europe, 2015. 
Notes: CARK: Central Asian Republics and Kazakhstan; CIS: Commonwealth of Independent States; EUR-A,B,C: Regions as in the 
WHO list of Member States, last available year; TFYR Macedonia: The former Yugoslav Republic of Macedonia.
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Fig. 3.4
Health expenditure from public sources as a percentage of THE in the WHO European 
Region, 2012 
Source: WHO Regional Office for Europe, 2015. 
Notes: CARK: Central Asian Republics and Kazakhstan; CIS: Commonwealth of Independent States; EUR-A,B,C: Regions as in the 
WHO list of Member States, last available year; TFYR Macedonia: The former Yugoslav Republic of Macedonia.
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By 2013, the private share of health care financing had increased to 41%. 
The increase in the level of private health care financing is primarily through a 
sharp increase in spending on VHI premiums (see Table 3.4, below).
Public health expenditure by service programme for 2012 is presented in 
Table 3.2.
The distribution of current expenditure by operating sector in 2012 was 
(CBS, 2015):
• government and local authorities: 6%
• HPs: 33%
• other non-profit-making institutions: 5%
• market producers (includes hospitals operated by the government, the HPs 
and other non-profit-making entities): 56%.
Over time, the share of public clinics and preventive care has increased and 
the shares of hospitals and research have declined (Table 3.3.).
Table 3.2
Public health expenditure by service programme, 2012
Percentage public 
expenditure on healtha
Percentage 
THEb
Health administration 2.2 4.4
Education and training n/a n/a
Health research and development n/a 1.2
Public health and prevention 0.3 0.4
Medical services:
Inpatient care (general hospitals, hospitals for psychiatric 
and chronic care)
47.1 32.7
Outpatient/ambulatory physician services 38.3 36.6
Outpatient/ambulatory dental services 0.2 7.7
Ancillary services n/a n/a
Home or domiciliary health services n/a n/a
Mental health n/a n/a
Supply of medicines, medical supplies and medical equipment 10.4 13.8
Fixed capital formation, total 1.9 3.1
Source : CBS, 2015b.
Notes : aIncludes financing through the government, local authorities and HPs; bIncludes financing through the government, 
local authorities, HPs, private financing and donations from abroad; n/a: Not available.
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Table 3.3
Public health expenditure on health by service input, five latest available years
Service input Public health expenditure (%)
2006 2007 2008 2009 2010
Medicines and medical supplies purchased 
by households 
4 4 4 4 4
Private physicians 5 5 5 5 5
Dental care 8 9 9 8 8
Hospitals and research 37 35 35 35 35
Public clinics and preventive medicine 44 46 45 46 46
Government administration 2 1 1 2 2
Source : CBS, 2014d.
3.2 Sources of revenue and financial flows
The Israeli NHI covers all citizens and permanent residents. It provides access 
to a broad benefits package (also called the “health basket”). Four competing 
HPs are responsible for providing the health basket benefits to their members.
The health budget tends to be fairly stable from one year to the next. However, 
in 2015, the health budget was increased substantially (Ministry of Finance, 
2015; Rosen & Merkur, 2015).
Each year, the government determines the level at which the NHI system will 
be funded. It is based on the previous year’s budget adjusted for demographic 
growth, technological developments, and a price index. Yet, it seems that these 
adjustments are not enough and recent studies show that the “real value” of the 
NHI budget has eroded since the enactment of the NHI law (Shmueli, Achdut 
& Sabag-Endeweld, 2008; Arieli, Horev & Keidar, 2012). The NHI budget per 
capita (adjusted for changes in the official health cost index) was essentially the 
same in 2013 as it was in 1995. If the additional funds received for additions to 
the benefits package (which of course also had concomitant additional costs) 
are deducted, then the per capita budget in 2013 was 12% lower than it was 
in 1995 (Ministry of Health, 2014a). The two main reasons for this erosion are 
the inadequate adjustment for the health cost index and the combination of 
demographic growth and population ageing:
Adjustment for the health cost index. The NHI budget is adjusted every year 
for the health cost index, which is supposed to adjust for the prices of inputs. 
In 2014, it was composed of indices for various inputs (i.e. the consumers 
price index, the average wage of health care providers and the average wage of 
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public servants) but did not explicitly reflect hospital costs (such as the per diem 
rate). As inpatient care represents 40% of the NHI budget, this component is 
important to the health cost index.
Demographic growth and population ageing. Neither of these has been fully 
reflected in the NHI budget adjustment. This has created pressures on the 
capacity of HPs to fund ongoing operating expenses, although to date it has not 
yet compromised their ability to maintain their capital stock. According to the 
report of the German Committee (see section 6.2), the demographic adjuster grew 
by 31% between 1995 and 2013, while the number of insured grew by 45% and the 
number of age-standardized persons grew by 57% (Ministry of Health, 2014a).
In May 2013, the government decided to increase the demographic adjuster 
from 1.2% in 2013 to 1.6% up to 2016. However, this has still been insufficient 
to maintain the per capita purchasing power, as it does not adjust for real 
population growth (1.9% in 2014) and ageing and does not compensate for 
erosion in earlier years. If no further improvement is made, in the medium and 
long term, the NHI budget erosion will cause pressures on fixed expenses too, 
as new infrastructure will be needed.
The erosion of the NHI budget, on the one hand, and the increase in the 
scope of the VHI market, on the other hand (section 3.5) led HPs to encourage 
their insured to use their supplemental insurance to obtain health care services, 
including services that formed part of the NHI benefits package. In this way, 
expenditure by the HPs decreased while their income remained the same. This 
trend contributed to the constant increase in the private financing share of the 
THE (Table 3.4) (Ministry of Health, 2014a).
Table 3.4
Sources of revenue as a percentage of THE according to source of revenue, 1990–2013
Sources of revenue 1990 1995 2000 2005 2008 2009 2010 2011 2012 2013
General government 
expenditure
21 23 37 36 34 36 36 35 35 35
Earmarked taxes or social 
insurance contributions
26 43 25 25 26 25 26 26 25 24
Total public financing 47 66 62 61 60 61 61 60 59 59
OOP payments n/a 28 28 26 25 25 24 25 26 27
VHI n/a 4 8 11 13 13 13 14 14 13
Other (i.e. donations 
from abroad)
7 3 2 2 2 2 2 2 2 2
Total private financing 54 34 38 39 40 39 39 40 41 41
Source : CBS, 2014d.
Note : n/a: Not available.
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The budget for the NHI benefits package (officially known as “the cost 
of the benefits package”) is distributed among the HPs mainly prospectively 
(as described in section 3.3.3). Fig. 3.5 illustrates the trends in health expenditure 
in Israel by financing source (Fig. 3.5a) and according to source of revenue 
(Fig. 3.5b).
Fig. 3.5a
Total expenditure on health by financing sector (%), 2000–2014 
Source : CBS., 2014d.
Fig. 3.5b
National expenditure on health by financing sector, 2013 
Source : CBS, 2014d.
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Services outside the NHI system are financed via VHI, and direct OOP 
payments. The VHI market in Israel offers two products: supplemental 
insurance provided by the HPs and commercial insurance provided by profit-
making commercial insurance companies. VHI does not cover or reduce 
co-payments in the public system. (For more details on the VHI market, see 
section 3.5.)
3.3 Overview of the statutory financing system
The Israeli health care system is financed by public sources (the NHI) and 
private sources (VHI and OOP) (Fig. 3.6). The financing system can be 
characterized by its breadth (population covered), scope (benefits covered) 
and depth (cost coverage). This section describes each of these dimensions 
of funding. Fig. 3.7 illustrates the public and private health financing systems 
according to these three dimensions.
Fig. 3.6
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Fig. 3.7
The Israeli health insurance market 
Source :Brammli-Greenberg et al., 2014.
3.3.1 Coverage
Breadth of coverage
Since 1995, all permanent residents of Israel have been entitled to a benefits 
package specified in the NHI Law (see below). They are free to choose among 
four competing, non-profit-making HPs, which must accept all applicants. 
Residents are allowed to switch between plans any time, up to twice a year. 
No resident can opt out of the NHI system.
Public NHI financing comes from two sources: the health tax and general tax 
revenue. The health tax is the NHI premium, which functions as an earmarked 
payroll tax collected by the NII. All permanent residents above age 18 must 
pay a health tax. The health tax is 3% of the wage for employees earning up to 
60% of the average wage,11 and 5% of the wage for those earning above it. The 
self-employed pay the same rates from their total income, and retired people 
pay the same rates from their pensions. Married women who do not have paid 
work are exempt from paying the health tax. Students and the unemployed must 
pay 5% of their income or cash transfers (e.g. unemployment benefits, income 
support, NII allowances or scholarships). Those who have no income pay a 
minimum rate of NIS 103 (about €20) (NII, 2014a). Soldiers in their regular 
compulsory service receive health care through the IDF’s Medical Corps, rather 
than through NHI; therefore, they do not pay the health tax. Income above 
five times the national wage is not taxed for NHI purposes. Failure to pay the 
required health tax will result in government action to enforce payment but in 
no way jeopardizes the individual’s right to NHI benefits.
11 In 2014, the average wage for Israeli employees was approximately NIS 9000 (€1850) (NII, 2014).
PUBLIC HEALTH EXPENDITURE (60.8% of THE) PRIVATE HEALTH EXPENDITURE (39.2% of THE)
VHI does not reduce co-payments
Breadth: universal coverage by 4 competing HPs
(% of population covered by each HP)
Scope (benefits 
covered): NHI 
health basket
Depth: all benefits cost 
covered except small 
co-payments (6.45% 
of HPs income)
Depth: 
OOP 65%; 
VHI 35% 
of private 
expenditure
Scope 
(benefits covered): 
Complementary
SupplementaryBreadth
(% of adult population covered by type of VHI)
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Populations excluded from the NHI include undocumented migrants, 
temporary residents, foreign workers and tourists. (For more details on the 
coverage of non-resident populations, see section 5.14.)
Scope of coverage
The NHI Law stipulates a standard benefits package, the health basket, which 
all residents are entitled to receive from their HPs. In setting out the details 
of the initial benefits package in 1995, the Knesset essentially adopted that 
of Clalit, the largest HP. Since then, all HPs are legally mandated to provide 
the same benefits package, which is specified and periodically changed by 
the government.
The health basket includes, for example, physician services, hospitalization, 
medication, diagnostic examination and in vitro fertilization treatment. New 
services recently included are dental care for children (introduced in 2010) and 
mental health care (starting in mid-2015). Institutional LTC, preventive care, 
dental care for adults, contraception and alternative medicine are not included 
in the package at the time of writing (mid-2015).
Mother and baby preventive care is funded by the Ministry of Health and 
provided by the Ministry of Health, the municipalities and HPs. The Ministry 
of Health provides needs-based assistance for institutional LTC. The remaining 
non-NHI care can be purchased privately either through VHI or OOP payments.
The health basket is an explicit list of services to be provided, and in many 
cases it also specifies quantities and conditions. In 2014, the Ministry of 
Health launched a web site that lists all the benefits provided by the NHI. It 
contains up-to-date information on key aspects of health insurance (public and 
voluntary). The idea was to empower insurees with knowledge and awareness 
of their rights and eligibility to benefits, so they can demand them from the 
HPs. If refused, they can refer the case to the regulatory body, the Ministry of 
Health. This policy instrument addresses market failures related to information 
asymmetry and can potentially improve competition among the HPs and within 
the VHI market (Brammli-Greenberg et al., 2014).
In 1997, Israel established a formal priority-setting process for the addition 
of new services to the benefits package (no technology is excluded from the 
benefits package). Each year, as part of the annual budgeting process, the 
government determines how much money will be available to fund new 
technologies. The Ministry of Health solicits recommendations from the HPs, 
pharmaceutical companies, the IMA, patient organizations and other groups 
for new technologies to be given priority for inclusion in the benefits package. 
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The Medical and Infrastructure Technologies Administration at the Ministry 
of Health performs technology assessments on the recommendations received, 
mainly regarding the medical effectiveness and safety of the technology. Based 
on the technology assessment, a technology forum, comprising technology 
specialists at the Ministry of Health, the Director-General, and representatives 
of the legal office at the Ministry of Health, rates the technologies according 
to a priority list. Technologies considered worth including undergo a costing 
procedure by a subcommission in which representatives of the Ministry of 
Health, Ministry of Finance and HPs participate. The costing also considers 
epidemiological patterns and predicts the overall cost of the technology for the 
NHI based on the number of people who would benefit from it. Finally, based 
on the technology assessments and their costing, a public committee (the Basket 
Committee) – made up of HP representatives, Ministry of Health, Ministry of 
Finance, IMA, experts in health economics and health policy, and public figures 
from outside the health care system – recommends which new technologies 
should be adopted. Final decisions as to what will be included are made by the 
Minister of Health (2010a).
An interesting development is that, in the beginning of the NHI era, most 
additions to the health basket were for life-saving technologies, and very 
few involved technologies that improve the quality of life without extending 
its duration. Recently, increased attention and priority is being given to the 
latter and even to preventive services. The Basket Committee process is also 
becoming more transparent, with greater public and media access and coverage.
Depth of coverage
Emergency, primary and inpatient care are provided free of charge. Secondary 
care, such as visits to specialists and diagnostic examinations, requires small 
co-payments of about NIS 25 (€5). Co-payments for drugs are generally 10% of 
the price with a minimum of NIS 15 (about €3). There are also small co-payments 
for rehabilitation care and paramedical care such as physiotherapy and speech 
therapy. Discounts and spending caps are provided for the chronically ill, the 
elderly and families. Co-payments and other user charges constitute 6.5% of 
HPs’ income (Ministry of Health, 2014g).
The HPs submit co-payment plans for approval by the Ministry of Health 
and the Finance Committee of the Knesset. Consequently, there are differences 
in co-payments among the HPs.
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Non-National health insurance financing
Services not included in the NHI benefits package and not generally provided 
by the HPs include LTC and dental care for adults. Non-NHI financing also 
covers investment in hospital construction and equipment, and medical 
research. LTC is financed via a mix of revenue sources, including households 
(through private insurance and OOP payments) and a number of agencies, 
including the NII, government ministries and HPs. Households pay OOP for 
the following services: private surgery and laboratory tests, visits to private 
physicians, complementary and alternative medicine (CAM), private nurses and 
ambulances, private psychological and psychiatric visits, and private dental care.
3.3.2 Collection
Table 3.3 presents information on the main sources of financing for the health 
care system as a whole. Before NHI, individuals paid their health insurance 
premiums directly to the HPs on a voluntary basis. HP premiums were 
subsequently replaced by the health tax (a payroll tax). Today, NHI funds are 
collected primarily via payroll and general tax revenues. The health tax is 
earmarked for health and is collected by the NII, which then transfers it to the 
Ministry of Health. By 2012, the health tax accounted for 24.5% of total health 
care financing. The NHI is also financed by general tax revenues transferred 
by the Ministry of Finance to the Ministry of Health (34.6% of THE). General 
tax revenue is derived from a mix of progressive taxes such as income tax 
and regressive taxes such as value-added tax and customs levies. General tax 
revenue is used to fill the gap between the officially determined level of NHI 
funding and revenue from the health tax. The system, therefore, lies somewhere 
between a social health insurance system and a tax-financed system.
3.3.3 Pooling of funds
Allocating from collection agencies to pooling agencies
The NII plays a central role in pooling funds for the NHI system. It is the 
NII that collects the health tax and receives the government’s funds for NHI 
and distributes that funding among the four HPs. As noted in section 3.3.1, 
the system is financed according to ability to pay (i.e. via the health tax and 
general revenue, which is, in turn, based mainly on progressive income tax). 
The monies are distributed to the HPs largely based on needs. Thus, because 
of the pooling function of the NII, an HP’s income is in principle a function of 
the needs of its members, rather than of the incomes of its members.
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Allocating resources to purchasers
The distribution of NHI funds, per the officially recognized cost of the benefits 
package, to the HPs by the NII is carried out to cover physical health and 
mental health.
Physical health
The main core is distributed according to a prospective capitation formula 
(which accounts for around 88.3% of HP income in 2014). The formula reflects 
each HPs share in the market (number of standardized persons enrolled) and 
three risk adjusters: age, gender and place of residence (in the periphery). The 
capitation formula is reviewed periodically by the “capitation committee”, which 
consists of representatives of the Ministry of Health and Ministry of Finance. 
Capitation weights are reviewed every three years and are set as a function of 
three expenditure categories (ambulatory care, pharmaceuticals and inpatient 
care), based on the previous year’s average use of each capitation group.
Small co-payments for pharmaceuticals, specialist physician visits and 
certain diagnostic tests also play a role in financing the NHI system (6.5% of 
the HPs’ income in 2014). In addition, HPs receive retrospective payments 
(5.3% of their income in 2014) from the Ministry of Health for enrolees with any 
of five “severe diseases; for example, in 2014, the diseases were thalassaemia, 
Gaucher disease, kidney dysfunction, haemophilia and cancer (Ministry of 
Health, 2015c).
Besides the NHI budget, HPs can receive special financial support from the 
government at the end of each year. The size of these payments is determined 
primarily by the extent to which the HPs meet various fiscal responsibility and 
efficiency targets. These targets are set by the Ministry of Health every three 
years, in accordance with key policy objectives. For example, in 2013–2014, 
the objectives included providing preventive care and oral health for children 
without co-payments, preventing hospital readmissions, promoting healthy 
lifestyles, tackling geographic and social disparities in health, and providing 
care for chronic obstructive pulmonary disease (Ministry of Health, 2014g).
Until 2010, the capitation formula’s sole risk adjuster was “age”. There were 
concerns that, because it only included that one risk adjuster, the Israeli formula 
did not do enough to prevent risk selection (van de Ven et al., 2003, 2007). 
Besides the change in 2010 (the addition of gender and place of residence), 
there have been various proposals to add additional parameters such as 
socioeconomic status, health status and disability status. These proposals 
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have not been implemented to date because of a mix of concerns related to, 
for example, data availability and reliability, potential adverse incentives and 
change in the balance of the current pooling of funds.
Recent studies still identify inefficiency and point to the pooling of funds 
for HPs, which might lead to incentives for selection of low-risk individuals 
by HPs (Shmueli, 2011; Achdut et al., 2012; Brammli-Greenberg et al., in 
press). Although the capitation formula was improved in 2010, there is not 
enough evidence that the additional risk adjusters have sufficiently improved 
the pooling of funds (Brammli-Greenberg, Waitzberg & Glazer, in press). 
Moreover, evidence is still lacking to evaluate whether the funds allocated to 
improve health care provision in the periphery (through the new risk adjuster in 
the capitation formula) have achieved their purpose, and many analysts believe 
that they were insufficient in magnitude.
Mental health
From June 2015, as part of the mental health reform, HPs receive an additional 
budget of about €360 million from the Ministry of Health to provide mental 
health services. This additional budget is approximately the amount the 
Ministry of Health spent on mental health before the reform. HPs will be 
responsible for providing (or contracting with private providers for) individual 
or group psychotherapy and psychiatric care in the community and will 
purchase inpatient care from hospitals (previously the Ministry of Health 
paid for psychiatric inpatient care in general or in psychiatric hospitals). In 
mid-2015, it was still not finalized exactly how the mental health budget would 
be distributed among HPs from 2016 onwards.
From June 2015, the budget would be distributed separately for inpatient and 
outpatient care. The inpatient care budget would be distributed according to 
the HP’s share in hospitalization days before the reform, with adjustments for 
projected changes based on trends from 2006 to 2013. Funding for outpatient 
care would be distributed among the HPs through a basic capitation formula 
with age as the sole risk adjuster (with two groups: children up to 18 years 
old and adults over 18 years). The current formula assumes that, each year, 
2% of the children will utilize mental health care (with 12 visits on average), 
and that 4% of the adults will utilize mental health care (with nine visits on 
average) (Tabibian-Mizrahi, 2006, 2007). In future, outpatient mental health 
care might be included in the general capitation formula as an additional 
expenditure category.
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3.3.4 Purchasing and purchaser–provider relations
Purchasing hospitals services
In recent years, contracting has become a very significant feature of relations 
between hospitals and HPs. In government and independent non-profit-making 
hospitals, almost all sales of services to the HPs are governed by such contracts. 
Contracts play a much more marginal role for the Clalit hospital system, as a 
large portion of its sales are to Clalit regional management.
The contracts build upon the official government reimbursement prices 
and mechanisms (see section 3.7) as benchmarks. Typically, in return for 
guaranteeing a minimum revenue stream, the HPs are given an additional 
price discount.
The HPs have significant market power in their negotiations with hospitals 
as there are only four plans and hence each has a sizable market segment (with 
concentration levels even higher at the regional level than at the national level). 
Moreover, a significant proportion of hospital expenditure is fixed, rendering 
them particularly vulnerable to the threat of sharp reductions in volume.
There is no law in Israel that forbids HPs from channelling patients to 
particular hospitals. With the spread of contracting arrangements, along with 
Clalit’s growing interest in hospitalizing its members in hospitals that it owns, 
channelling has become more common and tensions have arisen regarding this 
development. To limit the extent of the channelling, the Ministry of Health has 
recently decided that each HP will have to pay to each hospital 95% of what 
they paid to them in the previous year, even if the HP reduces consumption at 
a certain hospital by more than 5% (Ministry of Health, 2014a). Further steps 
are under consideration (see section 6.2).
Purchasing ambulatory services
In Israel, HPs provide most of the ambulatory services in house. However, they 
do purchase some services (from either hospitals or independent community-
based facilities), particularly in the imaging field for the particularly expensive 
technologies. In addition, they also purchase services from independent 
physicians – to some extent for primary care but more so for specialist care.
Regarding mental health services, the HPs have been developing 
multispecialty community mental health clinics since 2012, at the urging of 
the Ministry of Health. HPs will also purchase mental health services from 
government and public community clinics (the main providers before the 
reform), and from independent professionals such as psychologists, psychiatrists 
and other mental health caregivers.
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3.4 Out-of-pocket payments
In 2013, households financed 40.5% of THE, from which 26% was OOP 
payments (while the remaining 13% was premiums paid for VHI). OOP 
expenditure represents a high share of THE in Israel compared with other 
OECD countries (26% and 19%, respectively) (CBS, 2015; OECD, 2015). The 
rate of OOP expenditure as a percentage of THE in Israel has been relatively 
stable since the mid-1990s although it has been increasing in per capita terms 
(Fig. 3.8). OOP expenditure per capita in Israel in 2013 was similar to the OECD 
average (US$ 627 and 601 PPP, respectively).
Fig. 3.8
Out-of-pocket payments/capita, US$ purchasing power parity, 2006–2013 
Source : OECD, 2015.
Survey data from 2012 indicated that health care represented about 5.5% of 
household expenditure. In that year, households spent about €180 per month on 
health care, of which 35% was for private health insurance premiums, 25% for 
dental care, 16% for medications, 5% for glasses and 19% for other services. 
There were large differences in household expenditure on health by income 
quintile: while the lowest quintile spent approximately €90 per month, the 
highest quintile spent about €300, which represent 4.5% and 6.3% of each 
quintile’s total household expenditure, respectively (Horev & Keidar, 2014).
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There are two types of OOP payment: cost-sharing (user charges) for 
services included in the NHI benefits package and payment for services not 
included in the NHI benefits package. These are considered in turn.
3.4.1 Cost-sharing (user charges)
In 1998, the Knesset authorized all the HPs to charge their members for visits 
to specialists and community-based diagnostic centres. The HPs were also 
authorized to substantially raise their co-payment rates for pharmaceuticals. The 
Knesset stipulated that details of the co-payments would need to be approved by 
the Ministry of Health. The co-payments were part of an effort to alleviate the 
HPs’ financial deficits; the primary motivation for the new co-payments was 
revenue enhancement. However, the Ministry of Finance insists that it pushed 
the legislation through the system partly to reduce the frequency of unnecessary 
visits to physicians, with a view to containing costs. The co-payments for HPs 
are regulated by the Ministry of Health, and co-payments constituted 6.5% of 
HPs’ income in 2014 (Table 3.5 summarizes the cost-sharing mechanisms and 
protection for vulnerable populations). The cost-sharing (either co-payments or 
coinsurance described below) cannot be covered by the VHI.
Co-payments for visits to specialist physicians in the community are 
structured as follows. There is a flat-rate charge (about €5) for the first visit 
in any quarter; repeat visits within the quarter to the same specialist are not 
subject to co-payments. Elderly welfare recipients (aged 65 years and over) 
and children receiving disability payments are exempt from co-payments for 
all visits; people afflicted with end-stage renal disease, cancer, HIV/AIDS, 
Gaucher disease, thalassaemia or tuberculosis are exempt from co-payments 
at hospital outpatient departments and dialysis centres. There is also a quarterly 
ceiling on total co-payments at the household level, which is 50% lower for 
elderly people. Developmental care (e.g. speech therapy, occupational therapy, 
physiotherapy, and mental health care) is exempt from co-payments for children 
whose parents receive income support from the NII. In 2014, the ceiling for 
households was about €50 (the ceiling is not a function of family size) and about 
€75 for individual patients with chronic conditions (Ministry of Health, 2014b).
Key changes in co-payment requirements since 2010 include:
• oral health care for children up to 12 years was added to the health basket, 
with co-payments of about €5 per visit;
• co-payments for visits to well-baby clinics (preventive care for children) 
were abolished;
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Table 3.5
User charges for health services
Health service Type of user charge 
in place
Exemptions and/or 
reduced rates
Cap on 
OOP spending
GP visit None
Primary care visit None
Specialist physician visit Co-payment (~€5 for the 
first visit in each quarter)
Elderly welfare recipients, 
children receiving disability 
payments and people 
afflicted with severe 
diseases are exempt from 
co-payments for all visits
Quarterly ceiling on total 
co-payments at the 
household level (~€50), 
which is 50% lower for 
elderly people
Inpatient stay None
Oral health for children 
up to 12 years
Co-payment (~€5 for the 
first visit in each quarter)
Patent drugs Co-insurance (15% of the 
purchase price)
50% of discount to 
chronically ill who are 
elderly or receive welfare 
payments and for 
holocaust survivors
Quarterly ceiling of €65 for 
chronically ill
Generic drugs Co-insurance (10% of the 
purchase price)
50% of discount to 
chronically ill who are 
elderly or receive welfare 
payments and for 
holocaust survivors
Quarterly ceiling of €65 for 
chronically ill
Services for chronically 
ill (includes drugs and 
visits to specialists)
Diverse types of cost 
sharing
Monthly ceiling (about €75) 
for individual chronically ill 
patients; for chronically ill 
aged 65+ the ceiling is €35
Source : Office of the Deputy Director-General for Regulation of the Health Plans, 2014.
• fertility and in vitro fertilization treatments are also made subject to 
co-payments (at about €40 per treatment); and
• mental health services provided in HP clinics would require quarterly 
co-payments of about €5 per patient but patients wishing to choose 
their therapist outside the clinics may do so from a list of independent 
professionals with agreements, and pay co-payments for each visit; the 
co-payments rates for individual psychotherapy are about €11 for the first 
visit and €28 for each of the following visits, and about €13 per visit for 
group psychotherapy.
Coinsurance for pharmaceuticals is 15% of the purchase price for patent 
drugs and 10% for generic drugs, subject to a minimum co-payment of around 
€3 per item purchased (Ministry of Health, 2014g). For the chronically ill, there 
is a quarterly ceiling of approximately €65, varying according to HP. Those 
older than 65 years who receive income support benefit from a 50% reduction in 
pharmaceutical coinsurance, while those older than 75 years benefit from a 10% 
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reduction; veterans of the armed forces receive a 75% discount, and Holocaust 
survivors are exempt from coinsurance (Office of the Deputy Director-General 
for Regulation of the Health Plans, 2014).
There is evidence to suggest that co-payments have created financial barriers 
to access, particularly for people with low incomes (Gross, Brammli-Greenberg 
& Matzliach, 2007). In 2014, 11% of the adult population refrained from taking 
medicines or visiting physicians within the NHI because of co-payments or 
coinsurances. The rates were higher among chronically ill (17%) and the lowest 
income quintile (20%). Nevertheless, the recent financial protection measures, 
such as discounts and caps for vulnerable populations, have benefited the 
population and the rates of people refraining taking medicines or visiting 
physicians is lower than it was a decade earlier (Brammli-Greenberg & Medina-
Artom, 2015). User charges cannot be covered by VHI.
3.4.2 Direct payments
Another important type of OOP payment is for services not in the NHI and 
also not provided by the Ministry of Health. Some of these services, such as 
care in private hospitals (whether inpatient or outpatient), are usually purchased 
privately. Other services and products that are primarily paid for privately 
include optical care, dental care for adults, medical equipment, some prostheses 
and LTC. While these services are sometimes covered – in whole or in part – 
by VHI, OOP payments also plays a significant role in their financing.
In the community setting, there are no legal restrictions on the provision of 
private care, apart from the stipulation that those physicians who also work in 
the public sector receive permission from their employer to practise privately. 
Permission is almost always granted, although often with a limitation on the 
number of hours that the physician can practise privately. This situation is not 
monitored closely by the hospitals or the government, but if cases of serious 
abuse come to light, they are dealt with administratively.
In the hospital setting, physicians can legally practise privately only in private 
hospitals and in Jerusalem’s non-profit-making hospitals. Private services 
are illegal in public hospitals. This is primarily for equity considerations; the 
sentiment is that, at least in public facilities, all patients should receive the same 
level of care irrespective of their ability to pay. There have been many public 
debates on whether private practice should be allowed in public hospitals. The 
last one was in 2014 within the “Commission to Strengthen the Public Health 
System in Israel”, which decided that private practice would remain forbidden 
in public hospitals (see section 6.1).
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Most government hospitals have established “health trusts”. These are 
distinct legal entities that engage physicians to work after hours, usually on a 
per-visit or per-operation basis determined by negotiation between the trusts 
and individual physicians. However, this activity is not primarily “privately 
financed” in the sense of being funded by OOP payments or commercial VHI. 
Rather, the trusts’ revenue comes primarily from the sale to the HPs of surgical 
and outpatient clinic services carried out during late afternoon, evening and 
night hours.
3.4.3 Informal payments
There are indications that, despite the existence of universal health insurance 
coverage and widespread VHI coverage, there continues to be various forms of 
informal payment in Israel. These include giving cash to particular physicians 
and making gifts to a hospital ward. The objectives appear to include expressing 
appreciation with no expectation of future tangible benefit, securing the 
services of a particular physician in a situation where otherwise a physician 
would be randomly assigned and getting more time and personal attention from 
the clinical staff in general. In Israel, long-standing personal connections are 
also used to secure preferential treatment (Flic & Cohen, 2015).
3.5 Voluntary health insurance
3.5.1 Market role and size
Over and above the NHI, two forms of VHI are available in Israel: supplementary 
insurance, offered by the HPs to all of their own beneficiaries (HP-VHI); 
and commercial insurance offered by commercial insurance companies to 
individuals or groups. Even though the Israeli NHI benefits package is broad 
compared with that in other OECD countries, Israel’s VHI market is still one 
of the largest. In 2014, 87% of Israel’s adult population had HP-VHI, and 53% 
had commercial insurance (Brammli-Greenberg & Medina-Artom, 2015). In 
2010, this was higher than in all other OECD countries except for France and 
the Netherlands (OECD data for 2010).
The share of the Israeli population covered with VHI has been growing 
rapidly since the early 2000s, and it is the fastest growing component of 
private health care spending. Between 2002 and 2011, household spending 
on supplemental insurance increased by 70% and on commercial insurance 
by 90% (Ministry of Finance, 2012; Ministry of Health, 2012). The payments 
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for premiums of both supplemental and commercial health insurance increased 
by more than 100% from 2005 to 2013, compared with an increase of 18% in 
other insurance sectors. The Israeli per capita expenditure on private insurance 
in 2005–2012 skyrocketed by 111%, much faster than the average of 39% in 
OECD countries.
According to the Ministry of Health, the VHI market is not achieving the goal 
of financing health care privately while reducing OOP payments: household 
expenditure on health care has not changed since the early 2000s except for the 
sharp increase in spending on VHI premiums (Ministry of Health, 2012). Along 
with the increase in the number of VHI policyholders in recent decades, Israel 
witnessed an expansion of dual coverage: in 2014 50% of the adult population 
owned the two types of VHI, up from 5% in 1995 and 30% in 2005 (Brammli-
Greenberg & Medina-Artom, 2015; Brammli-Greenberg, Waitzberg & Gross, 
2016). It is worth noting that all the VHI owners are also covered by NHI. 
Multiple and dual coverage may be contributing to increases in THE, including 
in private spending (Brammli-Greenberg & Waitzberg, 2014). The Ministry of 
Health has included among its strategic goals restraining the growth in VHI 
ownership, and strengthening the public system.
One of the possible reasons for the high demand for VHI in Israel is the 
low trust and confidence in the public health care system. In 2014, about 
50% of the adult population (aged 22 years or more) reported that they were 
confident or very confident that they would receive the best and most effective 
treatment. Only 40% reported that they were confident they would be able 
to afford the treatment needed. In these two measures, Israel had the lowest 
score of all 11 countries in the 2010 Commonwealth Fund survey. This could 
be due, in part, to differences in terminology between the surveys, with the 
United States survey (and perhaps the surveys in other countries) asking about 
confidence in the system’s ability to meet their needs, and the Israeli survey 
using a Hebrew term that has connotations of both confidence and certainty 
(Brammli-Greenberg & Medina-Artom, 2015).
Another reason for the broad VHI coverage is that it is used by insurees to 
“jump queues”, both for elective surgery and for specialist consultation in the 
community. Insurees can receive faster access to elective surgery in private 
hospitals and can visit specialists in their private clinics – both financed by 
their VHI. This is instead of waiting for the public services provided by HPs 
under the NHI law.
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3.5.2 Market structure
In 2014, 87% of the adult population had HP-VHI, and 53% had commercial 
insurance (Brammli-Greenberg & Medina-Artom, 2015). Residents can 
only purchase HP-VHI from their HP. There is some variation in coverage 
rates among HPs ranging from 91% in Maccabi and 86% in Clalit to 77% in 
Leumit and Mieuhedet (in 2014) (Brammli-Greenberg & Medina-Artom, 
2015). HP-VHI is considered by the insured as part of the public health care 
system, and coverage is high among almost all the population, including among 
vulnerable population groups apart from Arabs: 92% among the chronically 
ill, 90% among older people, 85% among immigrants from the former USSR, 
81% among the lowest income quintile and only 54% among Israel’s Arab 
citizens (Brammli-Greenberg & Medina-Artom, 2015; Brammli-Greenberg, 
Waitzberg & Gross, 2016).
Commercial VHI offers individual and group policies. Commercial cover is 
offered mainly by five insurers, who account for 97% of commercial premiums. 
There are two types of buyer in the commercial market: people who buy their 
policies directly from an insurer for a risk-rated premium based on age, gender 
and pre-existing conditions (for whom enrolment is dependent on medical 
underwriting); and organizations (e.g. employers, labour unions) who purchase 
group policies for their members for a community-rated premium, reflecting the 
risk level of the group. Group premiums are lower than individual premiums 
for the same level of coverage, and usually less profitable.
The demographic profile of people with commercial VHI differs somewhat 
from that of those with HP-VHI, in that they tend to have higher incomes 
and better health (Brammli-Greenberg, Waitzberg & Gross, 2016). In the 
commercial market for VHI, limitations not related to price (e.g. coverage limits, 
waiting periods, risk-rated premiums, the exclusion of pre-existing conditions 
and the rejection of applications for cover) serve as a means of selecting 
healthier people and rejecting or charging higher premiums to less healthy 
people (Shmueli, 1998, 2001).
3.5.3 Market conduct
Health Plan Voluntary Health Insurance
Voluntary health insurance offered by the health plans (HP-VHI), called in 
Hebrew “supplemental insurance”, plays several roles in the health system. 
It can provide: (a) complementary services (that are not included in the 
NHI benefits package) such as adult dental care or alternative medicine; 
(b) supplementary services that are covered by NHI, but only to a limited 
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extent (e.g. IVF and physiotherapy); or (c) reimbursement for care purchased 
in the private sector that provide enhanced choice of provider, faster access or 
improved facilities (Brammli-Greenberg, Waitzberg & Gross, 2016). It does not 
include “substitutive” insurance for people excluded from the NHI system or 
coverage for user charges and co-payments in the public system.
Since the mid-1990s, there has been a substantial increase in the range of 
services covered by HP-VHI. Whereas initially these packages focused on 
services that were nonmedical (e.g. recuperative care), the newer services 
include many that are definitely medical in nature (such as advanced oncological 
and prenatal tests).
HP-VHI is a standard package of supplemental insurance offered by each 
HP to all of its policyholders, with relatively low fees that are determined solely 
by age (and not influenced by health status). No policyholder can be denied 
coverage, and HPs are prohibited from excluding pre-existing conditions. 
HP-VHI packages and rates must be approved by the Ministry of Health.
Since 2007, all HPs have developed a second layer of VHI coverage with 
extended coverage such as organ transplantation abroad and more genetic 
testing during pregnancy, which they have marketed for an additional premium. 
One of the HPs even created a third layer in 2013, which included aesthetic 
procedures, dental care and physical activity promotion. However, it later had 
to cancel its first layer in order to remain with two layers, as in all other the HP 
(Brammli-Greenberg, Waitzberg & Gross, 2016).
Commercial voluntary health insurance
Commercial insurance is not considered part of the publicly funded health 
system. It is offered by private insurers who are free to insure any medical 
service but who can offer cash benefits only. Commercial plans cover dental 
care and catastrophic events (such as transplants, operations abroad and LTC), 
as well as financial compensation for services in the private sector. Many of 
the policies also cover medications not covered in the NHI benefits package. 
They usually offer higher indemnity payments and greater choice of provider 
than HP-VHI. Consequently, commercial VHI has become an additional layer 
of insurance rather than an alternative to supplemental insurance, resulting in 
less direct competition between the two parts of the market (Fig. 3.9) (Brammli-
Greenberg & Gross, 2003).
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Fig. 3.9
Health insurance market and layers among insured adults (aged >22 years; 
self-reported), 2014 
Source : Brammli-Greenberg, Waitzberg & Gross, 2016.
Lifesaving medications
Currently only commercial VHI can cover life-saving medications that are not 
in the NHI benefits package. HPs attempted to include these medications in 
their policies in 2007. Adding these benefits in the supplemental coverage put 
the HP in direct competition with commercial insurers, particularly as they 
can offer coverage more cheaply than commercial insurers. However, in 2008 
the Ministry of Health and the Knesset prohibited HPs from doing so on the 
grounds that it would lead to inequality in access to health care (for those who do 
not own VHI) and would weaken the public pressure to add new medications to 
the NHI benefits package. The Ministry of Finance also feared that the change 
would increase total spending on health (Gross & Brammli-Greenberg, 2004). 
This debate was brought back onto the public agenda in 2014 (see section 6.2), 
and the Ministry of Health is currently considering allowing HPs to include 
coverage for life-saving medications in their VHI.
3.5.4 Public policy
The Ministry of Health regulates HP-VHI, while the Insurance Commissioner 
at the Ministry of Finance regulates commercial VHI. In mid-2015, the 
government’s policy is to allow both HPs and private insurers to offer VHI, 
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with the proviso that the HPs do not offer LTC insurance.12 In addition, the HPs 
must operate supplementary VHI under separate financial accounts and may 
not use NHI public funds to cross-subsidize supplementary VHI.
In practice, however, in some years the HPs have used profits from 
supplementary VHI to help to offset deficits in the NHI-related part of their 
activity. Lately, the HP-VHI has been perceived, and used more intensively, as a 
competitive tool by HPs seeking to attract low-risk and low-cost insured. They 
started offering benefits that are particularly attractive to young and healthy 
people, as well as large and young families. These included vaccinations for 
travellers (e.g. for tropical diseases), pregnancy diagnostic examinations, optical 
services for children and diagnostic examinations for child development, such 
as for attention deficit hyperactivity disorder. By offering such benefits, the 
HPs hope to earn more from supplemental premiums, and to increase the plan’s 
enrolment of young families, thus to earn more governmental funds from the 
NHI capitation formula (Brammli-Greenberg, Waitzberg & Gross, 2016).
Addressing dual coverage
One of the reasons for the dual coverage phenomenon is information asymmetry: 
Israelis lack knowledge about the coverage they are entitled to in each type of 
insurance, and about how to realize their benefits. Another factor may be that a 
significant portion of the Israeli public is not confident that their needs will be 
met if they become seriously ill (Brammli-Greenberg & Medina-Artom, 2015). 
This problem is reflected in the limited utilization of services covered both by 
NHI and VHI. However, sometimes VHI divert (profitable) services from the 
public to the private system (Brammli-Greenberg et al., 2014).
The phenomenon of dual coverage has led to concerns that many consumers 
may unknowingly be paying twice for insurance for the same risk (particularly 
private operations). As a result, the Insurance Commissioner has recently 
required commercial insurers to also offer policies that add to, rather than 
duplicate, the coverage available via the HP-VHI packages.
In order to tackle the lack of information, the Ministry of Health launched a 
web site in 2014 that gives access to transparent information about the coverage 
of the NHI and VHI benefits packages (see section 2.9). The idea is to empower 
insurees with knowledge and awareness of their rights and eligibility to benefits 
so they can demand them from the HPs and/or private insurers; if refused, 
they can refer the case to the supervisor (the Ministry of Health). This policy 
12 The HPs may market LTC insurance policies offered by the private insurers but cannot serve as the insurer for 
these policies.
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instrument addresses market failures related to information asymmetry and can 
potentially improve competition among the HPs and within the VHI market 
(Brammli-Greenberg et al., 2014).
In view of the increasing dual coverage, the Insurance Commissioner is 
currently consolidating a series of changes in commercial VHI in order to 
combine the commercial VHI market with the HP-VHI market. In 2014, the 
Insurance Commissioner expanded the allowable commercial insurance 
coverage to include, apart from surgery, also consultations with specialist 
physicians, alternative treatments, choice of surgeon (by covering the surgeon’s 
fee in private hospitals) and other costs of private surgery. The change aimed to 
increase the competition of commercial VHI with HP-VHI, since these services 
were already provided by the latter. The Insurance Commissioner also created 
a “standard” policy with uniform coverage, including new technologies, and 
uniform premiums by age group. The main coverage is private operations, 
which is the main reason that people buy VHI in Israel. The premiums and 
co-payments can vary only based on individual risk, gender and health 
condition (Ministry of Finance, 2014, 2016). In the future, this standard policy 
will be marketed also by HPs. The intention is to offer low-risk people a cheaper 
policy with unique basic coverage and thereby increase competition in the 
VHI market both among commercial insurance companies and between these 
companies and HPs. The standard policy also increases transparency in the 
VHI market and makes it easier for consumers to make comparisons among 
insurers. With greater competition and the same types of coverage, insurees 
might be able to make wiser choices of type of insurance and might give up 
dual coverage.
3.6 Other financing
3.6.1 Parallel health systems
Virtually all the health care services provided to soldiers are financed via the 
budget of the IDF and the Ministry of Defence The IDF’s Medical Corps is 
responsible for all medical care provided to all soldiers, in peace and in wartime, 
on and off the battlefield, whether they are conscripts (doing their two to three 
years of required service), reservists or career personnel. The IDF does not 
operate its own hospitals; it purchases all tertiary services from the general 
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(civilian) hospitals. The Medical Corps has special purchasing agreements with 
these hospitals and also has special arrangements whereby a certain number of 
IDF physicians are seconded to these hospitals.
Between 2011 and 2014 there was a pilot “Aviv Project” (Spring Project) 
that allowed soldiers from the bases not located on the front lines to receive 
health care from the HP where they were enrolled before becoming soldiers. 
The objective was to privatize part of the services in response to the shortage 
of physicians in the Medical Corps. Soldiers were allowed to receive primary, 
secondary and emergency care from their previous HPs and doctors. Dental, 
mental health and public health care were still provided by the Medical Corps. 
The project was suspended by the Ministry of Defence and Ministry of Health 
in 2014 because of concerns that HP physicians were too lenient about giving 
sick leave to soldiers (Maccabi Healthcare, 2015). There were also complaints 
that soldiers on the front lines were receiving lower quality health care (from 
the Medical Corps) than soldiers based in the rear (who received care from their 
HPs) (Cohen, 2014; Refuah, 2014).
3.6.2 External sources of funds
The health care system benefits from two sources of external funding. First, 
there are major donations from individuals (mostly Jews) residing in other 
countries, primarily the United States and western Europe, along with donations 
from Israeli philanthropists. These often play an important role in funding 
capital expenditure for new buildings, renovations and the acquisition of major 
equipment. In 2012, donations represented 2% of THE (CBS, 2015). Second, 
research grants from foreign governments and pharmaceutical firms are key 
in the financing of clinical and preclinical research.
3.6.3 Other sources of financing
Financing of LTC
Institutional LTC for individuals requiring skilled nursing care is generally 
the financial responsibility of the patient and/or her/his family. If they lack the 
necessary financial resources, they may receive funding assistance from the 
Ministry of Health, on a sliding-scale basis. The Ministry of Social Affairs 
provides partial funding for low-income elderly individuals who require less 
intensive forms of institutional care. Several years ago, the Ministry of Health 
proposed to add institutional LTC to the NHI benefits package, but the effort 
was not successful.
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Community-based LTC is financed in part by the government through the 
Community Long-term Care Insurance (CLTCI) Law, which is administered 
through the NII. This primarily finances assistance with activities of daily 
living for the elderly living in the community. Eligibility is conditional upon 
income level, and the amount awarded is determined by the age, disability level 
and living arrangements of the elderly person concerned.
In 2014, 54% of adults (aged over 22 years) in Israel reported having some 
form of LTC insurance, a rate that is quite high by international standards 
(Brammli-Greenberg & Medina-Artom, 2015). The ownership of LTC 
insurance might even be higher than the reported rate, as some of the insurees 
are not aware of their ownership (Waitzberg & Brammli-Greenberg, 2012). 
These insurance packages provide assistance for both community-based and 
institutional care. However, the coverage provided by many of these policies 
is significantly lower than what is needed for an extended stay in a very good 
facility. Therefore, in many cases, even when the person in need has LTC 
insurance, his/her family members ultimately become involved in the financing 
and provision of LTC services.
Currently, a significant share of LTC insurance is provided by group policies 
that the HPs have negotiated with commercial insurers for their members. This 
is a unique Israeli solution to the lack of public LTC insurance.
Dental health for adults
Dental health for adults and children older than 12 years is not included in 
the NHI benefits package and is financed privately either through direct OOP 
payments, or by VHI.
3.7 Payment mechanisms
3.7.1 Payment for health services13
This section discusses in turn payment for health services in general hospitals, 
psychiatric hospitals or psychiatric wards in general hospitals, public mental 
health clinics in the community, public health services, dental care and 
pharmaceutical care (Table 3.6).
13 Vadim Perman and Boaz Aricha contributed important information and insights for this chapter.
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Table 3.6
Provider payment mechanisms
Providers/
payers
Ministry 
of Health
HPs Other ministries Private/voluntary 
health insurers
Cost-sharing
GPs Salary + capitation FFS
Ambulatory 
specialists
Salary + capitation FFS yes
Other ambulatory 
provision
FFS FFS FFS yes
Acute hospitals PD + PRG + FFS PD + PRG + FFS 
(Ministry of 
Defence)
FFS (private 
hospitals only)
Other hospitals PD + FFS PD + FFS FFS
Hospital outpatient FFS FFS yes
Dentists Salary + FFS 
(children 
<12 years)
FFS
Pharmacies FFS FFS yes
Public health 
services
Salary Salary FFS
Social care Salary (for 
inpatient)
Salary (CLTCI, via 
NHI for community 
care)
FFS yes
Notes : FFS – Fee-for-service, PRG – Procedure-related groups, C – capitation.
General hospitals
Approximately 80% of general hospital revenue comes from sales of services 
to HPs. Other sources of revenue include the IDF Medical Corps, private 
insurers, the NII, the Ministry of Health and OOP payments. This section 
focuses on revenue from the sale of services to the HPs and on arrangements 
in what are referred to in Israel as “public hospitals”, comprising both 
government and non-profit-making hospitals (these include Clalit HP hospitals, 
non-profit-making “mission” hospitals, and other such as the Hadassah 
Medical Organization).
 Since the enactment of the NHI Law in 1995, public hospitals in Israel are 
reimbursed for inpatient care primarily by per diem fees and secondarily by 
case payments. Ambulatory care in hospitals is paid on a FFS basis (Fig. 3.10). 
Maximum price lists for public and non-profit-making hospitals are mandated 
by law and set by the government through a joint Ministry of Health and 
Ministry of Finance Pricing Committee. Government hospitals are subsidized 
by the government retrospectively.
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Fig. 3.10
Distribution of gross income for governmental hospitals by type of service provided 
and type of reimbursement, 2012 
Source : Ministry of Health, 2014c.
Until 2010, Ministry of Health price lists were not based on a methodical 
costing process. Per diem and FFS rates were set about three decades earlier 
based on the historical expenditure of certain hospitals. Since then, rates had 
been updated for inflation, but no major recalculations were undertaken despite 
significant changes in cost structure from technical and medical advances. 
Consequently, some activities were underpaid and others overpaid. The gaps 
between costs and prices create a series of inefficiencies caused by the influence 
of economic considerations on medical decisions.
In order to tackle these inefficiencies, the Ministry of Health concluded 
that it was important to narrow the gap between costs and prices through two 
changes: building a consistent costing and pricing mechanism and substituting 
the per diem payments with payments based on activity. The Ministry of Health 
thus initiated a hospital payment reform (the PRG reform), which consisted of 
gradually costing hospital activities and setting differential pricing for inpatient 
care per procedure. Once the price for a specific procedure has been set, the 
per diem payment is replaced by the PRG. This process has been an ongoing 
incremental reform that started in 2002 and has been enhanced since 2010 by 
the Ministry of Health. In 2015, there were over 280 PRGs, which account for 
half of the procedures. The plan is to adjust the PRG for case mix and severity 
of illness in the future (Brammli-Greenberg et al., in press).
Other
2%
Ambulatory
care – FFS
21%
Births
(NII rates)
8%
Inpatient
care – PRG
23%
Emergency
care – FFS
6%
Inpatient care
– per diem
40%
Health systems in transition  Israel78
The Fee-for-service charge list in outpatient care. A FFS charge list established 
by the government regulates payment for hospital outpatient care in ambulatory 
clinics and EDs. The list includes 1500 rates for ambulatory care and about 
65 rates for day hospitalizations. The day hospitalization component has been 
increasing as technologies improve and allow procedures to be performed 
with no need of overnight stays. Payment for outpatient department services 
accounts for approximately 20% of hospital revenue; emergency care accounts 
for an additional 6% (Fig. 3.10).
The per diem rate. Two thirds of inpatient admissions are reimbursed on a 
per diem basis; they account for half of the interventions performed. In 2015, 
there were about 50 per diem rates, which differ according to the department 
(e.g. intensive care units are higher than the standard rate, while geriatric and 
mental health units are lower) and period of hospitalization (the first three 
days are more costly that the fourth and so on). In a few specific cases, there 
are different rates by age (e.g. intensive care for children younger than 4 years).
Case payments, Procedure-Related Groups. During the 1990s, differential 
case payments were established for about 30 types of admission. The 
defining characteristic of the case is the principal procedure carried out 
(rather than the diagnosis, as is the case in countries using a diagnosis-
related group systems). Since 2010, the range of conditions for which 
case payments have been established (as an alternative to per diem 
reimbursement) has significantly increased. In mid-2015, case payments 
accounted for approximately 23% of total hospitals revenues, and 33% 
of hospital inpatient revenues (Brammli-Greenberg et al., in press).
The revenue cap
A significant proportion of a hospital’s expenditure is fixed and does not vary 
according to the volume of hospital activity. The prices HPs pay for services 
purchased from hospitals reflect “average prices”, which include fixed costs 
and are, therefore, higher than the marginal cost of the service purchased. 
A payment scheme that relied solely on these average prices would have 
created incentives for hospitals to increase volume (either hospitalization 
days or procedures), which would have led to increases in HP expenditure on 
hospitalization services, increases in public expenditure on health, and might 
even have led to moral hazard. In order to remove this incentive, a hospital 
revenue cap was established in 1997, and the rules of the capping regime are 
modified every three years. The capping system’s goal has been to eliminate 
incentives for hospitals to overprovide inpatient care, and to constrain growth 
in expenditure, particularly that related to hospital services.
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A revenue cap is set by the government for each hospital vis-à-vis each 
HP; since 2014, this is not published publicly. It is a function of the previous 
year’s HP’s consumption in each hospital plus an adjustment to reflect projected 
demographic growth, hospital bed growth, and price change (in particular, the 
Ministry of Health’s PRG price list and per diem rates).14
The model set in 2013 for the years 2014–2016 is innovative in relation to 
previous ones in that it sets a minimum for the total amount that each HP will 
pay each hospital each year (95% of the previous year’s consumption by the HP). 
This is done to financially protect the hospitals. In addition, the current capping 
system has three steps, each with different payment rates and incentives. HPs 
that purchase services beyond the cap pay the cap plus a percentage of the price 
of those services purchased beyond the cap.15
Individual agreements set between hospitals and health plans
HPs and hospitals also are allowed to negotiate alternative reimbursement 
contracts, which, if both sides agree, can take the place of the official cap. This 
is intended to allow greater flexibility and risk sharing among players. Since 
the early 2000s, HPs have set individual arrangements with more than 80% of 
hospitals, in which the hospitals provided bigger discounts than the capping 
mechanism. The individual contracts provide discounts that vary among HPs 
and among hospitals.
By virtue of its role as the owner of the government hospitals, the Ministry of 
Health reviews and approves all contracts with the government hospitals. Until 
recently, the Ministry did not play a significant regulatory role in determining 
the nature of contracts signed by other hospitals. It was felt that this would not 
be appropriate, since the Ministry, as the owner of its own hospitals, is also 
competing with those other hospitals. However, in recent years, the Ministry 
of Health has been more active in this regard.
Additional considerations
Despite the reimbursement mechanisms, the Ministry of Health subsidizes 
retrospectively almost all public hospitals. Subsides have more than doubled 
in the last decade (from around €75 million in 2006 to €170 million in 2012) 
(Ministry of Health, 2014c). Nevertheless, both public and non-profit-making 
hospitals have faced growing deficits in recent years. The extreme case of this 
14 The cap set for 2014–2016 was the gross spending in the previous year (i.e. disregarding individual discounts 
given by each hospital to each HP under individual agreements), added to 0.8% for demographic growth, 
0.6% for hospital bed growth, and increases in Ministry of Health’s list prices for the coming year.
15 From the cap (100%) up to 102%, HPs pay the cap plus 70% of the price of the services; from 102% to 112% 
of the cap HPs pay no more than 33% of the price; above 112% of the cap HPs pay up to 65% of the price.
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was the near-bankruptcy of the private non-profit-making Hadassah Medical 
Center in 2014. The hospital did not break-up because the Ministry of Health 
provided massive financial aid and increased the cap ceiling.
Psychiatric hospitals or psychiatric wards in general hospitals
From the mental health reform in June 2015, HPs purchase psychiatric services 
from psychiatric and general hospitals. Payments for the services are based 
mainly on per diem fees. Similar to other hospital services, prices are set by 
the Ministry of Health. In addition, similar to other hospitals services, the 
government sets maximum revenues caps for each hospital for each HP 
(Levi, 2013). There are two main differences between the physical health and 
the mental health cap: (1) there is no required minimum of payment from 
HPs for mental health service, in order to encourage HPs to divert care from 
mental health hospitals to the community; and (2) there are two cap ceilings 
that contain the increase of expenditure on mental health inpatient care by 
eliminating any incentives for hospitals to increase volumes beyond those prior 
the mental health reform.
In addition, HPs and hospitals are allowed to make further arrangements 
instead, or in addition to, the capping mechanism, similar to the discounts that 
hospitals provide the HPs for the services of general hospitals.
Public mental health clinics in the community
Until June 2015, the Ministry of Health provided and funded directly mental 
health services through its own clinics. Since that date, HPs are the providers 
and purchasers of mental health services and can purchase these services 
from the Ministry of Health-operated community clinics, which provide 
outpatient psychosocial services such as psychotherapy, group therapy, mental 
health rehabilitation (post hospitalization), social work, and pharmacological 
management and follow up (Ministry of Health, 2015b). For each patient, the 
HP will pay the mental health clinic for two initial “diagnostic” visits. Then 
HPs will pay prospectively for the treatment itself according to a treatment plan 
set by the clinic, which is a function of the diagnosis. There will be different 
treatment rates based on (1) age (children and adults), (2) average length of 
treatment (short or long term), and (3) type of treatment (individual or group).
Public health services
In Israel, the main public health service that is included in the NHI benefits 
package is the preventive care clinics for early childhood and pregnant women 
(Tipat Halav). There are about 1000 such clinics, many of which are owned by 
the Ministry of Health. HPs also own some of the clinics, mainly in towns and 
rural areas, as do several municipalities, such as Jerusalem and Tel Aviv.
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The Ministry of Health provides preventive care directly through its own 
clinics and purchases services from municipality and HP clinics. The Ministry 
of Health reimburses municipalities for 70% of their expenditure. For HP clinics, 
the Ministry of Health provides vaccines free of charge and partially reimburses 
them retrospectively (based on pay for performance) for services provided.
Dental care
Since 2010, dental care for children up to 12 years of age is provided within 
the NHI health basket. HPs are reimbursed prospectively for this type of 
service based on the number of children under 12 years of age in each HP. 
This capitation payment for paediatric dental care is separate from the main 
NHI capitation payment.
Pharmaceutical care
As pharmaceuticals are a part of the NHI benefits package, the HPs receive 
funding for them via the main capitation formula. They also charge coinsurance 
from insurees (see section 3.4). HPs purchase pharmaceuticals directly from 
manufacturers. Each HP negotiates prices vis-à-vis each manufacturer.
3.7.2 Paying health workers
Payment of physicians
In Israel, most physicians work as salaried employees of the HPs or the 
non-private hospitals; many others work as independent contractors for 
these institutions. A collective bargaining agreement between the IMA and 
the major employers governs the payment terms for employed physicians in 
those institutions. Physicians working independently are not covered by the 
agreement and instead are engaged via individual contracts.
Community-based services
In Clalit, the PCPs who are employees are paid on a monthly salary basis 
plus a capitation fee for each patient on the PCP’s roster beyond the norm 
(which reflects the number of patients, their age and their health status); this is 
referred to in Israeli as passive capitation as it does not depend on whether the 
member visited the PCP. Independent PCPs are paid on a straight capitation 
basis. Specialists are paid on an active capitation basis (i.e. a set amount for each 
patient who visits during a quarter-year, irrespective of the number of visits) 
plus FFS payments for various procedures (according to a set fee schedule) up 
to a quarterly ceiling.
Health systems in transition  Israel82
In Maccabi, the majority of physician (over 80%) are independent 
contractors. Both PCPs and specialists are paid on an active capitation basis 
plus FFS for various procedures, with the FFS component being a large share 
of compensation for the specialists.
In Leumit, the employed PCPs are paid on a passive capitation basis 
(i.e. irrespective of whether patients visited during the most recent quarter-
year). Specialists and the relatively small number of Independent PCPs are paid 
on active capitation basis, as were employed PCPs until recently.
Meuhedet uses a mix of these reimbursement systems.
Hospital services
In the government and non-profit-making hospitals, physicians generally work 
on a salaried basis, and for most such hospitals the terms are specified in the 
collective bargaining agreement. Salary levels are primarily a function of 
role (resident, board-certified specialist, department chair, etc.) and years of 
work experience.
In addition, some physicians (usually surgeons) in Ministry of Health 
hospitals are given the opportunity to work beyond the standard working 
hours for premium pay, which can be either in the form of an hourly rate or a 
per procedure rate. In the Clalit hospitals, there is a similar arrangement. In 
the Hadassah hospitals, physicians can also receive additional FFS payments 
for treating patients enrolled in the private medical service programme 
(see section 3.4.2).
In Assuta, a network of private hospitals owned by Maccabi, surgeons 
are not paid through the hospital but are typically paid on a FFS basis by 
patients’ private insurance programmes. Assuta pays other physicians, such 
as radiologists and anaesthetists, on either a salaried or FFS basis. Similar 
arrangements are in place in many of the other profit-making hospitals.
Physician pay levels
According to OECD health database, Israeli physicians’ annual salaries have 
risen significantly in recent years (OECD, 2015). For example, for board-
certified specialists employed by the Ministry of Health or Clalit, annual 
salaries have increased by approximately 50% (in dollar exchange rate terms) 
between 2010 and 2014. This rate of increase was unusual among the countries 
for which data are available.
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The OECD data also suggest that Israeli specialists are currently reasonably 
well-paid in comparison with their counterparts in most OECD countries, both 
in dollar terms and relative to the average wage in the country. However, any 
international comparisons of income levels should be treated with great caution 
because of differences in measurement methodology and differences in tax 
rates (which in Israel are relatively high).
The new financial incentives
In 2011, major new financial incentives were put in place to encourage physicians 
to live and work in the periphery and to pursue careers in distressed specialties.
The agreement provided for an immediate 10% addition to the ongoing 
monthly salaries of residents working in the periphery, with the size of the 
addition increasing to 25% by 2013. Similarly, in the case of board-certified 
physicians, who are not hospital directors or deputy directors, the agreement 
provided for an immediate increase of 8%, growing to 17% by 2013.
The agreement also awarded one-time payments to all physicians who begin 
working in the periphery; the size of these payments is NIS 500 000 (about 
€125 000) in the case of distressed specialties and NIS 300 000 (about €75 000) 
in other specialties. Initially, the payments are awarded as interest-free loans, 
but if the physician remains in the periphery for a specified number of years, the 
loans are transformed into grants that do not have to be repaid. To put the size 
of these payments into perspective, it is worth noting that the average annual 
income of Israeli physicians is approximately NIS 300 000 (about €75 000) and 
the median is approximately NIS 240 000 (about €60 000).
Physicians working in distressed specialties (such as anaesthesiology), 
irrespective of where they work, also received substantial bonuses; some 
observers believe that these bonuses have reduced somewhat the power of the 
incentives created for working in the periphery.
The number of physicians applying for the bonuses has been substantially 
greater than originally anticipated, creating substantial budgetary pressure. As 
a result, by the end of 2014 the allocated budget of about NIS 700 million that 
had been planned to last until 2019 had been exhausted.
At the beginning of 2015, the Ministry of Finance agreed to allocate an 
extra NIS 75 million (about €18 million) for bonuses for residents only, for one 
more year. This sum is considerably lower than what had been spent per year in 
previous years. In accordance, the number of distressed specialties receiving a 
bonus has been reduced, and residents working in the periphery will not receive 
a bonus unless working in a distressed specialty (in which case their bonus will 
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be higher than that of their colleagues working in the centre). The size of the 
payments will be decided in 2016, contingent on the number of residents who 
will be eligible for the bonuses.
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4. Physical and human resources
Israel is characterized by a low bed-to-population ratio, an extremely low average length of stay in hospital, a mid to high rate of admissions per 1000 population, and a high (compared with the OECD average) occupancy 
rate in acute care hospitals. The low bed-to-population ratio is the result of 
deliberate government policy to shift as much care as possible to community 
settings and to contain costs. The bed-to-population ratio is higher in the centre 
of Israel than in the periphery. Most of the beds are operated either by the 
government or by Clalit. The Ministry of Health has gone through an extensive 
process to assess the need for additional beds, which found a serious need for 
expansion, particularly in the periphery. In mid-2015, the implementation of a 
national bed expansion plan was under way, including the establishment of two 
new hospitals in the southern periphery. 
As of 2014, Israel had relatively few computed tomography (CT) and MRI 
units on a population basis, but these devices were being used intensively; in 
2015 a major government initiative was launched to increase the availability of 
these diagnostic devices. Regardless of the potential purchaser, many types of 
medical equipment require Ministry of Health approval.
In 2014, the Ministry of Health launched a national health information 
exchange for sharing clinical patient data across all general hospitals, HPs and 
additional providers.
Historically, Israel had a very high physician-to-population ratio but this 
ratio has seen a marked decline. By 2012, Israel’s rate and the OECD average 
converged, and at that time the rate for Israel was projected to decline even 
further. Recently, several concrete steps were taken to expand the overall supply 
of physicians, the number of newly licensed physicians has reached a record 
high, and Israel’s rate has not fallen below the OECD average.
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The nurse-to-population ratio has been decreasing and is lower than the 
average for the 15 Member States of the European Union (EU) before May 2004 
(EU-15). Recently, several policy measures have been undertaken to increase 
the supply of nurses, which are beginning to prove successful.
Since the early 2000s, the dentist-to-population ratio has declined, but it is 
still slightly above the EU-15 average. In contrast, the pharmacist-to-population 
ratio has increased markedly and is now similar to the EU-15 average.
4.1 Physical resources
4.1.1 Capital stock and investments
In 2013, Israel had 45 general (acute) hospitals, with approximately 15 300 beds; 
13 psychiatric hospitals, with approximately 3500 beds; 28 chronic disease 
hospitals and 287 nursing facilities, with approximately 25 000 beds (Table 4.1). 
This section focuses on general hospitals.
Table 4.1
Overview of hospitals in Israel, 2013
Total 
hospitals
General (acute) 
hospitals
Psychiatric 
hospitals
Chronic disease 
hospitals
Rehabilitation
Institutions 373 45 12 314 2 
Beds 44 627 15 340 3 425 24 799 703
Beds per 
1 000 population
5.44 1.89 0.42 3.05 0.09 
Source : Ministry of Health, 2014d.
Almost half of all acute hospital beds (47%) in Israel are located in hospitals 
owned and operated by the government. Another 30% of the acute beds can 
be found in hospitals owned and operated by Clalit. Approximately 3% of 
acute beds are located in private profit-making hospitals and the remaining 
acute beds are to be found in church-affiliated and other voluntary, non-profit-
making hospitals. Virtually all hospital physicians are directly employed by 
the hospitals. The exception is the private profit-making hospitals, in which 
most physicians work as independent practitioners with admitting privileges. 
Interestingly, several of the private hospitals (the Assuta chain) are owned by 
the Maccabi HP as a profit-making subsidiary, and another private hospital 
(Herzliya Medical Center) is partly owned by the Clalit HP.
Health systems in transition  Israel 87
While Israel does have a few small “single specialty” hospitals, particularly 
in the maternity field, the vast majority of the country’s hospital beds are located 
in general hospitals. Almost all Israeli hospitals have university affiliations and 
operate training programmes for medical students, interns and residents. The 
range and depth of these university affiliations varies. Of Israel’s 45 general 
hospitals, six have been recognized as supraregional hospitals and they tend to 
have the greatest concentration of research and training activities, as well as 
being centres for complicated and expensive treatments.
While the number of beds in private hospitals is fairly stable, the leading 
private hospitals have recently undergone serious modernization and upgrading 
of their facilities, supporting their capacity to increase the range and number of 
operations they are able to perform. In these private hospitals, care is covered 
via a mix of OOP payments, commercial insurance and supplemental insurance. 
Patients are able to exercise a great deal of choice with regard to the surgeon, the 
anaesthetist and, where applicable, the medical equipment to be used (such as 
the grade of implant to be used). The upgrading of these facilities has aroused 
concerns in the public hospitals that they will lose both staff and patients.
4.1.2 Infrastructure
Israel’s 45 acute hospitals are spread throughout the country. In 2012, the overall 
general care bed-to-population ratio was 1.9 per 1000 population. As in other 
countries, the bed-to -population ratio is higher in the centre of the country than 
in the periphery, ranging from 1.4 in the southern region to 2.6 in the Haifa 
region. Even so, the vast majority of the population lives within an hour’s drive 
of a hospital. All the hospitals tend to have up-to-date medical equipment and 
provide specialty services. There is more variation with regard to the physical 
buildings themselves, although several major modernization efforts have been 
undertaken in recent years.
Compared with other OECD countries and the EU and EU-15 averages, 
Israel is characterized by a low bed-to-population ratio (Fig. 4.1), an extremely 
low average length of stay (Fig. 4.2), a mid-to-high rate of admissions per 
1000 population, and a high occupancy rate (Fig. 4.3). The low bed-to-population 
ratio is the result of deliberate government policy based on the view that care 
should be provided in community settings when it is possible to do so and on the 
assumption that the greater the number of beds, the larger the hospital’s share 
of total health resources. There is also recognition that Israel’s relatively young 
population and its well-developed community services make it possible to 
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maintain a relatively low bed-to-population ratio. Budget constraints have also 
played an important role. Interestingly, there is a growing discrepancy between 
the official number of beds, and the number of beds actually in operation.
Fig. 4.1
Acute care hospital beds per 100 000 population, 1990–2012 
Source : WHO Regional Office for Europe, 2015.
Fig. 4.2
Average length of stay, acute care hospitals only, 1990–2012 
Source : WHO Regional Office for Europe, 2015.
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Fig. 4.3
Bed occupancy rate, acute care hospitals only, 1990–2012 
Source : WHO Regional Office for Europe, 2015.
The Ministry of Health has gone through an extensive planning process to 
assess the need for additional beds. It determined that there is a serious need 
for expansion, particularly in the periphery. A national bed expansion plan 
was developed and approved by the Ministry of Health and implementation is 
under way.
Until recently, no new acute care hospitals had been established in Israel 
for many years. This is beginning to change. A major new hospital is being 
built in Ashdod, which will be in part public and in part private. In addition, 
the government has recently decided to establish a new (second) hospital in 
Beersheba, in the country’s Southern District.
In recent decades, the average length of stay has declined dramatically, from 
6.8 days in 1980 to 4.0 days in 2012, and has been relative stable since 1997. 
Similarly, the discharge rate increased dramatically from its 1980 level of 145 per 
1000 population to 177 in 1995, and stabilized thereafter, with a level of 163 in 
2012. The number of acute care hospital beds per 1000 population continues 
to decline and in 2012 it was below 1.9 per 1000 (Fig. 4.1 and Table 4.2). As 
the decline in average length of stay has been greater in percentage terms than 
the increase in admission rates, the rate of patient days per 1000 population 
has declined. The volume of day care and ambulatory surgery has increased 
dramatically since the mid-1990s.
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Table 4.2
Trends in acute hospitals, 1980–2012
1980 1985 1990 1995 2000 2005 2010 2012
Beds (per 1 000 population) 2.95 2.83 2.53 2.33 2.23 2.09 1.91 1.88
Discharge rate 
(per 1 000 population)
145 148 157 177 175 173 172 162
Patient days 
(per 1 000 population)
991 911 834 815 761 728 685 662
Average stay (days) 6.8 6.1 5.3 4.5 4.3 4.2 3.9 4.0
Bed occupancy rate (%) 0.90 0.90 0.88 0.95 0.93 0.96 0.98 0.96
Source : Ministry of Health, 2014d.
Since the outbreak of the intifada in September 2000, and even more so in 
the wake of more recent rocket and missile attacks on civilian population centres 
emanating from Gaza and Lebanon, hospitals have had to mobilize to care for 
the casualties, including victims of shock, which requires an increase in both 
medical and psychiatric services. because other threats to the population persist, 
hospitals continue to prepare for a range of potential emergency situations. This 
includes staff training, the development of protected facilities and a broad range 
of additional measures.
4.1.3 Medical equipment, devices and aids
There are seven different types of medical equipment, the acquisition of which 
requires Ministry of Health approval – irrespective of whether the potential 
purchaser is a governmental agency, a non-profit-making provider or a profit-
making provider. The devices requiring approval are CT, MRI and positron 
emission tomography scanners; gamma cameras, pressure chambers; linear 
accelerators; and angiography devices. Regulations adopted in 1994, and 
subsequently amended, set national ceilings for each of these devices, in terms 
of units per million population. The Ministry of Health must also decide how 
to allocate these national quotas among providers (in response to applications 
for purchase approvals) and (implicitly) among regions. To some extent, the 
considerations are detailed in the regulations, but there remains ample room for 
taking into account additional factors (Tal, Sheffer & Vaknin, 2008).
With regard to CT scanners, Israel had 9.2 devices per million population 
in 2012, which is relatively low by international standards, but which is 
markedly higher than 6.2 reported in the 2009 Israel HiT (Rosen, Samuel & 
Merkur, 2009). While it is about mid-way between the rates for the United 
Kingdom (8.1 per million) and the Netherlands (10.9), it is much lower than the 
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rates for the United States (over 40 per million) and Denmark (approximately 
30 per million). The OECD average is approximately 20 per million (2012). 
Note, however, that the CT units in Israel are used particularly intensively, so 
that it has about 15 000 scans per year compared with about 7300 for the OECD 
countries on average.
With respect to MRI devices, Israel had only 3.0 units per million-population 
in 2012, well below the comparable figures for the United States (34.5), the 
Netherlands (11.8), and even the United Kingdom (6.8). The OECD average 
is 14.0. Here too, utilization in Israel is particularly intensive, with 9200 scans 
per year compared with about 5300 for the OECD countries on average.
4.1.4 Information technology16
In 2014, the Ministry of Health launched a national health information exchange 
for sharing clinical patient data across all of Israel’s general hospitals, its four 
HPs and additional health care providers. This provides Israeli clinicians 
with the world’s first national data exchange programme, enabling secure 
authorization-based sharing of clinical data among caregivers. In particular, 
the system facilitates the flow of information between hospital-based providers 
and providers based in the community. Citizens can utilize the “opt-out” feature 
if they do not wish for their data to be accessible.
Additional significant developments over the last few years have been in the 
mobile and videoconference arenas. All of the health funds provide extensive 
mobile applications, striving to emulate what they already offer in a web 
setting. Services include booking appointments with all clinicians, specialists, 
dieticians and therapists; accessing full laboratory results and laboratory history 
going back over 10 years, and ordering recurring prescriptions and medications 
with their complete history. Patients can view relevant imaging, can request 
confirmation and make payment for procedures carried out at other providers, 
and can check their vaccination history. Another major improvement has been 
the secure e-mail connection to PCPs, thereby eliminating unnecessary visits 
for routine items or to ask a question. In summary, patients are able to initiate 
end-to-end health care-related interaction cycles, both clinical (e.g. e-visits and 
e-prescriptions) and administrative (e.g. billing), through a secure, personal 
health account.
Clalit has implemented a highly popular “doctor online” video conferencing 
service that connects patients with “on-call” paediatricians backed up by 
the children’s hospital. With over 4 million members, there have been half 
16 This section was prepared in collaboration with Phillip Libman.
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a million web site accesses (i.e. visits) in a typical month, with 40% via the 
cellular application. A 100 000 appointments are booked online per year. A new 
initiative allows for doctors to send out relevant health care materials by e-mail 
in conjunction with a patients’ visit, and this has reached a million e-mailings 
per year. New data-mining initiatives have been used, for example to identify 
hospital patients who are most at risk for re-hospitalization, and this initiative 
has reportedly lowered re-admissions.
Macabi has greatly expanded its videoconferencing services for patients 
needing chronic care, especially those served by relatively small clinics in the 
periphery. Services offered include wound care for diabetics, who are looked 
after by a dedicated local nurse with specific instruction from the specialist. 
Other areas covered include endocrinology, dieticians and hypertension. There 
is a mobile application for pregnancy that is linked to the patient’s clinical 
data, allowing for greater connectivity and follow-up and immediacy with the 
patient’s status. A new rules-based system issues relevant alerts based on a 
patient’s age and health status for preventative medicine initiatives, such as 
faecal occult blood testing.
Of Macabi’s over 2 million members, 85% are registered on their Internet 
site with well over 10% using it monthly. Maccabi has also set up an internal 
messaging and video conferencing system for its physicians, allowing for 
greater and timely communication and consultations. Also significant has 
been Maccabi’s MOMA project, to provide sophisticated and ongoing care 
at a distance for members living at home with multiple and/or complex 
chronic conditions.
The Ministry of Health’s NAMER project, one of the largest hospital 
administration information systems projects in Israel, has continued to extend 
its reach in 10 general hospitals. It provides admissions/transfers/discharge 
data, billing, ward management, patient acceptance and discharge capabilities. 
In addition, it is tied into a picture archiving and communication systems, 
operating rooms, laboratory and local hospitals/electronic medical records and 
has a module for multicasualty incidents. The biggest advance has been in 
the implementation of a clinical electronic medical record system, which has 
been implemented in eight hospitals and in 80 wards, resulting in “pen-less” 
wards. The system enjoys a unique backup system which ensures that, should 
a disaster occur and the hospital’s generator and disaster-recovery system are 
down or inaccessible, each ward can continue to operate for four hours on its 
own power.
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The Clalit Research Institute has developed innovative approaches to using 
clinical and other data (big data) in daily patient care, focusing on new models 
of preventive care that were widely adopted at Clalit.17
Israel’s achievements in the health information technology area are due in 
part to its highly organized system of health care and in part to its position as 
an international centre for high-technology start-ups.
4.2 Human resources
This section presents trend and comparative data for a variety of health 
professions. The trend data rely primarily on Israeli sources, which relate to 
licensed professionals up to age 65 (as in Table 4.4), while the comparative 
data rely primarily on Health for All data (WHO Regional Office for Europe, 
2015) regarding employed professionals (as in Table 4.3). Naturally, there are 
differences between these two variables, as not all licensed professionals under 
age 65 are employed, and some licensed professionals continue to work beyond 
age 65.
4.2.1 Health workforce trends
Tables 4.3 and 4.4 summarize the changes in the health worker-to-population 
ratios since the 1980s.
Table 4.3
Health workers in Israel per 100 000 population, 2000–2012 (employed professionals)
 2000 2005 2010 2012
Physicians 344.51 321.78 332.30  
Physicians, medical group of specialties   85.88 85.43
General practitioners   25.37 25.52
Nurses 566.32 544.36 491.90  
Midwives 23.07 21.04 20.99 22.00
Dentists 79.50 81.28 83.52  
Pharmacists 63.60 64.93 75.20  
Source : WHO Regional Office for Europe, 2015 (at April 2014).
Note : n/a: Not available.
17 The Institute was designated in 2014 as the WHO Collaborating Centre for Non-Communicable Disease Research 
Prevention and Control, and is involved in various planning efforts mainly in the WHO European Region.
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Table 4.4
Licensed health professionals up to 65 years of age per 1000 population, 1980–2013
1980 1990 2000 2005 2010 2013
Physicians 2.28 2.71 3.44 3.40 3.25 3.11
Physicians, medical group 
of specialties
0.74 1.19 1.50 1.67 1.77 1.73
General practitioners 1.54 1.52 1.94 1.73 1.48 1.38
Nurses, all n/a n/a 6.49 6.43 6.08 5.79
Nurses, registered n/a n/a 4.09 4.61 4.81 4.80
Midwives n/a n/a n/a n/a n/a n/a
Dentists 0.49 0.90 1.05 1.03 1.02 1.00
Pharmacists 0.36 0.44 0.58 0.66 0.78 0.80
Source : Ministry of Health, 2014i.
Notes : aUp to 65 years of age; n/a: Not available.
Physicians
The physician-to-population ratio has been relatively stable during the 1990s 
at 3.6–3.7 physicians up to age 65 per 1000 population, followed by a gradual 
decline to 3.3 per 1000 in 2012 (Fig. 4.4). This is in contrast to major changes 
that took place in this ratio during the previous decades and the changes being 
projected for the years ahead. There is substantial variation in the practising 
physicians-to-population ratio across regions; it ranges from 2.2 per 1000 in 
the north of the country to 4.4 in Tel Aviv.
Fig. 4.4
Physicians per 1000 population in Israel and selected countries, 1990–2012 
Source : WHO Regional Office for Europe, 2015.
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Until recently, Israel had one of the highest physician-to-population ratios 
in the world; even in 2006, it was still approximately 20% higher than the 
OECD average. After 2006, while the ratio continued to decline in Israel, it 
continued to increase in most OECD countries. By 2012, Israel’s rate (3.30) 
and the OECD average (3.25) had essentially converged. When compared with 
EU-15 countries the physician-to-population ratio is somewhat low (Fig. 4.5); 
it has been trending downward in Israel, while it has been increasing among 
EU-15 countries. Recently, Israel has taken several concrete steps to expand 
the overall supply of physicians and to channel more physicians into peripheral 
regions and distressed specialties (see section 6.1.4). In 2014, the number of 
newly licensed physicians reached a record high, and Israel’s rate has not fallen 
below the OECD average.
With regards to specialist numbers, a Ministry of Health-appointed 
committee of experts found severe shortages of physicians in 2010 in the 
following specialties: anaesthesiology and critical care, neonatal care, child 
psychiatry, child development/neurology, geriatrics and physical/rehabilitation 
medicine. It also projected future shortages in the following specialties: 
pathology, internal medicine, family medicine and general surgery.
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Fig. 4.5
Number of physicians and nurses per 100 000 population in the WHO European 
Region, 2012 
Source: WHO Regional Office for Europe, 2015.
Notes: CARK: Central Asian Republics and Kazakhstan; CIS: Commonwealth of Independent States; EUR-A,B,C: Regions as in the 
WHO list of Member States, last available year; TFYR Macedonia: The former Yugoslav Republic of Macedonia.
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Nurses18
The nurse-to-population ratio is declining. In 2013, the ratio of nurses under 
age 65 to population declined to 5.79 per 1000 population, compared to 5.85 in 
2012 and 6.43 in 2005 – a decline of 10%. At the end of 2013, the ratio of state-
registered nurses (RNs) under 65 years of age was 4.80 per 1000 population, an 
increase of 4% from 2005. The percentage of RNs among all nurses in Israel 
below 65 years of age is on the increase – 83% at the end of 2013 compared 
with 63% at the end of 2000.
In 2012, the number of new nursing licences began to increase for the first 
time in a decade, following the intensive recruitment of nursing students and the 
awarding of grants. It is expected that the results of these efforts will continue 
to be evident in the coming years.
The percentage of young nurses has declined in the past decade. At the 
end of 2013, 40% were under 45 years, compared with about 48% in 2005; 
39% were aged 45–64 years (38% in 2005), and 21% were over 65 years (14% in 
2005). The percentage of male nurses is rising: 11.3% of the RN workforce were 
men in 2013, compared with 9.6% in 2005.
According to the CBS’s Labor Force Survey (CBS, 2015c), in 2012, 
38 000 nurses were employed in the civilian sector in Israel – 4.8 per 
1000 population – compared with 5.3 in 2005. The rate of employed nurses is 
low in the Southern District (3.3 per 1000 population) and Northern District (3.9) 
compared with the Haifa District (7.1), the Tel Aviv District (5.8), the Jerusalem 
District (4.7) and the Central District (4.6) (averages for 2009–2011). Three 
quarters of all nurses are employed in hospitals and one quarter in the 
community. This rate has been stable for the past two decades.
The nurse-to-population ratio in Israel is lower than the average for EU-15 
countries (Fig. 4.5) and has been decreasing in recent years (Fig. 4.6). Several 
policy measures have been undertaken recently to increase the supply of nurses, 
including the expansion of accelerated nursing degree programmes for people 
with bachelor’s degrees in other fields.
18 This section and others about nurses was prepared in consultation with Shoshana Riba and Ruth Rotstein.
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Fig. 4.6
Nurses per 1000 population in Israel and selected countries, 1990–2012 
Source : WHO Regional Office for Europe, 2015.
Dentists
The ratio of dentists (up to age 65) to the population has declined somewhat 
since the early 2000s, with the number of working age dentists per 1000 
dropping from 1.12 in 2000 to 1.00 in 2013. Approximately 40% of working-
age dentists are women.
At the end of 2013, 9% of all working age dentists were specialists in Israel 
and 30% of these were women. The three largest groups of dental specialities 
are prosthodontics (19% of all specialists); orthodontics (18%); and oral and 
maxillofacial surgery (16%). Recognition as a specialist is granted by the 
Scientific Council of the Israeli Dental Association. Other dental professionals 
include dental hygienists (whose numbers are increasing), dental assistants and 
dental laboratory technicians.
The vast majority of dentists in Israel work in private clinics or in group 
practices (Nefesh B’Nefesh 2008). Some dentists work in school dental services 
and are paid by the local municipality. The army employs dentists and conducts 
periodic dental examinations and a wide range of free treatments for soldiers. 
Dentists also practise in public clinics run by charitable societies. Other 
employment opportunities include kibbutzim and moshavim, where the dentist 
is not a member of the community but an employee (Nefesh B’Nefesh, 2008).
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Fig. 4.7 presents trend data on the dentist-to-population ratio in various 
countries. It is worth noting that Israel’s ratio is relatively high and that the 
ratios have been fairly stable for all the countries covered. The dentist-to-
population ratio in Israel is slightly above the average for EU-15 countries. 
That gap has been narrowing over time, primarily through an upward trend 
among EU-15 countries.
Fig. 4.7
Dentists per 1000 population in Israel and selected countries, 1990–2012 
Source : WHO Regional Office for Europe, 2015.
Pharmacists
The ratio of pharmacists (up to age 65) to 1000 population has grown from 
0.61 in 2000 to 0.80 in 2013. The percentage of pharmacists below the age of 
45 years has been growing since the mid-1990s. At the end of 2013, Israel had 
approximately 8000 licensed pharmacists, of whom 57% were under the age 
of 45 and approximately 15% were over 65 years. At the end of 2013, 58% of the 
pharmacists in Israel were women. Pharmacist’s scope of practice is expanding 
(see section 5.6).
Fig. 4.8 presents trend data on the ratio of pharmacists (up to age 65) to 
population in various countries. Note that Israel’s ratio is similar at the time of 
writing to that in most of the other countries covered; whereas in 1990 it was 
lower than most of those countries. Israel’s pharmacist-to-population ratio is 
similar to that of the average for EU-15 countries, after increasing markedly 
in recent years.
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Fig. 4.8
Pharmacists per 1000 population in Israel and selected countries, 1990–2012 
Source : WHO Regional Office for Europe, 2015.
Other health workers
In 2008, the Knesset passed laws regulating the work of physical, occupational 
and communication therapists; dieticians/nutritionists; clinical criminologists; 
chiropractors; podiatrists and surgical podiatrists.
Physiotherapists. There are about 0.5 physiotherapists up to age 65 per 
1000 population in Israel. Numbers are increasing and in 2013 the ratio 
was 1.6 times that in 2000. Many physiotherapists are employed in private 
frameworks, such as health care institutes, community centres, businesses 
and factories, sports teams and therapeutic swimming pools. Over 
2000 physiotherapists are employed in all the health funds, of them some 1500 
in Clalit. Around 700 are employed in general, rehabilitative and geriatric 
hospitals. The number of physiotherapists per 1000 population is similar to the 
rate in other Western countries.
Nutritionists. There are about 0.19 nutritionists up to age 65 per 1000 population. 
Again numbers are rising and in 2013 there was 1.4 times the ratio in 
2000. This ratio It does not differ substantially from the situation in other 
Western countries.
Speech therapists. There are about 0.35 speech therapists up to age 65 per 
1000 population; the 2013 ratio was 2.1 times that in 2000.
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Occupational therapists. There are about 0.42 occupational therapists up to 
age 65 per 1000 population; the 2013 ratio was 1.6 times that in 2000. In recent 
years, the demand for occupational therapy has grown, following its expansion 
into a variety of newer areas such as respiratory rehabilitation wards, subacute 
wards for young people, palliative care wards and national burn centres.
Psychologists. The number of psychologists is increasing. At the end of 2013, 
there were 1.16 psychologists up to age 65 per 1000 population (compared 
with 0.87 at the end of 2000); 73% are women. About a quarter (23%) of 
all psychologists are certified to work as instructors. In 2013, 54% of all 
psychologists were specialists and their number is rising. Specializations in 
psychology include clinical (57%), educational (27.7%), social–occupational–
organizational (4.2%), rehabilitative (4.2%), developmental (4%) and 
medical (3%).
CAM practitioners. The estimated workforce in CAM in Israel is more than 
20 000 practitioners who have completed a systematic training programme. 
Overall, half of all alternative treatments make use of traditional Chinese 
medicine, while the others use different methodologies. Some caregivers in 
Chinese medicine, in both the public and private sectors, are conventional 
physicians but many others are not.
Other accredited professions. These includes medical laboratory workers 
(0.8 per 1000 population), clinical geneticists (0.012) and optometrists (0.189).
In 2012, the Ministry of Health prepared projections of needs for several 
health professions. For physiotherapists, dieticians, speech therapists and 
occupational therapists, it appears that, overall, the supply is expected 
to increase substantially in the coming years and that there is no need to 
significantly expand training. However, in general, the availability of health 
professionals relative to the size of the population is lower in the north and 
south than in the centre of the country. Furthermore, some of these professions 
have seen movement from the public to the private sector, because of better 
income opportunities. The projections show that nationally there is no shortage 
but it is recommended that more attention be paid to certain geographical 
regions that have experienced difficulty in recruiting some types of 
health professional.
Further information on these health care professionals appears in the 
sections below and also in sections 2.5 and 2.8.3.
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4.2.2 Professional mobility of health workers
At the end of 2013, graduates from Israel constituted 41% of all physicians up 
to age 65 (up from 37% in 2006); other substantial groups were from eastern 
Europe (40%), western Europe and North America (15%), and Asia/Africa (3%). 
In 2013, there were 1011 new licences given, with the following distribution 
of place of graduation: Israel 41%; eastern Europe 34%; western Europe 10%; 
Asia/Africa 10%; and United States 4%.
About half of all working-age dentists are immigrants. In addition, many 
Israeli-born dentists travelled abroad for training, so that only 29% of all 
working-age dentists were trained in Israel, with 49% trained in eastern Europe, 
8% in western Europe, 7% in the United States, and 7% in Africa/Asia in 2013.
Among licensed pharmacists up to age 65, 53% were trained in Israel, 19% in 
Asian or African countries, 17% in eastern Europe, 8% in western Europe and 
3% in the United States. Since the early 2000s, there has been a major increase 
in the number of Israelis who go abroad to study pharmacy and then return 
to practise in Israel. Many of them are Israeli Arabs who study pharmacy in 
neighbouring Arab countries (particularly Jordan, Egypt and Syria).
Most (76%) psychologists up to age 65 were trained in Israel, with 12% 
trained in the United States, 5% in western Europe, 5% in eastern Europe and 
2% in Asia/Africa.
4.2.3 Training of health workers
Physicians
Israeli medical schools currently offer several pathways to a doctor of medicine 
degree. The most common pathway entails six years of study, of which the 
first three focus on the basic sciences and the latter three focus on clinical 
knowledge and skills, with one year of rotating internship and a submission 
of a scientific thesis. Entrance to that pathway does not require a bachelor’s 
degree. Another pathway is open to university graduates (with a bachelor of 
science degree) who have done significant coursework in the basic sciences, 
and it entails only four years of study in medical school. A third pathway is 
available to students who completed basic science studies in a medical school 
outside of Israel. These students can receive their medical degrees after 
completing an additional three years of clinical studies in an Israeli medical 
school. The distribution of students between the three pathways is currently 
approximately 80%, 15% and 5%, respectively.
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Most students enter medical school after completing their compulsory 
army service (two years for women and three years for men) or other voluntary 
assignments (i.e. a period of a “National Service”).19 A small number of students 
who have signed on to serve as physicians in the army after completing their 
medical studies can begin those studies immediately after high school.
Israel has a well-developed system of specialty training, with residencies 
lasting four years on average (with significant variation across specialties). 
Board certification is handled by the IMA’s Scientific Council in cooperation 
with the Ministry of Health and the various specialty societies. Typically, 
residents take their specialty examinations in two stages, with the first stage 
taking place after two years of residency and the second taking place after 
completion of the residency. Most residency places are funded by the hospitals 
out of their regular operating revenues; there is sometimes special government 
funding for a certain number of places, for example in the effort to encourage 
employment of immigrant physicians in the early/mid-1990s. Israel also has 
a well-developed system of subspecialty training and fellowships. Many 
promising Israeli physicians pursue fellowship training abroad, typically in 
the United States or Europe.
In recent years, there has been growing interest in moving a greater 
proportion of residency training from hospital settings to community 
settings. This is because a growing proportion of medical care is taking place 
in the community, and it is important to prepare young physicians for this 
changing reality. This effort has had some success in family medicine training 
programmes, but significant barriers to change remain in other specialties.
Nurses
By the end of 2015, all nursing studies will be to a bachelor of science in nursing 
and will be carried out under the auspices of universities and colleges. This is 
expected to include 2800–2900 students.
The government is acting vigorously to increase the number of nurses 
being trained. Over five years, the number of nursing students has doubled 
with 2850 students beginning their studies in 2014 compared with 1692 in 2010. 
However, this is still not enough to reach the nurse-to-population ratio declared 
in government policy.
19 Israelis exempt from military service can begin their medical studies immediately after graduation from 
high school.
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The number of RNs under 65 years who have graduated from advanced 
courses is increasing, from 39% in 2005 to 43% in 2013. At the end of 
2013, 16 869 RNs under 65 years had completed advanced courses: 2.1 per 
1000 population.
The advanced courses are intended for RNs with academic degrees who 
are interested in working in specialized areas such as emergency medicine, 
intensive care, nephrology or operating rooms. In order to provide high levels 
of professional care in these units, the RNs are required to undertake additional 
training. The advanced courses last approximately one year, at the end of which 
the nurses receive a diploma and this is recorded in their file in the official 
registry of nurses.
All the universities and several of the colleges offer master’s degree 
programmes in such areas as nursing, health care management, epidemiology, 
occupational medicine and gerontology. It is estimated that the number of 
nurses with master’s degrees is in the thousands and 300–400 nurses hold 
academic doctorates (PhDs).
Dentists
Regardless of place of training, since 1992 it is necessary to pass a government 
licensing examination in order to work as a dentist in Israel. Almost all those 
trained in Israel pass the examination, and approximately half of those trained 
abroad do so.
Pharmacists
In 2013, 167 new licences were granted to pharmacists, of whom 56 had trained 
in Israel. In previous years the numbers were significantly higher: 300 overall 
of whom over 150 had been trained in Israel.
Other health workers
Physiotherapists. Physiotherapy studies last four years and graduates receive 
a bachelor’s degree in physiotherapy. In recent years, the average number of 
diploma recipients was a little over 200 a year.
Nutritionists. Nutrition studies last three years with an internship of up to six 
months (in hospitals and/or in the community). On overage, 260 nutritionists 
graduate and receive a diploma each year.
Speech therapists. Speech therapy studies last three and a half years, including 
supervised practical period, and lead to a bachelor’s degree. These studies are 
currently available in two universities and five colleges. Every year, about 
200 new graduates enter the system.
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Occupational therapists. Occupational therapy studies last four years and 
lead to a bachelor’s degree. Three universities provide an option of doctorate 
study, which last three and a half years. Every year, some 225 new occupational 
therapists enter the market.
Psychologists. To work as a clinical psychologist, the requirements are a 
master’s degree in psychology in a clinical area, which usually takes two 
years, and a four-year half-time internship (partly in hospital and partly in 
a community setting). In recent years, approximately 550 new licences were 
granted to psychologists, of which approximately 400 were granted to those 
trained in Israel.
CAM practitioners. There are nearly 100 CAM training programmes, including 
brief courses (several months long) by private individuals and institutional 
schools of varying quality. None of them gives an academic degree in this area. 
Some meet international standards and are accompanied by a strict supervision 
mechanism, while others are unsupervised. Training at some of the bigger 
schools entails 3000 hours of study over four years.
4.2.4 Career paths for physicians
There are several career paths available to physicians in Israel. One is the 
academic path and both full academic and clinic appointments are available. 
A second pathway is to advance up the organizational hierarchies in the HPs, 
hospitals or government (Kokia, Siegal & Shemer, 2008). A third pathway is 
professional through increasing skill level and/or extent of specialization. This 
last is often combined with efforts to rise on the academic or organizational 
ladders, but this is not always the case.
4.2.5 Career paths for nurses
As part of the transformation of the nursing profession to an academic profession 
with broad authority, the academic level of those entering the profession is 
rising and the wish and potential to develop a career is growing. Israel offers 
nurses three main career paths: clinical, academic and management.
Clinical. Professional development is in the context of direct care of a patient 
at various levels, from specialist in-service training in selected units such as 
intensive care, emergency medicine, oncology, through to the status of specialist 
nurse with the authority to provide independent treatment for a variety of 
clinical problems experienced by the patient in the nurse’s care.
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Academic. The basic academic training pathway for nurses requires the 
development of academic staff within the training institutions. This is a teaching 
and research pathway for nurses, from a master’s degree to an academic 
doctorate in nursing and through to the status of professors, as required by 
each academic institution.
Management. The management pathway allows for the development of a 
hierarchical management scale in nursing, from nurses in charge of their unit 
through to the head nurse at a medical institution. In recent years, many positions 
have opened up in the field of health system management. For several years, 
these positions have been open to nurses with an advanced degrees, master’s 
degree or higher. These positions include quality assurance, responsibility for 
the service, risk management, spokesperson, internal audit and so on.
5. Provision of services 
The Ministry of Health provides national leadership in a broad range of public health domains including food safety, control of communicable diseases, screening, health promotion, environmental health and 
epidemiologic monitoring. Its key partners include HPs, municipalities and 
the Ministries of Education, Sport and Culture, Finance, and Environment.
Primary care is provided almost exclusively by HPs via salaried physicians 
(and other professionals) working in clinics owned by the HPs, and independent 
physicians with whom they contract.
HPs are also the predominant source of specialized ambulatory care, which 
is mostly provided in community settings. Hospital outpatient departments 
are also an important, albeit secondary, source of such care. In contrast, the 
hospitals are the main providers of emergency care, with a relatively small but 
growing role for community-based providers (such as evening service centres 
sponsored by HPs and independent urgent care centres).
Israelis have access to a secure, safe and stable supply of a wide range of 
pharmaceuticals. HPs have community pharmacies of their own, but they also 
have arrangements with independent pharmacists, and the rapidly growing 
pharmacy chains, to bill them for pharmaceuticals dispensed to their members. 
Israel also has a large, successful and growing pharmaceutical industry, with 
an emphasis on generic pharmaceuticals.
In the LTC area, Israel has a well-developed system of day-care centres 
for the elderly, a growing system of supportive neighbourhoods, legislation 
that provides for government financing of non-professional home care, and 
a relatively high level of LTC insurance coverage. However, the LTC system 
suffers from fragmentation and other ills.
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Palliative and hospice services are covered as part of the NHI benefits 
package. However, there are no governmental guidelines on when, how and 
to what extent HPs are required to provide these services. Hospital- and 
community-based palliative and hospice services exist, but they are less well 
developed than optimal.
Responsibility for the provision of publicly financed mental health 
care (not including substance abuse care) was shifted in mid-2015 from the 
government to HPs. The government continues to operate most of the psychiatric 
hospitals and a network of community clinics as well as a comprehensive 
programme of rehabilitation services for the chronically mentally ill. The private 
sector is also a major provider of community-based mental health services.
Dental care, particularly for adults, is predominantly provided by the private 
sector by independent dentists, but HP chains and commercial chains are also 
significant providers. In the wake of the 2010 expansion of NHI to include 
dental care for children, this is increasingly being provided by HPs and financed 
by the government. The government also provides financial support for school 
dental services and limited programmes of dental care for poor people.
The use of complementary and alternative medicine (CAM) has grown 
markedly in Israel in recent decades. Moreover, mainstream health care 
providers – including hospitals, HPs and physicians – are increasingly involved 
in provision of CAM.
People living in Israel who do not have formal residency status are not 
covered by Israel’s NHI Law. However, a variety of special arrangements have 
been put in place by the government and the HPs to facilitate the financing 
and provision of care for foreign workers, children who lack residency status 
and others.
5.1 Public health
The Ministry of Health operates the Public Health Service with national 
headquarters that, in turn, operates regional and district offices and a variety 
of field units.20 These units are staffed by career public health physicians, 
public health nurses, environmental engineers and other public health-related 
professionals. Several Israeli universities have programmes in place for the 
training of public health personnel. Five of Israel’s seven universities offer 
20 This section was prepared by Nadav Davidovitch in collaboration with Itamar Grotto.
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master’s of public health programmes and recently a new undergraduate public 
health programme was established at the Ashkelon Academic College. The 
Israeli Public Health Physicians Association is responsible for developing the 
standards and syllabus for training of public health physicians, in collaboration 
with the Israeli public health services and the schools of public health.
Environmental health
For decades, the Ministry of Health has had a department of environmental 
health. An important structural change took place in 1988 when certain 
responsibilities were reassigned to the newly formed Ministry of Environmental 
Protection. That Ministry assumed the lead responsibility for controlling noise 
levels, air pollution, radiation, and waste collection and disposal. The Ministry 
of Health remained the lead agency for food safety, ensuring water quality 
and regulating water recycling efforts and the use of pesticides in agriculture. 
Coordination efforts between the two ministries were not always effective after 
this 1988 structural change. However, since the mid-2000s, communication 
and coordination between the two ministries has improved and currently they 
are working together to formulate and implement a comprehensive national 
environmental health policy.
An important change in recent years was the opening of a department for 
environmental epidemiology within the Ministry of Health’s Public Health 
Service, in addition to the long-existing Department of Environment and 
Health. The new department is part of the larger epidemiology division that 
had traditionally a strong focus on infectious diseases.
Water shortage used to be one of the most crucial environmental problems 
facing Israel, exacerbated by the deteriorating quality of water resources under 
demographic, industrial and agricultural pressures. The establishment of large 
water desalination facilities helped to solve this problem in coordination with the 
Ministry of Health. Issues such as adding magnesium into desalinated water to 
prevent health risks are among the new challenges for policy-makers. Recently 
new water quality standards were adopted with one of the consequences being 
the decision to stop water fluoridation, a mandatory measure that had been 
employed in Israel. Currently that decision is being challenged in the Supreme 
Court by several professional associations (public health and paediatrics) as 
well as by some municipalities.
The main sources of air pollution in Israel are energy production, 
transportation and industry. Dense vehicle traffic is a major cause of air 
pollution, especially in the heavily populated urban centres of Tel Aviv, 
Jerusalem and Haifa. The relatively new Air Act presents the option to declare 
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regions as endangering public health, thus demanding the development of a 
regional plan to reduce air pollution. Until now no such region has been declared, 
although several deliberations were held within the advisory committee for the 
environmental epidemiology department.
The establishment of the Environment and Health Fund in 2007 helped to 
improve the funding for environmental health research, for example to fund 
scholarships for postdoctoral study abroad and international workshops in 
various subjects such as exposure science and health impact assessment.
Control of communicable diseases
The Ministry of Health takes the lead in efforts to prevent, monitor and control 
communicable diseases, with important support from the HPs, hospitals, 
community clinicians and laboratories.
The national immunization schedule for children (until 6 years of age) is 
implemented by a network of mother and child health centres (Tipat Halav; 
“drop of milk” in Hebrew) that are operated by the Ministry of Health, the 
HPs and a couple of municipalities.21 They are primarily staffed by public 
health nurses, with a relatively small number of physicians involved, and 
have developed both the commitment and the capacity to engage in intensive 
outreach efforts in the areas of immunization and well-child care more generally. 
Immunizations after the age of 6 years are given by the school health services 
and immunizations for adults are given by the HPs.
After the enactment of the NHI Law, the introduction of new vaccines to the 
national programme has been slow. For many years, the committee responsible 
for additions to the NHI benefits package did not consider new vaccines. This 
created the situation that Israel, which for many years had been among the most 
advanced countries in its immunization schedule, fell behind and several new 
immunizations were not included in the national publicly funded immunization 
scheme. Although some of these new immunizations were included in 
supplementary insurance packages offered by the HPs, the co-payments 
involved and the fact that they were not offered in the mother and child health 
centres created a problematic situation of partial coverage and health disparities. 
In 2008, a scheme to gradually include the new immunizations was adopted 
by the Ministry of Health, and in the last few years new vaccines have also 
been discussed by the Basket Committee. The current immunization scheme in 
21 The family health centres were started by Hadassah in 1912, then further developed during the British Mandate 
and focused on services for mothers and children.
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2015 is robust and comparable to those of other developed countries, including 
immunizations against rotavirus, human papilloma virus, pneumococcal 
infection, and the combined vaccine for measles, mumps and rubella.
Vaccination coverage in Israel is high, with approximately 92–94% coverage 
among infants. The vaccination programme is updated regularly, with input 
from an epidemiological advisory committee. Until recently, vaccination 
coverage in Israel compared favourably with other developed countries, both 
in terms of the range of vaccines provided free of charge and the proportion of 
the population inoculated.
The Ministry of Health’s district and regional offices support and monitor 
the front-line efforts of the mother and child health centres. They receive reports 
from physicians, clinics and hospitals on conditions reportable by law, which 
include routine reports and those related to outbreaks of communicable diseases. 
An epidemiology unit at the national level within the Ministry of Health uses 
geographic information systems and other sophisticated tools to identify and 
analyse suspected outbreaks. This work is performed in coordination with the 
ICDC, and reports to WHO are routinely made.
In addition, there is a network of school health services providing, among 
other things, preventive care, immunization and health education, with an 
emphasis on risk-taking behaviour. In April 2007, the school health system 
was transferred from the Ministry of Health to a small non-profit-making 
organization, a move that was criticized and proved to be detrimental, especially 
in the south of Israel where there are communities of low socioeconomic status 
such as the Bedouins.
Individual physicians also play an important role in this system, diagnosing 
and treating patients with communicable diseases and advising patients on steps 
to prevent further spread of illness within the family and the school system.
Physicians are required by law to report to the Ministry of Health all cases 
on a specified list of reportable illnesses.
Typically, the Ministry of Health covers the cost of public information 
campaigns for adult vaccination, while the HPs provide vaccines and are 
responsible for service delivery at patient level, with some vaccines provided 
free of charge and others at subsidized prices. For many years, very effective 
cooperation took place between Israel’s Ministry of Health and its Palestinian 
Authority counterpart in the area of communicable disease control. The 
primary types of cooperative activity undertaken were training, research, 
service development and provision, policy planning and conferences, seminars, 
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dialogues and youth activities (Barnea et al., 2000). This was important to both 
Israelis and Palestinians because there were substantial flows of people and 
goods between Israel and the Palestinian Authority. Since the intifada began in 
September 2000, cooperation in this area has deteriorated significantly. While 
some improvement has taken place since 2004, especially in the response to 
avian influenza, following the division between the West Bank and Gaza, 
cooperation has been challenging.
The Ministry of Health has developed a detailed pandemic preparedness 
plan that relates to the key elements of surveillance, hospital and laboratory 
preparedness, stockpiling and distr ibution of antiviral drugs, and 
risk communication.
During March 2006, an outbreak of highly pathogenic Avian influenza 
(H5N1) occurred in multiple poultry farms in southern Israel. A simultaneous 
outbreak was identified in the Gaza strip and Jordan. This outbreak was 
contained by a joint effort of the Ministries of Agriculture and Health 
(Balicer et al., 2007). Mitigation of this outbreak was characterized by 
regional collaboration between Israel, the Palestinian Authority and Jordan 
(Leventhal et al., 2006).
In 2013, the discovery of poliovirus in Israeli sewage led the Israeli 
Government to institute a polio vaccination campaign in Israel, a highly 
unusual occurrence in a developed country. The campaign included a risk 
communication component that used both traditional media and social media. 
One of the main issues in public and professional discussion was the possibility 
of reintroducing the oral live “trivalent vaccine” (Sabin vaccine), which had 
been discontinued in 2004 in Israel as in other developed countries. The 
response was followed closely by WHO, with whom the Israeli authorities 
consulted intensively. This case is very relevant to other countries that moved 
to inactivated poliovirus vaccine only, and more broadly for final global 
eradication efforts (Kopel, Kaliner & Grotto, 2014).
In 1994, the Ministry of Health established the ICDC. Its primary goal is to 
collect and analyse updated health-related data, with the aim of providing health 
policy-makers with the evidence base necessary to make informed decisions. 
The ICDC plays important data collection, monitoring and analysis roles 
with regard to both communicable and noncommunicable diseases (including 
ongoing reporting of surveillance data from the HPs for early identification 
of outbreaks).
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Israel has an extensive and active Healthy Cities Network (Donchin et al., 
2006) in which the municipalities, residents, businesses and NGOs work 
together to ensure the vitality and health of their cities. The Network was 
initiated in 1990 and by 2015 over 50 cities were participating. The Network 
has been very important for the larger health promotion initiatives led by the 
Ministry of Health, including the National Programme to Promote Active and 
Healthy Lifestyle together with the Ministry of Education and the Ministry of 
Culture and Sport. Recently, following large cuts in the overall national budget, 
the programme has suffered from major cuts.
Screening
Screening is also characterized by the involvement of both governmental 
and nongovernmental actors. All neonates are screened for phenylketonuria 
and congenital hypothyroidism; those found to be positive are followed up in 
specialized national centres or in mother and child health centres. The latter 
also offer prenatal screening services, but many women prefer obstetricians, 
many of whom provide care through the HPs while others practise privately.
Mother and child health centres are the primary source of screening for 
problems in child development and for vision and hearing problems. They also 
screen children pre-school before this function is taken over by schools. The 
HPs have become increasingly active in the field of women’s health, including 
establishing special women’s health centres. Screening constitutes an important 
part of their activities. Some screening tests – particularly those that are new 
and whose cost–effectiveness has not yet been proven – are provided by the 
HPs through VHI. Others, such as screening for breast and colorectal cancers, 
are carried out by the HPs as part of the NHI benefits package. At the time of 
writing, screening programmes for these cancers are implemented via special 
national programmes as part of the effort to increase compliance among 
target populations.
Health promotion and education
In this field, too, a number of actors are involved. The Ministry of Health has 
an active Department of Health Promotion, the aim of which is to enable the 
population to increase control over their own health and to improve it.
To achieve this aim, the Department produces educational tools and provides 
support to aid health-related behavioural change at the individual, community, 
environmental and political levels. In addition, a special Health Promotion 
Committee, reporting directly to the Director-General of the Ministry of Health, 
fosters collaboration between governmental and nongovernmental actors. The 
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HPs are increasingly involved in both patient education in the care of specific 
illnesses and health education for their members more generally, making use of 
their physicians and other professionals, as well as their web sites, newsletters 
and other printed materials. However, currently the “health promotion basket”, 
unlike the health basket for mainly clinical treatments, is not part of the NHI 
Law and there is no clear definition of what should be included in promotion 
and prevention programmes.
As mentioned, a National Programme to Promote Active and Healthy 
Lifestyle was initiated by several government ministries, yet its viability has 
been compromised by recent budget cuts.
The Ministry of Health has initiated a major effort to set national health 
targets for the year 2020, along with strategies for achieving them. (For further 
details, see subsection Health targets within section 4.2 in Rosen, Samuel & 
Merkur, 2009.)
Health promotion efforts within the HPs face a challenge in terms of 
engaging physicians to be active in the area of health promotion. However, 
the National Quality Measures Programme, which includes many measures 
related to primary and secondary prevention, is helping to increase the rates of 
performance of these activities by PCPs.
Recent developments and key issues
A key issue relates to the funding level for public health services. By mid-2015, 
only 1.2% of total health expenditure was channelled through the Ministry of 
Health’s Public Health Service. There is a fairly broad consensus that increasing 
this share could lead to substantial gains in population health.
Other recent activities in the public health field include the establishment 
of a new coalition, “The Public Health Forum” led by the Israeli Public Health 
Physicians Association (part of the IMA) in order to promote a public health 
reform. This includes legislation towards a new public health act22 with a focus 
both on structural changes (such as creating a public health agency at the Prime 
Minister’s Office) and ensuring the necessary budget and adequate personnel 
for addressing Israeli public health needs.
The Israeli Public Health Physicians Association is also working on 
developing a public health ethics code, in cooperation with other public health, 
medical and nonmedical organizations.
22 The current one is based on an outmoded law from 1940, enacted during the British Mandate with many amendments.
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At the forefront of the Ministry’s efforts is the nationwide system of 
mother and child health centres. Most of these are owned and operated by 
the government, although in Tel Aviv and Jerusalem they are run by the 
municipalities and in some areas they are run by the HPs. In recent years, 
a group of researchers at Ben Gurion University along with the Ministry of 
Health’s Public Health Services conducted a study funded by the Israeli National 
Institute for Health Policy Research to promote a National Quality Measures 
Programme for the mother and child centres. The recent full computerization 
of these centres has made the time ripe for such a move.
5.2 Patient pathways23
A typical pathway through the Israeli health system is described using a patient 
with a hip problem needing a hip replacement as an example.
All Israelis are insured in one of four HPs. When facing a medical problem, 
patients will usually begin by contacting their family physician, who is 
acquainted with them and their medical history. Patients can choose any family 
physician working in their HP and there is no co-payment for such a visit.
In the case of a hip problem, the family physician might refer the patient 
for imaging, for which the patient will pay a small co-payment; this will be 
performed in one of the HP facilities, or a private facility with which the HP 
has an agreement. The family physician would then refer the patient to an 
orthopaedic specialist for further evaluation. Alternatively, the patient can 
go directly to a community-based orthopaedic specialist without referral. In 
both cases, the patient would pay a minimal co-payment for the visit to the 
orthopaedic specialist.
The orthopaedic specialist will refer the patient to hospital for surgery if 
necessary. If the patient stays within the mainstream publicly financed system, 
the HP will cover all costs of the operation. Patients have some choice regarding 
the hospital they will be treated in, depending on the agreements their health 
fund has with different hospitals. However, they cannot choose the specific 
doctor who will operate on them.
Some patients who have supplementary or commercial health insurance will 
decide to use their private insurance to finance care outside the mainstream 
publicly financed system. They might choose to do so for several reasons, 
23 This section was prepared in collaboration with Yael Ashkenazi.
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including the ability to choose a particular surgeon, get more time and attention 
from the surgeon, shorten the waiting time, or secure better amenities for the 
hospital stay. In most parts of the country, this would entail going to a profit-
making hospital, although in Jerusalem the non-profit-making hospitals also 
offer private medical services.
Following surgery, the patient will stay at the hospital for as long as is 
necessary before being released either to home or to a rehabilitation hospital 
depending on factors such as the patient’s condition, the support available at 
home and the availability of rehabilitation beds.
Upon release from hospital, the patient will be given a discharge summary 
detailing further treatment (such as physiotherapy) or medications needed. 
The patient will then return to the family physician with this letter; the 
family physician will refer the patient to any treatment needed and provide 
a prescription for the medications, which the patient can buy at a pharmacy. 
For both the treatments and the medication, the patient will be required to pay 
a co-payment.
After surgery, the patient might need special equipment such as walking aids. 
Patients can rent this equipment at a minimal cost from one of several NGOs 
who work with the Ministry of Health.
5.3 Primary/ambulatory care
Primary care is highly accessible in Israel.24 The cost of primary care visits is 
fully covered by NHI, and co-payments are limited to specialist visits. There 
are approximately 7000 PCPs working with the HPs throughout the country. 
In a 2014 national survey of the general population (Brammli-Greenberg & 
Medina-Artom, 2015), 91% reported being “satisfied” or “very satisfied” with 
the professionalism of their PCP; and 92% reported being “satisfied” or “very 
satisfied” with the interpersonal skills and behaviour of the PCP.
Israel has a well-developed system for monitoring the clinical quality of 
primary care (Rosen et al., 2011a; Jaffe et al., 2012; OECD, 2012a). The HPs have 
made use of the data generated by this monitoring system to make significant 
quality improvements rapidly (Rosen et al., 2011b). The OECD (2012a) cites 
the organization of physicians and other PCPs into teams as a key factor 
facilitating quality improvement. Others have emphasized the pivotal role of 
24 This section was prepared in consultation with Ishay Lev, Hava Tabenkin, Eyal Jacobsen and Shlomo Vinker.
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the HPs as organized systems of care and learning, as well as for the alignment 
of incentives between physicians and HPs (Rosen et al., 2011b). Another key 
factor has been the virtually universal availability of high-quality, computerized 
medical records. The public release, in recent years, of comparative quality data 
across HPs has given the plans a further, competitive, incentive to invest in 
quality improvement.
The HPs regularly monitor, and compare, quality performance across 
regions, subregions, clinics and – in some plans – also between individual 
physicians. They also work closely with the regions, clinics and physicians on 
performance improvement.
In a 2010 survey of PCPs, the vast majority of respondents (87% of 
605 respondents) felt that the monitoring of quality was important and two 
thirds (66%) felt that the feedback and subsequent remedial interventions 
improved medical care to a great extent (Nissanholtz-Ganot & Rosen, 2012). 
Almost three quarters (71%) supported continuation of the programme in an 
unqualified manner. However, many physicians also reported that various 
problems had emerged to a great or very great extent: a heavier workload (65%), 
overcompetitiveness (60%), excessive managerial pressure (48%) and 
distraction from other clinical issues (35%). The steps being taken to address 
these issues include controlling the pace with which new quality indicators are 
introduced and increasing the extent to which nurses are involved in improving 
performance as measured by the indicators.
In the 1970s and 1980s, Israel had one of the world’s highest rates of visits 
to physicians per 1000 population (visits to PCPs and specialists, with visits 
to PCPs accounting for the major share), partly because patients’ medical and 
psychosocial needs were not being adequately addressed, resulting in repeat 
visits (Shuval 1988; Sax 2001). However, rates have fallen since then, and in 
2012 the annual number of outpatient contacts per person in Israel (6.2) was 
below the EU average of 7.0 (Fig. 5.1). At least within Clalit, Israel’s largest 
HP, a very high percentage of members visit their PCP at least once per 
year (Rosen et al., 2014) and they tend to stay with the same PCP over time 
(Dreiher et al., 2012).
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Fig. 5.1
Outpatient contacts per person per year in WHO European Region, 2012 
Source: WHO Regional Office for Europe, 2015.
Notes: CARK: Central Asian Republics and Kazakhstan; CIS: Commonwealth of Independent States; EUR-A,B,C: Regions as in the 
WHO list of Member States, last available year; TFYR Macedonia: The former Yugoslav Republic of Macedonia.
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5.3.1 The employment structure for primary care physicians
The government does not make NHI funds directly available to individual 
physicians; all NHI funds are channelled through the HPs. Any PCP who 
finds employment with an HP, either as a salaried employee or as a contracted 
independent physician, can accept patients under the NHI framework.25 The 
HPs exercise discretion regarding the PCPs with whom they want to work, in 
which regions they want them to work, and whether they want to work with 
them on a salaried or independent physician basis.
Any licensed physician can work as a PCP in the private sector. Only a very 
small number of patients visit private PCPs and pay for their services as OOP 
expenditure (generally speaking, the HPs do not allow their physicians to see 
HP patients privately).
The vast majority of Clalit members receive primary care from salaried 
physicians at clinics owned and operated by Clalit. Patients are free to choose 
their PCP and can switch as often as they want. Some Clalit members receive 
their primary care from independent physicians operating their own facilities. 
Most of the independent physicians in Clalit work in solo practices, although 
there are some group practices. Officially, any Clalit member can choose to 
enrol with an independent physician of his/her choosing, but this opportunity 
is often limited by the number of independent physicians working near the 
member’s home, and their willingness to take on additional patients.
Leumit members also predominantly receive primary health care from 
salaried physicians, although the share receiving care from independent 
physicians is increasing. The two other HPs (Maccabi and Meuhedet) 
engage some PCPs in facilities owned and operated by the HPs, but a clear 
majority of PCPs work as independent physicians. Most of these independent 
physicians will accept patients from different HPs. Both group and individual 
practices exist (most group practices consist only of PCPs, but some contract 
with subspecialists to provide services within their facility). In the smaller 
HPs, patients are free to switch PCPs quarterly, although few patients avail 
themselves of this option.
In Clalit, each patient is registered with a particular PCP who acts as his/
her personal physician. In Leumit, each patient is associated with a particular 
clinic but not a particular physician. In Maccabi and Meuhedet, there is no norm 
of associating patients with a particular PCP or clinic; even so, most patients 
25 Salaried employment is the dominant form in Clalit, while independent physician arrangements are the dominant 
form in some of the smaller HPs.
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receive the bulk of their care from one PCP. Moreover, in all but the largest HP, 
Clalit, there is a process under way of associating each patient with a particular 
physician for purposes of accountability for the quality of care.
As the independent physicians (in all the plans) are paid on a capitation basis 
(either active or passive), they have an incentive to increase the size of their 
patient rosters. There is a concern among government regulators that, in some 
cases, this has led to overly large rosters, which jeopardize the quality of care.
The salaried PCPs tend to work with only one HP, while many of the 
independent physicians work with several plans.
5.3.2 The role of nurses in primary care
Nurses play an extensive role in the primary care provided via the HPs in such 
areas as preventive health care, counselling, triaging of urgent cases, home care, 
chronic disease management and the handling of clinical paperwork related to 
the patients’ eligibility for various social benefits.
Another mechanism through which nurses are playing an increasingly 
important role is the call centres operated by each of the four HPs. These are 
staffed primarily by specially trained nurses who provide members/patients 
with 24-hour guidance on how to respond to various illnesses and symptoms.
5.3.3 The primary care practitioner specialty mix
As of the end of 2012, approximately 38% of PCPs who worked with adults were 
general practitioners – that is, non-specialist graduates of medical schools – 
and 43% were board-certified specialists in family medicine. Other specialties, 
such as internal medicine, accounted for the other 19% (Nissanholtz-Ganot & 
Rosen, 2012).
During the 1980s and 1990s, there was considerable dispute among primary 
care leaders in Israel over whether family medicine or paediatrics and internal 
medicine training was the best basis for high-quality primary care. While 
differences of opinion on this issue remain, the debate is not nearly as heated as 
it was at that time. The general – but by no means unanimous – consensus is that 
paediatrics and internal medicine training (and not just family practice training) 
can provide a good base for primary care but only if those training programmes 
are modified to provide more exposure to primary care settings. Today, most 
children are cared for by paediatricians rather than family physicians and most 
of the paediatric PCPs work in group practices.
Health systems in transition  Israel 121
5.3.4 Primary care practitioners and gatekeeping
In all the HPs, visits to hospital-based specialists require prior authorization, 
either from a PCP or a community-based specialist. In the smaller HPs, members 
have unrestricted access to all plan-affiliated community-based (as opposed to 
hospital-based) specialists, without prior authorization from a PCP. In Clalit, the 
PCP plays more of a gatekeeper role; members have free access to specialists 
in five areas – ear, nose and throat; dermatology; orthopaedics; ophthalmology; 
and gynaecology – but access to other specialists is contingent upon referral 
from a PCP.
5.3.5 Recent developments in primary care and key challenges
Technological developments are having a major impact on primary care. HP 
members are increasingly making use of online consultations on such topics 
as chronic disease self-care, after-hours primary care and how to respond to 
troubling symptoms in children. Many members maintain an online personal 
health record, which includes automatic reminders for health care. These are 
accessed by members either via their personal computers or, increasingly, via 
their smart phones. Prescriptions are increasingly being renewed digitally by 
physicians and sent directly to the relevant pharmacy (thus removing both the 
face-to-face meeting with the physician and attendance at the clinic). Progress 
is being made in facilitating asynchronous, distal communication between 
PCPs and patients, particularly through the use of e-mail. Health information 
exchanges are increasingly alerting PCPs when their patients are admitted to, 
or discharged from, hospitals and providing information about the care in the 
hospital that is vital for after-care in the community.
The HPs are continuing to shape primary care provision in their ongoing 
search for efficiency. They are merging smaller clinics and encouraging 
teamwork between PCPs and other health care professionals. Some HPs are 
setting limits (or at least guidelines) on how much time PCPs can spend with 
each patient, and focusing the PCPs’ time on direct patient care in the clinics 
(as opposed to activities such as staff meetings or home visits). They are also 
providing PCPs with after-hours back-up by specialized units.
Broader forces are also affecting primary care. Societal changes, backed 
by various legislative initiatives, are empowering patients and making care 
more patient centred. In addition, the government has added various health 
promotion and disease prevention services to the NHI benefits package, and 
PCPs are being called upon to play a role in such areas as smoking cessation 
and weight reduction. Moreover, increased attention to chronic conditions and 
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their management has put the PCPs in a position where they are increasingly 
expected to manage (or at least be mindful of) their patients’ use of secondary 
and tertiary services.
Key challenges currently facing primary care, as discussed in the recent 
German Committee report (see section 6.2), include:
• a projected shortage of PCPs as growing numbers reach retirement age 
and relatively few young physicians are entering the field (OECD, 2012b);
• insufficient time to spend with each patient, which limits the PCP’s ability 
to coordinate care and go beyond the most pressing health issues; and
• the need to expand the PCPs’ capacities to engage in health promotion, 
deal with an ageing population and address mental health needs.
5.4 Specialized ambulatory care/inpatient care 
(secondary care)26
Board-certified specialists
In 2012, Israel had approximately 17 900 board-certified specialists, 13 900 
of whom were below the age of 65. As in other countries, the proportion of 
specialists among all licensed Israeli physicians below the age of 65 years is 
increasing rapidly, reaching 54% by 2012. Of course, not all board-certified 
specialists engage in secondary care. In 2012, among board-certified specialists 
up to the age of 65 years, there were approximately 1650 working as family 
physicians (12%) – almost all of whom work in primary care – as well as 
approximately 2700 internists (19%) and 2050 paediatricians (15%), many of 
whom worked at least part-time in primary care. There are no definitive figures 
on the number of Israeli physicians engaged in secondary care.
The location of specialist care
While all Israeli hospitals operate outpatient clinics, most specialized ambulatory 
care has traditionally been provided in community-based settings, and in recent 
decades there has been a further shift towards the community. There are several 
reasons for this shift. First, the HPs felt that they often lost control of treatment 
plans and expenditure when their patients were cared for at hospital outpatient 
clinics. Second, the HPs were able to provide and/or purchase community-
based specialty care at costs well below those of the hospitals. Finally, various 
technological innovations and cultural changes facilitated the shift from the 
26 This section was prepared in consultation with Eyal Jacobson and Avi Porath.
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hospital to the community setting. There has also been a shift in the location 
of emergency services. The HPs have developed community-based emergency 
centres as well as emergency home visit services as alternatives to hospital EDs 
(Taragin, Milman & Greenstein 2000; Greenstein & Tiaragin, 2001).
A 2012 survey found that only 10% of adults and about 33% of children 
who visited a specialist using public financing did so in a hospital setting 
(Brammli-Greenberg Waitzberg & Guberman, 2015).
In recent years, many of the hospitals have made a special effort to try 
to attract activity to their outpatient departments. The prices for hospital 
ambulatory services have been substantially reduced, and there have been cases 
where hospitals, in negotiating overall contracts with HPs, have proposed to 
provide these services free of charge as part of an overall package.
The expansion of community-based specialist care involves facilities owned 
and operated by both the HPs and independents, from whom they purchase 
services. In many cases, hospital-based specialists work part-time in community 
settings in order to supplement their incomes, raising both hopes and concerns. 
The hopes are that this will enhance hospital–community communication, 
continuity of care, the quality of community-based specialist care and health 
care system efficiency. The concern is that physicians working in both settings 
may not be putting enough hours into their hospital jobs and may lack a sense 
of institutional loyalty to either of their employers; this concern is particularly 
great with regard to physicians who also work privately.
The nature of community-based specialist care
All of the HPs work with a mix of employed and independent community-based 
specialists. In Clalit, most of the specialists are employees who work in facilities 
owned and operated by the HP, although Clalit also works with independent 
specialists. Conversely, in the other HPs the majority of the specialists are 
independent individuals working in their own facilities, but the HPs also use 
some employed and independent specialists in plan-owned facilities.
Cooperation and communication between community-based specialists and 
PCPs are reasonably good. In Clalit, the PCPs function as gatekeepers to the 
less common specialties and – to some extent – as care integrators for all types 
of care. In the other HPs, gatekeeping and integrating roles are less prevalent.
More cooperation and communication problems occur between the hospitals 
and the HPs. The hospitals are unhappy with the HPs’ efforts to shift more 
care to community settings and to increase monitoring and control. The HPs 
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do not like what they perceive as the tendency of hospitals to overtreat patients, 
repeating tests already carried out in the community and not providing the HPs 
with full and up-to-date information in real time on the care of their members.
Not surprisingly, specialists tend to be concentrated in urban areas. This can 
result in inconvenience and access problems for people living at the periphery 
and in small villages, although distance does not prevent most residents from 
visiting specialists. Waiting times for specialists also appear to be reasonable. 
In 2012, among people who visited a specialist in the preceding three months, 
45% reported waiting one week or less, 16% waited one to two weeks and 36% 
waited more than two weeks (Brammli-Greenberg & Medina-Artom, 2015).
The average waiting time for a specialist physician in the community 
(publicly funded) is 3.2 weeks (median of 2 weeks). Yet, there are wide 
differences in waiting times among the various specialties. For example, the 
mean waiting time for common specialties (e.g. orthopaedics, ophthalmology, 
dermatology, otorhinolaryngology and gynaecology is two weeks compared 
with four weeks for less common specialties. The gap is even wider in the 
periphery and in small localities. The specialties with relatively long waiting 
times are rheumatology, vascular surgery, haematology, endocrinology and 
plastic surgery (Brammli-Greenberg, Waitzberg & Guberman, 2015).
Sometimes, when a patient realizes that the waiting time to see a specialist 
within the NHI basic insurance framework would be what he or she perceives 
to be too long, the patient will obtain specialist care via the “second opinion” 
clause of his/her supplementary insurance package. This happens despite the 
fact that this is not really a second opinion.
Rates of visits to specialist physicians are substantially lower among Israeli 
Arabs than among Israeli Jews. This finding is particularly significant in light of 
the fact that visit rates to PCPs and hospitalization rates are higher among Arabs 
than Jews. The reasons for the large gap in specialist visit rates are not fully 
understood. A key factor appears to be the time and inconvenience involved in 
travelling from many Arab villages to urban centres, particularly for mothers 
of large families and people who do not own cars. Another factor may be 
the shortage of Arabic-speaking specialists. A third factor may be a greater 
tendency among Jews than Arabs to insist on being seen by a specialist rather 
than a PCP, a factor which may, in turn, be linked to differences in educational 
and socioeconomic levels, as well as urban–rural differences.
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Nirel et al. (2008) found that community-based specialists saw an average of 
34 patients per working day. The number of patients whom specialists saw in a 
day raises the issue of how much time and attention they are able to devote to 
their patients. In this context, the time that physicians allocate to their patient 
appointments was examined. According to the results of the study, specialists 
allocated an average of 13 minutes to an appointment.
In that same study, 80% of specialists reported that their patients exercised 
freedom of choice in selecting a specialist physician, and that the physicians 
were chosen by their patients and not referred by the HP.
Specialist care in hospitals
Almost all the specialists working in Israeli hospitals are salaried employees of 
those hospitals. This is similar to the situation that prevails in most European 
countries, in contrast to the North American system of independent attending 
physicians. Only the few private hospitals have implemented the independent 
attending physician model.
Department heads play a dominant role in Israeli hospitals. They have a 
major say in the selection of the specialists who will work with them and the 
tasks they will be assigned.
Generally speaking, patients in Israeli hospitals cannot select which 
specialist will care for them. They are assigned a physician according to the 
rotation schedule determined by department heads and their assistants. The 
exception is the private medical service in Jerusalem’s non-profit-making 
hospitals where, in return for an additional fee, the patient can choose her/
his physician.
As indicated in Chapter 4, Israel is projecting an overall physician shortage 
and, according to the Director-General of the Ministry of Health, there are 
already shortages in certain hospital-based specialties such as anaesthesiology, 
intensive care and neonatology. The shortages are particularly acute in hospitals 
in peripheral regions.
The 2011 collective bargaining agreement between the IMA and the major 
employers introduced major financial incentives for physicians to pursue 
residencies in a range of distressed specialties. The initial indications are that 
these incentives are proving effective.
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5.4.1 Day care
The data summarized here on inpatient institutions and day-care units in Israel 
are derived from Haklai (2014). At the end of 2013, Israel had approximately 
1600 registered day hospitalization beds. About two thirds of them were in 
general hospitals, one fifth were in psychiatric hospitals, and one tenth were 
in hospitals for chronic diseases. In recent years, the number of such beds in 
general hospitals has been increasing slowly, while it has been stable in the other 
settings. The day hospitalization beds are highly concentrated in the centre of 
the country.
Day hospitalization is defined as “a diagnostic and/or therapeutic framework 
without overnight stays which includes admissions, discharge, as well as 
diagnostic, therapeutic and hotel capacities”. General day hospitalization 
handles internal medicine, paediatrics and gynaecology. There are also 
specialized units for surgical oncology, psychiatric care and geriatric day care.
The HPs also operate various community-based care centres that provide 
some, but not all, of the services provided in a day hospitalization framework 
(e.g. provision of intravenous fluids and medications).27 In 2013, there were also 
444 day-care beds for mental health care, with two thirds of them in psychiatric 
hospitals and a third in general hospitals. There were also five community-
based mental health day-care units.
The psychiatric day-care units provide crisis care for patients referred directly 
from the community. In contrast, psychiatric hospitalization units are for patients 
who have been recently discharged from a psychiatric hospital and are intended 
to help the patient to transition gradually to functioning within the community.
Israel also has a network of day-care centres for the elderly, which have a 
social rather than a medical orientation (see section 5.8). There are also various 
community-based day-care services with a rehabilitation focus (see section 5.7).
5.5 Emergency care
Israel has a system of emergency care delivery that arises from its routine 
needs and from the needs of national disaster preparedness.28 The country’s 
routine needs are addressed primarily from fixed locations: hospital-based EDs, 
27 There are a few examples of community-based care centres (such as Clalit’s Linn Center in Haifa) with a much 
more diverse set of day services.
28 This section was prepared in consultation with Eyal Jacobson.
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independent urgent care centres and evening/weekend care centres sponsored 
by the HPs. Official ambulance carriers and private carriers deliver Israel’s 
prehospital point-of-care service.
The National Emergency Committee supervises Israel’s activities relating 
to disaster planning (or disaster training/care), wartime and other national 
emergencies. Training to deal with disasters and research into the community 
impact of natural and manmade disasters is performed by the Ministry of 
Health’s Division of Emergency and Disaster Management and the IDF Home 
Front Command. The training function is carried out in coordination with 
Israel’s official ambulance service, the general hospitals and army medical units.
The nature of medical care
EDs deliver the full range of services customary in similar European 
departments: advanced cardiac and trauma care as well as paediatric, 
orthopaedic, gynaecological and general medical care. They also compete with 
the stand-alone urgent care centres in the care of ambulatory patients with 
less severe medical problems. Psychiatric emergency care is delivered both in 
general EDs and in psychiatric hospitals at intake/emergency centres.
Urgent care centres (approximately 15 nationally, mostly in major urban 
centres) deliver primary care and have advanced life support capabilities 
to sustain life until transfer to an ED is accomplished. One of the leading 
providers, which operates several such centres, also delivers intermediate care, 
such as fluid resuscitation. In some cases, the centres are supported by basic 
imaging and laboratory services.
In recent years, the Ministry of Health has encouraged the development 
of night-time emergency centres in several small towns and rural areas in the 
geographic periphery where travel times to hospital EDs can be problematic. 
These centres are typically run by private providers and serve all four HPs, 
with the financing coming from the HPs, the local authority and the Ministry 
of Health.
The HP-affiliated evening care centres are spread throughout all major 
population centres in the country and they tend to treat less severe cases.
Magen David Adom delivers advanced and basic life support services, 
including cardiac and trauma care, as does the independent non-profit-
making Red Crescent ambulance service. There are also private profit-making 
ambulance services, including some who sell yearly subscriptions; they deliver 
advanced life support and cardiac/medical services, but not trauma care. One 
of them also has a well-developed telemedicine programme to treat its patients 
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from home and another offers private, FFS home care. Other private ambulance 
services cater to specific sectors of the Israeli population (e.g. the ultra-religious) 
and usually limit their level of care to basic life support.
The disaster aspect of care is two-fold: the planning section (the National 
Emergency Committee) and the IDF Home Front Command, with the affiliated 
ambulance and ED branches offering the full range of advanced and basic life 
support services.
Affiliation and issues of human resources
Hospital-based emergency care is delivered in EDs of hospitals; six hospitals 
have received the designation of national trauma centres. Physicians and nurses 
staff the EDs. In Israel, emergency medicine was recognized as a board-
certified specialty in 1999. However, the number of Israeli physicians who 
are board certified in this field continues to be small because of the ongoing 
shortage of residency training places. Most of the board-certified physicians 
working in the EDs are still certified in other fields, such as internal medicine, 
general surgery and orthopaedics. Some of them work predominantly in the ED 
(typically during the day shift), while others work there on a part-time basis 
(typically evening and night shifts) “on loan” from their departments. The EDs 
also employ residents in emergency medicine and a small, but growing, number 
of board-certified emergency physicians.
The ED nursing staff are dedicated exclusively to emergency care. Some of 
the nurses have obtained the six months’ training in advanced emergency care.
The HPs are required to provide access to care 24 hours a day, and not 
just during the daytime hours when their regular community clinics operate. 
Accordingly, in some areas they have opened their own “emergicentres” and in 
others they outsource this care to private providers. The emergicentres vary in 
the range of services offered, with some limited to basic physician and nurse 
care and others having imaging and laboratory services as well.
The HPs are also required to provide home care services outside the usual 
clinic hours of operation. They usually do this via outsourcing to private 
provider groups.
Urgent care centres (private) and HP night and weekend/holiday-care 
centres are staffed by emergency paediatricians and family medicine-trained 
physicians, physicians with some postgraduate training and by post-internship 
practitioners (some awaiting their specialty training). The nurses are licensed 
RNs. Urgent care centres often deliver radiology, laboratory and specialty 
medical services as well (e.g. Terem in Jerusalem).
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Paramedics, emergency medical technicians, physicians and volunteers staff 
ambulance services. They offer a variety of services. The Supreme Health 
Authority, established by the Emergency National Council, is composed of 
government staff, IDF (Home Front Command), Magen David Adom and 
hospital representatives.
Reimbursement issues
Employees of the EDs are in the employ of their respective hospitals. The 
hospitals typically receive payment for the services delivered either from the 
HPs or from the consumer as a private payment. However, they cannot condition 
the provision of emergency care on payment. In practice many undocumented 
residents, who lack insurance, receive uncompensated care.
Urgent care centres are private enterprises. They often have special billing 
agreements in association with the major HPs. The evening/weekend care 
services of the HPs are staffed and paid for by the HPs themselves, with a 
small additional charge falling upon members availing themselves of these 
services. The private providers working with the HPs on an outsourcing basis 
also charge co-payments.
Ambulance reimbursement in the Magen David Adom is made by the HP, 
the local authorities and the individual using the service. The private ambulance 
services offer their services to pre-paid registered members and have their 
medical information on computer databases.
Disaster care is covered for the most part by governmental agencies. Some 
of the committee work is carried out on a volunteer basis.
Training programmes
Emergency medicine is recognized as a subspecialty, requiring 2.5 years of 
training after an initial residency period, or as a basic specialty also requiring 
about 2.5 years of training. The RNs specializing in emergency care must 
complete a six-month training programme.
Physicians working in urgent care centres are a mixed group, some having 
completed specialty training but the majority without a completed residency 
period. Nursing staff usually undertake onsite training.
Paramedics have a number of possible training programme options, the 
longest standing of which is a 15-month course run by the Magen David Adom. 
There is a university-based programme conferring a bachelor’s degree after three 
years at Ben Gurion University. A special programme added to the four-year 
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nursing course exists in Assaf Harofe Hospital (Hebrew University affiliated) 
and the IDF has a training programme to provide front-line paramedic care in 
place of physicians.
Israel recently created a new, legally recognized, role of emergency 
medicine physician assistant. The role is open to licensed paramedics who 
receive additional training, with the first such training course scheduled to 
begin in 2015.
Disaster drills are held regularly, typically on a regional basis. They include 
components of chemical, biological and conventional mass casualty situations.
All paramedic training, army physician training, and emergency medicine 
training programmes contain the essential elements of disaster protocol and 
organization according to how this relates to their individual function(s).
Advanced (master’s degree) disaster programmes are available across 
three sites:
• Haifa University: a programme with an emphasis on geographic aspects 
of disaster planning;
• Tel Aviv University: a programme emphasizing the logistical support 
aspects of disaster preparation; and
• Ben Gurion University: a programme dealing with medical/psychological 
response to disaster planning and care implementation, with an emphasis 
on research.
International cooperation
The IDF has emergency rescue teams that are dispatched to sites of natural 
disasters around the world (e.g. tsunami in Asia, earthquake in Turkey). 
Ben Gurion University and the Jordanian Red Crescent Society have 
collaborated on a joint programme to train paramedics.
One of the private ambulance services (Shahal) is an international 
corporation that develops and shares technology and research with its affiliates 
in Germany and the United States.
Future prospects
A special committee appointed by Ministry of Health to examine the 
advancement of quality care in EDs recently completed its report (Ministry of 
Health, 2014h). Its recommendations included:
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• updating staffing requirements for EDs
• increasingly basing staffing of EDs on emergency physicians
• developing ED triage systems
• deploying physician assistants
• further computerization in EDs
• monitoring quality of ED care
• limiting the time taken from a decision to hospitalize until its 
implementation.
5.6 Pharmaceutical care
Israelis have access to a secure, safe and stable supply of a wide range of 
pharmaceuticals.29 In 2013, expenditure on pharmaceuticals and disposable 
medical supplies accounted for approximately 20% of total HP expenditure. 
Outlays on pharmaceuticals also accounted for 14% of total household spending 
on health care.
Israel has a large, successful and growing pharmaceutical industry. The major 
companies include several that are traded on the New York Stock Exchange, 
most notably Teva, the world’s leading generics company. Although there are 
many new biotechnology research and development companies, it is important 
to keep in mind that most manufacturing companies focus primarily on generic 
pharmaceuticals. The vast majority of patented medications dispensed in Israel 
are imported from abroad or are produced in Israel under licence from foreign 
pharmaceutical companies. Imports account for approximately half to two 
thirds of the total market in terms of sales.
The government plays several key roles in the pharmaceutical sector, 
including approving pharmaceuticals for sale, establishing the NHI formulary 
of pharmaceuticals that all HPs must make available to members, setting 
maximum prices, licensing pharmacists and regulating the pharmaceutical 
market. The Pharmaceutical Administration is the regulatory agency overseeing 
the pharmaceuticals market. There are more than 4000 products approved 
as medications.
29 This section was prepared in consultation with Eli Marom.
Health systems in transition  Israel132
Although advertising of non-prescription pharmaceuticals is allowed, direct-
to-consumer advertising of prescription pharmaceuticals is prohibited. Patient 
information brochures are permitted for distribution by the prescribers provided 
they meet the strict criteria defined by Ministry of Health guidelines. The 
Ministry of Health has recently established regulations regarding disease 
awareness campaigns so that consumers can be empowered with information 
about the availability of new treatments in a manner that does not involve the 
promotion of a particular commercial product.
Apart from commercial homeopathic preparations, no CAM products are 
regulated. Mail order or remote ordering (including Internet procurement) are 
permitted, according to defined guidelines.
Under NHI, HP members must make a co-payment for pharmaceuticals 
(see sections 3.1 and 3.4.1). Most community-based pharmaceutical use 
is provided under NHI and is, therefore, financed primarily by the HPs 
and secondarily through co-payments. In addition, individuals purchase 
pharmaceuticals without contributions from their HPs, especially for over-the-
counter medications. Individuals cover the full cost of prescribed medications 
that are not in the NHI formulary and all prescriptions by private physicians.
The Ministry of Health establishes maximum prices for all pharmaceuticals 
approved for sale. This is done using reference pricing (the “Dutch model”), in 
which a maximum price is set based on the average price for the item in seven 
European countries (Germany, Belgium, France, the United Kingdom, Spain, 
Portugal and Hungary). These prices serve as ceilings only and are relevant 
primarily in the case of private purchases by individuals. All the HPs negotiate 
substantial discounts with manufacturers and importers, which are applied in 
every type of pharmacy. Various efforts are under way to promote the use of 
generic medications and the use of lower cost pharmaceuticals in particular. For 
example, the HPs highlight these types of medication in various circulars or 
lists of recommended pharmaceuticals; in some cases, very expensive patented 
alternatives can be prescribed, provided special permission is obtained from 
the management of the HPs.
Many of the HPs’ clinical protocols developed to reduce costs and improve 
the quality of care are related to pharmaceutical use. Some HPs monitor the 
prescribing behaviour of individual physicians and groups, by specialty, sending 
them periodic feedback regarding their prescribing pattern compared with 
others in the same specialty. Frequent updates regarding suggested prescribing 
are sent out from the HPs’ central offices, based on computerized systems, to 
register the HPs’ prescribing preferences. There are no formal or automatic 
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financial penalties for physicians who overprescribe. The management may 
contact them to discuss their prescribing patterns, giving them an opportunity 
to explain, and to exhort them to be more careful in future.
As in other countries, the vast majority of pharmaceuticals are dispensed 
in community settings, as opposed to hospitals. There are approximately 
1900 pharmacies in Israel: 40% are operated by HPs (usually in clinics owned 
by the HPs) or hospitals; 45% are private (independent) pharmacies; and 15% 
are part of large-chain pharmacies.
All four HPs have community pharmacies of their own, but they also 
have arrangements with the pharmacy chains and independent pharmacists 
to bill them for pharmaceuticals dispensed to their members. The role of HP 
pharmacies is most pronounced in Clalit. Recently, independent pharmacies 
have been closing while the pharmacy chains have been intensively growing, 
and the system is in the end stages of stabilization. Some of the HPs have also 
begun to expand their in-house pharmacy networks.
Most pharmacists are salaried employees. In HP pharmacies, they sometimes 
receive bonuses that can be tied to sales volume and measured in revenue or 
according to the number of prescriptions.
Pharmaceutical services also play a significant role in hospitals. The 
main services provided by hospital pharmacies consist of pharmaceutical 
preparations and inventory management. There are also efforts under way to 
expand the deployment of clinical pharmacists as integral parts of the clinical 
care teams – both in hospitals and in community settings.
In 2014, Israel authorized pharmacists to renew drug prescriptions for 
chronic diseases (see section 5.6.1).
Israeli hospitals are a major locus for large, multisite international clinical 
trials. This is believed to reflect the high level of medical care provided and 
the reputation for careful adherence to study protocols. Efforts are under way 
to streamline the process of clinical trial approvals.
Israelis are generally perceived to be eager consumers of medication(s). 
Physicians often feel pressured to conclude a visit by writing a prescription 
and there is substantial public pressure to keep adding new medications to the 
NHI benefits package.
In recent years, the regulation of the pharmaceutical sector has undergone 
several important changes. In part, these involve adapting practices that 
are prevalent in the EU. For example, in the area of pharmacovigilance, all 
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pharmaceutical distributors in Israel are now required to collect, and share 
with the Ministry of Health, postmarketing data on the side-effects of their 
drugs, both in Israel and in other countries. In addition, instead of having the 
Ministry of Health certify the quality of each batch of product, pharmaceutical 
manufacturers do it themselves by appointing an internal qualified person who 
then reports on the results to the Ministry of Health.
Efforts to encourage the use of generic pharmaceuticals continue apace, 
including generic substitution by pharmacists. Moreover, regulations have 
recently been put in place to govern the use of biosimilars, in the interest of 
controlling costs while minimizing the risks to safety and quality.
The Ministry of Health has also:
• established a new system for identifying and tracking medication 
shortages, which encompasses both short- and long-term problems;
• published regulations that allow organizations to disseminate information 
to the general public about the types of treatment available for various 
diseases, while prohibiting the mention of specific commercial products; 
and
• published regulations on how pharmaceutical companies and others are 
allowed to encourage compliance among consumers who have been 
prescribed medications.
5.6.1 Pharmacists’ expanded role
On 3 March 2014, the Knesset’s Health Committee approved a new regulation 
that extended the authority of pharmacists and allowed them to renew 
prescriptions for continued medication (Knesset, 2014).30 Its intention was 
to reduce the workload of physicians renewing drug prescriptions and to 
streamline the treatment process for consumers.
According to the regulation, licensed pharmacists with at least five years 
of experience, after undergoing special training, will be able to renew certain 
prescriptions for the treatment of chronic disease that were initially prescribed 
by a physician. The regulation gives pharmacists more authority but also 
limits and determines their autonomy in this new practice. The pharmacist 
will have the authority to ascertain whether there were significant changes 
in the patient’s condition during the period of the drug intake, or whether 
there were any side-effects that require reconsideration before renewing the 
30 This section was prepared in consultation with Eli Marom and Tal Morgenstin.
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prescription. The pharmacist is authorized to renew prescriptions but only after 
enquiring regarding the patient’s current medical condition, comorbidities and 
additional medication being taken. In addition, the prescription renewal will 
be for a period not exceeding six months from the initial prescription given 
by the attending physician and the patient will continue to be under medical 
supervision (Efrati, 2014).
The prescriptions can be renewed for almost all medications; the main 
exception is for medications that are addictive.
The regulations explicitly relate to concerns about patient privacy. 
Pharmacists are required to maintain strict privacy and patients will be required 
to sign a letter of consent annually authorizing the pharmacist to review their 
medical records. This consent may be cancelled at any time. In addition, HPs 
interested in allowing their insured to benefit from the new service can provide 
access to medical information (for those patients who provided their consent) not 
only for their own pharmacies but also for hundreds of private pharmacies with 
which they have contractual arrangements. The impact of the new regulations 
will depend, in part, on the extent to which the HPs will provide pharmacies 
with access to their members’ medical records.
The approved regulation is part of a broader set of recent and planned 
regulations promoted by the Ministry of Health to relieve pressures and 
workload for physicians and to increase autonomy for pharmacists. The 
Ministry plans not only to expand the list of drugs that can be renewed by 
pharmacists but also to increase pharmacists’ authority to prescribe specific 
drugs independently.
5.7 Rehabilitation/intermediate care
Rehabilitation is included in the NHI benefits package and responsibility for its 
provision, therefore, lies with the HPs.31 Rehabilitation services are provided 
in the general hospitals, in designated rehabilitation hospitals, in geriatric 
medical centres and in the community. Outpatient services include clinics 
for child development and rehabilitation, clinics for general rehabilitation and 
day-care rehabilitation. All these services are provided in community facilities 
of the HPs. All rehabilitation services incur a co-payment. The co-payment 
for inpatient services is approximately NIS 1000 (€235) per month, and for 
community clinics it is approximately NIS 30 (€7) for three months.
31 This section was written by Netta Bentur.
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In mid-2014, there were 732 general rehabilitation beds in Israel. Of these, 
37% were in two big rehabilitation centres, 35% in 10 rehabilitation wards in 
general hospitals and 28% in six geriatric rehabilitation centres. Approximately 
one third (31%) of the beds were for neurological rehabilitation, 25% for people 
comatose for an extended period, 18% for general rehabilitation, 13% for 
children and 13% for orthopaedic rehabilitation (Haklai, 2014).
About 35% of these beds were owned by the government, 37% by Clalit, and 
28% by profit-making or other non-profit-making providers.
The general rehabilitation bed rate per 1000 population was 0.09 in mid-2014, 
compared with 0.14 at the end of 2006 and 0.10 in 2000. Between 2006 and 2009 
there was a temporary growth in the number of beds, which was attributable 
to beds for people who were comatose for an extended period of time. The 
definition/target of these beds was then changed from rehabilitation beds to 
complex-supportive beds. Since the end of 2009, there has been a decrease of 
9% in the number of general rehabilitation beds per 1000 population. Although 
the rate of general rehabilitation beds has remained steady for more than a 
decade, when taking into account the ageing population, there is a notable 
decrease in capacity relative to potential needs.
About 70% of the general rehabilitation beds are concentrated in the central 
region of the country with fewer beds in other regions, especially in the southern 
and northern regions.
The overall bed occupancy rate in 2014 was 100%. Average length of stay 
was 44 days, although it has been decreasing steadily since the early 1990s. 
Stays in hospitals specializing in chronic diseases are longer, on average, than 
stays in rehabilitation hospitals (Ministry of Health, 2006).
The four HPs operate rehabilitation clinics within the community, offering 
specialist physicians and physical, occupational and speech therapy. In order 
to receive care at one of these clinics, a patient must obtain a referral from a 
family physician or rehabilitation specialist, and this incurs a co-payment. The 
clinics provide neurological and orthopaedic rehabilitation services, as well as 
child development services. Many clinics contain the latest equipment and are 
operated by licensed professionals who remain abreast of the changes within 
their fields. Clalit operates several day-care rehabilitation centres, which is 
equivalents to 72 beds. To a limited extent, the HPs also provide rehabilitation 
services in the home, through their medical home-care services as well as 
pioneering work in tele-rehabilitation.
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The Ministry of Health participates in the cost of purchasing some 
rehabilitation equipment and provides a limited number of devices to the 
population, such as walkers and vision aids, without requiring co-payment. 
Yad Sarah, one of the largest non-profit-making organizations in Israel, loans a 
wide variety of rehabilitation devices to the public free of charge.
In 2014, there were approximately 7625 rehabilitation professionals in Israel 
up to age 65: 122 physician specialists in physical medicine and rehabilitation 
(0.915 per 1000), 3170 physical therapists (0.46 per 1000 population), 
2670 occupational therapists (0.39 per 1000) and 1790 speech therapists 
(0.26 per 1000). Israel has 15 schools for rehabilitation professions. Most of 
them operate within faculties of medicine and health at the country’s four large 
universities and a few of them in colleges. Nevertheless, there is a significant 
shortage of rehabilitation professionals both in hospitals and within community-
care settings; the shortage is particularly striking in geriatric rehabilitation 
services and in psychiatric hospitals.
5.7.1 Critical issues facing rehabilitation
There is a continuing shortage of specialist physicians in rehabilitation. In 
addition, although there is no longer a shortage of physical and occupational 
therapists, the relatively low salary of these skilled professionals is an incentive 
for leaving the field and/or the public sector. The salaries are low compared 
with those of other trained professionals in the health care system, such as 
nursing personnel or radiography technicians. Moreover, the high wages paid 
to rehabilitation professionals in the private sector, where compensation is 
awarded on a FFS basis, also provide an incentive to leave public sector jobs.
Because of a shortage of outpatient rehabilitation clinics, many patients 
have to wait months for treatment. Consequently, the clinics often have two 
parallel queues: one for acute cases, consisting primarily of younger people 
after a road or work accident and traumatic orthopaedic needs, and the other 
for patients with chronic problems, consisting primarily of older adults who 
suffer from back pain or neurological diseases such as a stroke or Parkinson’s 
disease, or even those with deconditioning (physiological changes following 
a period of inactivity such as bedrest, with functional losses in such areas 
as musculoskeletal system or mental status and loss of ability to accomplish 
activities of daily living). However, because of the constant pressure on these 
clinics, treatment of patients in the latter group is often postponed for months 
or even longer. The main victims of this serious shortage of rehabilitation 
services in the community are older patients with chronic conditions. In the 
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absence of appropriate provision, frequency and scope of rehabilitative care, 
they suffer from disabilities and limitations that could be treated to improve 
their functioning and, in some cases, even to postpone the need for nursing care.
5.8 Long-term care
The system of health and welfare services for the elderly with disabilities 
in Israel has been developed enormously in the past decades.32 In particular, 
accelerated improvements in home care and other community services has 
occurred, chiefly for the population with disabilities. There have also been 
developments in institutional facilities, particularly those for elderly individuals 
with varying levels of disability who are unable to remain at home.
The vast majority of elderly people live or are cared for at home, with 
only 3.5% residing in any kind of institutional setting (with some 2.5% in a 
skilled nursing home). Even among the disabled elderly, nearly 80% still live 
in the community because of the extensive care provided by families and the 
development of formal services (some quite innovative) intended to reinforce 
this social support and to help families to cope with the burden of care.
The Community Long-term Care Insurance Law (CLTCI Law)
Of the various models available, Israel chose to adopt the social insurance 
approach to the provision of non-professional home care. In 1980, a 
0.2% employee contribution to the NII was levied to create a reserve fund 
for implementing the CLTCI Law. By 1986, the Knesset had completed the 
enactment of the CLTCI Law, and full implementation began in 1988. The 
basic entitlement is for in-kind services, carefully delineated as a “basket of 
services” closely related to the direct care functions normally provided by 
families, such as personal care and housekeeping. Benefits may also be used 
to purchase day-care services, laundry services, absorbent undergarments for 
the incontinent, or membership to a 24/7 emergency call system.
Actual services are provided on the basis of benefit levels, according to the 
level of disability (equivalent to 10, 16 or 18 hours of home care per week). Since 
March 2009, those who receive the highest two levels of benefits, and employ 
an Israeli home-care worker (as opposed to a foreign worker) are eligible for 
an additional three to four hours of care weekly. Eligibility for benefits is 
dependent on disability and not affected by any informal assistance an elderly 
person may receive. There is a means test for receiving benefits under the 
32 This section was prepared by Jenny Brodsky.
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CLTCI Law, but it is set at such a high level relative to the income status of the 
elderly that the majority of those who meet the clinical requirements are eligible 
for the entitlement.
The less disabled elderly, who are not eligible for such services, may still 
receive home care services from the social welfare system under a budget-
restricted, income-tested programme. This programme, however, provides 
fewer hours of care. Home care (personal care and housekeeping services), is 
provided by semiprofessional staff working for certified, licensed agencies. 
These agencies may be NGOs or profit-making agencies. The choice of 
service provider is made by a local committee responsible for care planning, 
in consultation with the client and her/his family.
The first effect of the CLTCI Law was a tremendous increase in the resources 
earmarked for community care. This decision resulted in a more balanced 
allocation of public resources between institutional and community care. Prior 
to the Law’s implementation, expenditure for community services was limited, 
representing only 17% of public funds for LTC. However, by 1994 (six years 
after the Law’s implementation), public funds for community care grew to 
constitute half of public funding for LTC. This legislation has had a dramatic 
effect on health care coverage for disabled elderly people in the community. 
For example, the proportion of elderly receiving home care increased from 
2% prior to implementation of the law to 18% of the total elderly population 
(approximately 160 000 elderly people in 2013) (NII, 2014a).
Day-care centres
In addition to some 1400 social clubs that provide a framework for activities 
and facilitate interpersonal contact and socialization for the elderly population 
who are in good health, a network of day-care centres for the disabled elderly 
has been developed. Day-care centres contribute significantly to the ability of 
the disabled elderly to remain in the community. The service also improves the 
quality of their lives and releases the family from caregiving duties during the 
day, freeing them to work and attend to other tasks.
A network of some 175 centres serves approximately 15 500 elderly 
individuals, just over 2% of the country’s elderly population. The number 
of centres has expanded since the enactment of the CLTCI Law, which also 
provides entitlement to day-care services. Most centres are stand-alone 
organizations, although some are affiliated with other institutions (sheltered 
housing, old-age homes, etc.). The centres must be licensed by the Ministry of 
Social Affairs and they usually operate five or six days a week, offering social 
and recreational activities, personal care, hot meals, transportation, counselling 
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and health promotion. Day-care centres in Israel differ from centres in other 
countries as they emphasize social rather than medical care, and consequently 
are relatively lower in cost.
Another significant development within the day-care centre network has 
been the establishment of special programmes for the cognitively impaired, 
including elderly people with Alzheimer’s disease and other types of dementia. 
Recently adopted standards for adult day care in Israel require that all new 
facilities set aside a special place for cognitively impaired elderly individuals.
Supportive neighbourhoods
One of the most important and innovative developments in community care 
in recent years has been the supportive neighbourhood programme, designed 
to emphasize the neighbourhood as a force that provides the elderly with a 
sense of security and access to services. Elderly people who live in supportive 
neighbourhoods in cities, towns or rural areas enjoy a basket of services 
that includes:
• a neighbourhood facilitator who ensures their personal safety, as well as 
the safety and security of their homes, and also provides home repairs;
• an emergency call button;
• a physician/ambulance on call 24 hours a day; and
• social activities.
The elderly pay a fee to join the programme, which is subsidized by the 
Ministry of Social Affairs for those with low incomes. In 2015, there were more 
than 230 supportive neighbourhood programmes across Israel, serving some 
48 000 elderly people (about 6% of the country’s elderly population).
Other services in the community
In addition to the above-mentioned services, the network of services available 
to the elderly includes:
• tele-health services, provided by the HPs, for the frail elderly;
• social workers, with approximately 400 social workers across the country 
caring for the elderly population in the municipalities, providing features 
such as consultation, case management and supportive care;
• home repairs and adaptations;
• sheltered workshops;
• medical equipment and devices for functionally disabled people, primarily 
by Yad Sara, a voluntary organization;
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• information and counselling centres; and
• home visits by volunteers.
Institutional long-term care
While the acute and rehabilitative aspects of care are highly socialized, in 
terms of institutional LTC, the Israeli system is more analogous to the 
American Medicaid programme. Unlike the system operating in the acute and 
rehabilitative care sector, institutional LTC is not covered by the universal 
mechanism. Patients are categorized according to (one of) five levels of 
dependency for institutional placement. Institutions are regulated by two 
ministries: the Ministry of Health (institutions for the skilled nursing of the 
elderly) and the Ministry of Social Affairs and Social Services (institutions for 
the semi-independent and frail elderly).
As is the case in the American system, families who are able to purchase 
care from a licensed long-term institution (whether profit-making or non-profit-
making) are expected to do so. However, given the high cost of such care 
(approximately US$ 2900 per month, or €2700), more than two thirds of families 
turn to the Ministry of Health for a subsidy (which can cover up to the entire 
cost of care). Co-payments are applied according to income in a progressive 
system. Interestingly, according to the Alimonies Law, which provides for 
filial responsibility, children in Israel are required to contribute to the cost of 
institutional care for their parent(s), depending on their economic situation and 
that of the elderly parent concerned.
Issues and challenges
In recent decades, Israel has increased the resources it earmarks for community 
care and created an infrastructure of community services. This has resulted 
in a more balanced allocation of public resources between institutional and 
community care, and a better balance of responsibility between the family and 
the state. While the solutions are still far from meeting all needs, and families 
continue to be the primary caregivers, the services provide at least a modicum 
of care to all elderly people. Moreover, the system implicitly recognizes the 
value of caregiving, and the government shares at least some of the burden of 
caring for the elderly population.
Nevertheless, the significant growth in the number of elderly, and the 
ageing of the elderly population itself, has led to a substantial rise in the need 
for LTC and to pressure on the formal system of care. The backdrop to this 
situation is very complex. On the one hand, social policies and the welfare state 
in general are being called into question, in part through pressure to reduce 
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public expenditure. This provides an impetus to develop home and community 
services, which are viewed as the best solution in both economic and human 
terms. “Aging in place” is perceived as being preferred by the elderly and, in 
the majority of cases, a less expensive alternative to institutional care. On the 
other hand, there is increasing pressure on families to care for their elderly 
relatives precisely when many women (the majority of primary caregivers) 
have joined the labour force and have less time to devote to the care of elderly 
relatives. In this context, it is important to promote and develop legislation 
and work agreements that facilitate family members to care for and look after 
their elderly parents and relatives while continuing to fulfil their obligations to 
their employers and the nuclear family. Such an example in the Israeli context 
is the Sick Pay (Absence because of Parent’s Sickness) scheme, which allows 
employees to ascribe up to six days of their accumulated annual sick leave to 
absences caused by the illness of their own or their spouse’s parents aged over 
65 years. It is important to continue to promote this type of development.
Support of informal caregivers should entail the development of a range 
of intervention activities that reflect the caregivers’ needs in various areas, 
such as information, counselling, acquisition of skills, care management, 
socioemotional support, provision of respite options and financial support.
In addition, there is serious concern about the lack of professional and 
non-professional personnel to care for the growing number of elderly. 
Already there is a shortage of doctors and nurses, as well as home caregivers. 
Government ministries are working on ways to make the system more efficient 
and provide the incentives needed to ensure nursing personnel.
Another policy issue that continues to be a major concern in the system 
is fragmentation between health and social services, as well as among LTC 
services, which leads to wasted personnel and financial resources and all but 
precludes the adequate utilization of services. Problems of coordination must be 
solved at the levels of both policy-making and service provision. Reforms and 
innovative programmes to better integrate among the different components of 
the system are now in the agendas of the health and social ministries.
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5.9 Services for informal carers
Informal care refers to the provision of unpaid care, typically by a family 
member, to an individual who requires help with activities of daily living.33 
Examples of individuals with such needs could include people with dementia, 
the physically disabled, individuals with learning disabilities, the terminally ill 
and people with mental health problems.
In Israel, informal care has remained extensive despite the accelerated 
development of the formal service system, and informal caregivers provide 
most of the care for the elderly and people with disabilities, as described above 
(Brodsky et al., 2004; Wertman et al., 2005). It is estimated that 30% of adults 
(aged 20 and older) provide informal care; among individuals aged 45–64 years 
this rises to 38%. Approximately two thirds of informal caregivers provide 
support to a relative aged 60 years or older. Most primary caregivers live with 
or in proximity to their elderly relative. Informal caregivers provide assistance 
in a range of areas (CBS, 2008), for example:
• activities of daily living (e.g. washing and dressing): 43%;
• instrumental activities of daily living (household management, such as 
preparing meals and shopping): 25%;
• errands outside the home (e.g. going to the bank and post office, 
purchasing medications and accompanying the patient to medical 
treatment settings): 71%; and
• social support: 86%.
A significant number of primary caregivers (between half and two thirds, 
depending on the population) report feeling burdened. According to various 
studies, more than two thirds of caregivers report having physical difficulties 
(including that caregiving requires too great a physical effort and adversely 
affects their health). More than two thirds report that their social and leisure 
activities have suffered (e.g. that caregiving leaves the caregivers little time for 
themselves or their family). Over 90% of caregivers report emotional stress 
(e.g. that caregiving increases tension in the caregiver’s own home, or that the 
relative’s condition worries and upsets the caregiver).
Furthermore, studies have shown that caregiving also has implications for 
the caregiver’s participation in the job market, and for the work of those who 
are employed. A total of 58% of all caregivers are employed; this percentage 
33 This section was written by Jenny Brodsky.
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increases to more than 66% among caregivers who have not yet reached 
retirement age. A considerable proportion of caregivers who are employed (19%) 
report losing working days during the past month (CBS, 2006).
In general, there are two ways to alleviate the burden on family caregivers:
• provide formal services for the elderly and those with disabilities 
(e.g. a home caregiver, a day-care centre); and/or
• provide services to caregivers (such as monetary or emotional support).
Section 5.8 provides a description of the main formal services provided 
to those in need of LTC. These services aim to enhance the quality of life of 
the disabled and provide assistance and support to informal caregivers. It is 
interesting to note that, in the past, the formal subsidized help provided by 
public agencies focused on elderly people who had a dysfunctional family or no 
family at all – these were the only situations in which society felt responsible for 
the welfare of the elderly. The coverage provided by the service system today 
is broader, recognizing that the family alone cannot carry the entire burden of 
care, which has ramifications for society. In fact, assistance to the family is 
often now official policy, affecting the development of formal services.
The status of informal caregivers in Israel: laws, programmes and policy
The service system sees the family as primary agent of an elderly person’s 
well-being and welfare, and formal services as supplementary. Moreover, in 
Israel, family members are legally obligated towards their elderly relatives; it 
is one of the few countries in which the obligation of children towards their 
elderly parents is anchored in law. Not only is an elderly person entitled to 
demand subsistence payments from his or her relatives but also, in principle, 
government offices may also require families to care for an elderly relative 
before they agree to supply formal services. As long as the elderly person 
remains in the community, the government rarely exercises its right to require 
his or her family to provide care. However, the government does demand 
that families fulfil their legal obligation to finance the residence of an elderly 
relative in an LTC institution.
The legal rights of family caregivers centre on finances and employment. 
Four laws govern caregiving by a relative:
• an individual is entitled to miss workdays because of the illness of a 
parent or spouse, these being considered as “sick days”;
• an individual is entitled to compensation from her/his employer if the 
individual has to resign because of a relative’s poor health;
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• an individual is granted a tax exemption if he or she is helping to finance 
a parent’s placement in an institution; and
• an individual is entitled to an income supplement without undergoing an 
employment test if she or he cares for a sick relative.
Direct support of other kinds for family caregivers is limited. Some 
local programmes exist, but the national government has not devised any 
comprehensive programmes to support family caregivers directly. For 
example, since no clear guidelines exist, local government is not obligated 
to offer programmes, and these remain dependent on good will and the 
availability of a budget. Nevertheless, important new initiatives have been taken 
by governmental entities such as the NII and by several non-profit-making 
organizations. These are developing “information and referral” services and 
developing support groups over the country.
5.10 Palliative care
Palliative and hospice services are covered as part of the NHI benefits package.34 
However, there are no governmental guidelines on when, how and to what extent 
the HPs are required to provide these services. In Israel, there is an awareness 
of individual rights regarding end-of-life decisions, but there are also cultural 
concerns that impede its development into reality and policy. For many Jews 
in Israel, the concept of “sanctity of life” (kedushat hakhayim) is a central tenet 
(Glick, 1997). However, the community is pluralistic and substantial segments 
of public and health professionals reject this outlook and would prefer end-of-
life practices found in other countries. This situation is further complicated by a 
lack of widespread familiarity with palliative care precepts among many health 
care professionals and the public.
Legislation
The Dying Patient Act, adopted in 2005, attempts to allow patients to end their 
lives with dignity while respecting cultural reluctance to withdraw treatment 
and offering practical solutions that respect the wishes of patients and families. 
The Act supported the right of terminally ill patients with a life expectancy 
of less than six months to formulate advanced directives that may include the 
forgoing of treatment and the withdrawal of ventilator support (Steinberg & 
Sprung, 2006). However, implementation of the Act is only getting under way 
now, about 10 years after the legislation was passed.
34 This section was written by Netta Bentur.
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In addition, in 2009, the Director-General of the Ministry of Health issued 
a directive specifying standards for the development and provision of palliative 
care services by hospitals or HPs. The directive defines the target population 
for palliative care services as patients with considerable physical and emotional 
distress. It defines minimal standards for a palliative care service, which must 
include a physician, a nurse, a psychologist and a social worker. The document 
also details credentials required and hours of availability (State of Israel, 2009).
Service provision
As of 2015, about half of the general hospitals in Israel provide consultative 
or inpatient palliative care services. Three hospitals have well-developed 
palliative care services, including consultation services, ambulatory palliative 
care, inpatient palliative care and close coordination with community resources 
for home care. Services at others hospitals are typically limited to either a 
part-time palliative care consultant physician or a palliative care nurse. Some 
of them supply palliative services only to the oncology department and some 
supply consultation to all hospital departments. Nevertheless, most of the cancer 
centres in Israel do not have any designated physicians responsible for palliative 
care services. There is clearly a need to develop these services further.
There are two inpatient hospices in Israel – in Jerusalem and Tel Aviv – 
which have been allotted a total of about 41 beds. Additionally, a few hospitals 
belonging to Christian missionary organizations take in end-of-life patients 
who cannot be at home or for whom there is no hospice in their vicinity. They 
offer dedicated care, but the staff’s palliative training is very limited.
Israel has about 10 home-hospice units, most of which are operated by Clalit. 
They rely on multiple sources of financing, including Clalit’s budget, the sale 
of services to other HPs and (mainly) philanthropic contributions. There is no 
steady supply of funds to these units, making their existence precarious and 
impeding their ability to expand their activities. There is also one privately 
owned home-hospice organization which accepts patients, on an outsourcing 
basis from the four national HPs. It currently has only about 200 patients 
nationwide, but it is growing.
In addition, Israel’s four HPs operate home medical care units in all of their 
districts that provide medical, nursing and rehabilitative home care. These 
units treat housebound individuals, mostly elderly, who suffer from a variety of 
chronic and functional disabilities. The units supply palliative care for patients 
with metastastic cancer and neurological and degenerative diseases. However, 
they almost never provide palliative care for dying patients with dementia. 
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Moreover, the staff are typically available only during normal working hours. 
Although some are on call by telephone until evening, with some exceptions 
they are not generally available to provide services in the evening and at night.
The palliative care credentials of the members of these teams are very varied, 
and some have no formal training in palliative care. However, many home 
care units employ oncology or palliative care nurses on their staff who are 
available by telephone 24 hours a day. For the most part, these nurses guide 
other community health care providers in coping with complex situations 
and sometimes care directly for dying patients. They play a central role in 
coordinating hospital and community services, developing and implementing 
oncology and palliative projects in their district, training medical personnel and 
overseeing this type of care in their district (Bentur, Resnizky & Shnoor, 2005).
Although a large proportion of the residents of LTC institutions suffer from 
multiple symptoms at the end of life, overall many of these institutions still 
abide by conservative treatment methods. Nonetheless, they are beginning 
to adopt palliative and geriatric approaches and to integrate them into their 
routines. For example, more attention is being given to symptom management 
(e.g. by prescribing antidepressants) and pain reduction (e.g. by increasing 
the use of opiates). More attention is also being given to coordination of 
expectations with the families.
Overall, opioid availability and accessibility for patients with cancer is good. 
For these patients, medications covered by the benefit package, including all 
opioids, are dispensed at no cost. Most opioids are widely available in community 
pharmacies and patients need not present themselves to special pharmacies. 
However, the regulations regarding opioid prescription and dispensing make 
no provision for emergency physician prescriptions by telephone or fax, or 
emergency prescriptions by nurses or by pharmacists (Bentur, Emanuel & 
Cherney, 2012).
In Israel, although hospital- and community-based palliative and hospice 
services exist, they are less well developed than optimal. It is estimated they 
serve less than 10–15% of those who could benefit from them, but there are 
no robust statistics on how many people are referred to palliative care. Lack 
of resources for palliative care is a substantial problem, and Ministry of 
Health policy initiatives for the development and provision of new palliative 
care services and training, without allocation of any new resources, may not 
produce substantial change. This concern is especially grave given the extreme 
limitation of resources already allotted to the health care sector, which is 
struggling to address other core elements of its mandate; however, because of 
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the lack of services and the misconceptions that abound regarding palliative 
care, referral is probably very low. The development of grassroot programmes 
plus the existing infrastructure of primary home care, processional organization 
and focal areas of expertise provide excellent substrata for the development of 
palliative care in Israel. Inadequate resource allocation, lack of educational 
guidelines at all levels of medical and paramedical training and difficulties in 
facilitating the development of human resources with credentials in palliative 
care are among the key factors that continue to thwart the development of 
palliative care in Israel.
Education and training
Palliative medicine was finally approved in 2013 as a new subspecialty for 
physicians (requiring another specialization first, which is usually internal or 
family medicine) after over 10 years of resistance from the Scientific Council 
of the IMA. The palliative medicine training programme lasts 24 months. It 
is expected that the new specialization will substantially increase awareness 
among the public of their entitlement to good palliative care, just as the 
recognition of pain medicine as a specialty was achieved in 2010.
The nursing division of Israel’s Ministry of Health recognized palliative 
care as a subspecialty in 2012. Currently, there are over 35 palliative care nurse 
specialists across Israel and their duties range from coordinating palliative care 
programmes to personally administering care. All nurse training programmes 
in oncology and chronic diseases have incorporated palliative care into 
their curriculum.
Today, the curricula of education and training programmes for health 
professionals, both undergraduate and postgraduate, provide very little formal 
training in palliative care. Issues relating to suffering and terminal illness have 
been included in the curricula of medical and nursing schools only as part 
of general topics such as ethical issues or pain management. Israeli medical 
schools include very limited training in palliative care. The family medicine 
residency training programmes include an elective in palliative education. 
There is also a National Palliative Care Training Programme (INPACT) for 
postgraduate education, which includes approximately 40 hours of training, 
as well as a variety of enrichment and continuing medical education courses 
(Shvartzman et al., 2011).
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5.11 Mental health care
The cuurent mental health care system is described here.35 However, it is in the 
midst of a major reform effort, which is described in more detail in section 6.1.2.
5.11.1 Providers and financing
The data in this section draws heavily on the Public Summary Report of the 
Ministry of Health (2013a). In 2012, Israel had 3467 psychiatric beds: 0.43 beds 
per 1000 population. About half these beds are for short-term psychiatric 
care and half are for psychiatric LTC. Approximately 10% of all psychiatric 
beds were in psychiatric wards in general hospitals and they accounted for 
approximately 15% of psychiatric admissions. The proportion of psychiatric 
beds in general hospitals is lower than in most developed countries, but as in 
other countries the trend is for a higher proportion of the beds to be located in 
general hospitals.
The psychiatric hospital network comprises 13 psychiatric hospitals, of 
which eight are government owned, three are privately owned and two are 
owned by HPs. In addition, there are 12 psychiatric departments in general 
hospitals and one in the prison system. The government and HP psychiatric 
hospitals treat a mix of long-term and short-term patients, while the private 
psychiatric hospitals treat long-term patients almost exclusively.
The number of beds has declined dramatically from 2000, when there were 
5619 beds. The share of private (for profit) beds has declined from 25% to 6% 
from 2000 to 2012.
In 2012, government hospitals accounted for approximately 82% of the 
beds, admissions and patient days in psychiatric hospitals (Haklai et al., 2014). 
The rest of the beds are in hospitals owned by non-profit-making groups. The 
Ministry of Health finances mental health care in government hospitals, private 
hospitals and psychiatric departments in general hospitals.
In the community, there are a large number of private, independent mental 
health practitioners and, as of May 2015, there were approximately 120 public 
mental health clinics (including outpatient clinics in psychiatric hospitals). 
About half of these were established by the HPs in the 2012–2015 period with 
financial support from the government, as part of the mobilization for mental 
35 This section was prepared in collaboration with Hadar Samuel.
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health insurance reform (see section 6.1.2). Among the clinics that had been 
established prior to 2012, the vast majority are operated by the Ministry of 
Health, while others are operated by Clalit.
The Israeli component of the World Mental Health Survey 2003–2004 
((Levinson et al., 2007a) found that the prevalence of common psychiatric 
disorders and the rate of care seeking were within the ranges found in other 
developed countries. Even so, only half of the respondents who met the criteria 
for a psychiatric disorder actually sought care for that disorder (Levinson 
et al., 2007b).
In a 2013 MJB survey of the general adult population (Elroy et al, 
forthcoming), 18% of 2,246 respondents indicated that they had experienced 
mental distress over the past year that was difficult to cope with alone. From 
among that group, 23% did not seek any assistance, 31% sought assistance from 
informal sources (such as friends and family members), approximately 36% 
sought assistance from professionals and 10% sought care from non-professional 
formal sources. 40% of those who sought assistance from professionals did so 
within the framework of their HPs: 21% turned to their PCPs; and 19% sought 
help from HP-affiliated mental health specialists. Another 27% of all those 
who sought care from professionals turned to a government clinic, while 30% 
turned to private practitioners.
The Mental Patients’ Treatment Act 1991 empowered the district 
psychiatrists employed by the Ministry of Health to order compulsory 
psychiatric examination or psychiatric inpatient and outpatient care. The 
courts can also order psychiatric admissions. In 2011, approximately 30% of 
new psychiatric hospitalizations were compulsory. There are various efforts 
under way to reduce the powers of the district psychiatrists, for example by 
transferring more of the powers to the courts.
In 1990, the Ministry of Health created a Unit for Addiction Treatment within 
the Mental Health Services Division in order to have an effectively organized 
administrative system to respond to the complex needs of addiction treatment. 
Israel has three centres for drug abuse and mental disorders comorbidity, which 
cared for approximately 400 patients in 2014. Israel also had 14 methadone 
maintenance centres, which together cared for approximately 4000 opiate 
addicts in the year 2014, plus eight inpatient care units for drug addicts, with 
a total of approximately 140 beds. While services for people with addictions 
are much more widely available than they were in the mid-1990s, they are 
increasingly recognized as falling far short of need. The Ministry of Health 
has targeted this area as a priority for expansion.
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There is a growing recognition of the need to develop services for people 
suffering from both mental illness and substance abuse. These people have 
traditionally been passed back and forth between psychiatric and addiction 
treatment centres, being treated properly in neither. At the time of writing, there 
are several new programmes targeted at this section of the population, but these, 
too, fall far short of need.
5.11.2 Recent changes in infrastructure and utilization
Since the early 1990s, the mental health care system has undergone several 
significant changes. Consistent with international trends, the supply of 
psychiatric beds per 1000 population has been reduced, from 1.48 in 1990 to 
0.76 in 2005 and to 0.43 in 2012. There has also been a dramatic reduction in 
the utilization of psychiatric hospitals. Following a rapid decline during the 
1990s, inpatient care days per 1000 population fell from 496 in 1990 to 204 in 
2005 and 155 in 2012 (Ministry of Health, 2014d). There has also been a shift 
in the composition of psychiatric hospitalizations, from long-term to short-term 
admissions and to day care.
During the same period, there was an expansion of community-based mental 
health services, including both public mental health clinics and rehabilitation 
services involving hostels, independent housing, social clubs and others. In 
2012, approximately 16 000 people used one or more of these services. Some 
have argued that this expansion of community-based services has been one 
of the factors that permitted the reduction of inpatient volume, while others 
dispute it (Aviram & Rosenne, 1998). There was also a deliberate government 
policy of closing psychiatric beds in order to reduce costs. Advances in the 
psycho-pharmaceutical domain may also have played a role. In any case, it is 
generally believed that, although the community-based service network has 
expanded, it continues to fall short of need, as approximately 70 000 Israelis 
receive disability allowances in conjunction with a mental health disability.
Rehabilitation has been given a significant push recently, with the passing 
of the Community-Based Rehabilitation of the Mentally Disabled Act in 2000 
and a subsequent increase in government funding.36 The Law grants people 
with psychiatric illnesses the entitlement to a range of rehabilitation services, 
including appropriate housing in the community, supported employment, leisure 
time activities, supplementary education, dental care, family support and case 
management. Entitlement to specific services is determined on a case-by-case 
36 The phrase “mental disability” is still used extensively in legislation and public debate, despite the fact that its use 
is believed by some to be contrary to recent trends not to stigmatize mental health problems.
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basis by a regional committee. Individuals use this entitlement to receive 
services operated by profit-making and non-profit-making organizations in 
their area and are financed by the Ministry of Health.
Financing from the Ministry of Health has led, since 2006, to a rapid 
expansion of a range of rehabilitation services within the community. However, 
these services are being used by less than a quarter of persons receiving 
mental health-related disability allowances. In addition, some of the services 
being developed have, to a large extent, targeted people who were previously 
in hospital, for whom rehabilitation services are being expanded as a more 
cost-effective form of care than long-term hospitalization. The vast majority of 
individuals with psychiatric illnesses live in the community, often imposing a 
severe burden on families (see section 5.9). Rehabilitation services are difficult 
to obtain for these people.
In addition to financing on the basis of individual entitlement, the 2000 
Community-Based Rehabilitation of the Mentally Disabled Act called for the 
establishment of two services to be directly funded by the Ministry of Health: 
a national mental health information centre and regional family support centres.
5.12 Dental care
When Israel adopted NHI in 1995, dental care was not included in the benefits 
package, except for maxillofacial surgery for trauma and oncology, and 
dental care for oncology patients.37 The 1990 Netanyahu Commission had 
recommended that services provided under NHI include maintenance and 
preventive dental care for children aged 5–18 years, and maintenance and 
rehabilitative dental care for elderly people, but these were not included in the 
NHI Law.
The situation concerning children changed in 2010, when the NHI benefits 
package was extended to include preventive and preservative dental care for 
children up to age 8. The age limit was later extended to 12. Care is provided by 
the four HPs, with preventive services free and preservative services provided 
with small co-payments (Rosen, 2012). In 2013, the MJB Institute and the 
Ministry of Health completed a survey that provides extensive data on the extent 
of use of these services by different population groups and on the remaining 
barriers to care among children. The survey found that 45% of children aged 
2–12 years used the publicly funded services (Ashkenazi et al., 2015).
37 This section was prepared in collaboration with Yael Ashkenazi and Shlomo P. Zusman.
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The government plays a growing role in the provision of dental services. 
The Ministry of Health provides financing to local authorities offering oral 
preventive services in schools. Until 2009, only 25% of municipalities offered 
school dental services (Machnes & Carmeli, 2009); these services were 
financed jointly by the municipality, the Ministry of Health and parents. Since 
2010, the government has been fully funding the school dental service, which 
expanded in 2012 to 80% of the municipalities. The Ministry of Social Welfare 
subsidizes dental care costs for indigent people, though to a much lesser extent.
Although access to dental care for children up to age 12 has been secured, 
serious concerns remain regarding take up of access to care for this age 
group, particularly for vulnerable populations. Dental treatment for specific 
groups of patients with congenital syndromes compete with other new medical 
technologies to be added to the NHI. Because of budget limitations, only a few 
of these groups receive publicly funded services. Budget limitations have also 
prevented the introduction of two other measures that have been considered in 
recent years to improve access to dental care: extension of dental coverage for 
children up to age 18 and extending dental coverage within the NHI benefits 
package to the elderly, to ensure access to dental care for those who need it 
most and can afford it least.
In 2002, a national survey of 12-year-old children showed improvement 
in dental health, with an average decayed/missing/filled teeth level of 1.66 
compared with 2.99 in a similar survey in 1989. Moreover, 46% were caries 
free (ICDC, 2008). No national survey has been carried out since.
In 2011, dental care expenditure accounted for about 8% of THE (CBS, 2014d), 
almost all of it in the form of direct OOP payments. Approximately 10% of 
the population has VHI from commercial insurers covering dental care (see 
section 3.5). In addition, approximately 80% of Israelis have VHI from their 
HPs (Ministry of Health, 2013a) that provides substantial discounts for a set 
of dental services, which has been substantially enlarged in recent years. In 
2011, the average household spent NIS 193 (about €40) per month on dental 
care, which accounted for 25% of household spending on health, not including 
the health tax (CBS, 2014c). Among households in the lowest income deciles, 
average spending on dental care was only NIS 82 (about €17) per month, 
58% below the national average (CBS, 2012), and spending on dental VHI was 
negligible, despite the greater-than-average prevalence of dental problems in 
this group.
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Until the mid-1990s, almost all the dental care in Israel was provided by 
independent private dentists. Since then there has been substantial growth in 
commercial dental chains and the HPs have also expanded their own chains of 
dental care clinics; services provided by these clinics are paid through either 
OOP or VHI payments. In 2007, independent private dentists accounted for 
approximately 66% of dental care provision, while the HPs accounted for 9% 
and commercial chains accounted for 20%.
Licensing of dentists is the responsibility of the Ministry of Health. In 2012, 
Israel had 10 448 licensed dentists: 1.31 per 1000 population, which is among 
the highest in the world. This was also significantly (64%) higher than the 1989 
figure of 0.94, primarily the result of immigration of over 1200 dentists from 
countries of the former USSR in the early 1990s. There were also 4065 licensed 
dental technicians and 2027 registered dental hygienists, whose tasks are 
centred on dental health education and prevention of dental illnesses.
Another important government role was promoting fluoridation of the 
water supply. Israel’s fluoridation programme began in the late 1970s. In 2010, 
approximately 70% of the population benefited from having fluoride in the 
water. However, the issue of water fluoridation has been the subject of much 
debate in recent years, and in August 2014 fluoridation was stopped.
5.13 Complementary and alternative medicine
Major changes in the status and influence of CAM have occurred in Israel since 
the early 1990s.38 These changes are similar to those seen in other developed 
countries and ref lect growing disillusionment with the technology and 
bureaucracy of biomedicine, increased questioning of its excessive invasiveness, 
heightened consumer awareness of iatrogenic effects of modern medicine, 
growth in expectations for quality services, and widespread demystification that 
has led to considerable erosion of confidence in modern medicine (Clavarino & 
Yates, 1995; Rees & Wieil, 2001).
In Israel, a 1976 law provides that only those holding a recognized medical 
licence may practise medicine. The IMA deplores the unscientific and 
unproved basis of “alternative” medicine, the absence of acceptable training 
by its practitioners and its potential dangers to “un-knowing” patients. At 
the same time, it acknowledges the possible usefulness of certain forms of 
alternative medicine (e.g. acupuncture, chiropractic, podiatry), provided these 
38 This section was written by Judith T. Shuval.
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are practised by or under the full supervision of a biomedical physician. As for 
homeopathy and herbal medicine, the IMA states that only licensed physicians 
are authorized to practise in these fields (IMA, 1997).
Despite this formal stance, many physicians in Israel view certain CAM 
methods as useful. Research shows that some physicians, nurses, midwives and 
physiotherapists have studied and actively practise in one or several CAM fields 
(Shuval & Mizrachi, 2004; Shuval, 2006; Shuval & Gross, 2008; Averbuch-
Smetannikov, 2010; Shuval & Averbuch, 2012a,b).
Approximately 25% of children who visited a CAM practitioner had been 
referred by a physician (Ben Aryeh et al., 2011).
Over 20 forms of CAM are in widespread use in Israel. In 2011, there were 
13 000 CAM practitioners in Israel, about 7000 in full-time practice. CAM is 
taught in a large variety of programmes; over 45 000 persons have studied in 
such courses varying in length from a few months to four full years. These 
programmes differ considerably as to the level and quality of teaching, with no 
institutionalized form of supervision or control.
The proportion of the adult population that consulted with a CAM practitioner 
during the previous year has increased from 6.1% (1993) to 9.8% (2000) to 
12.2% (2007), with 2.7 million total visits in 2009 (CBS, 2010b). Relatively large 
increases have been observed in women, people who are younger and people 
with more years of schooling, higher economic status or residing in large cities. 
Between 1993 and 2011, non-conventional medicine in Israel grew from an 
infant industry into a mainstream health commodity (Shmueli & Sihuval, 2004; 
CBS, 2010b; Shmueli, Igudin & Shuval, 2010).
The 1995 NHI Law sought to reduce costs and encourage competition among 
the hospitals and among the four HPs (Chinitz & Rosen, 1993). While the 
mandatory benefits did not include CAM, the context of growing competition 
spurred health care providers to initiate such services as a cost-effective means 
to expand their services and augment their income by attracting growing 
numbers of consumers who were willing to pay for CAM services. As a result, 
there has been a growth in the establishment of community clinics dedicated 
to CAM under the auspices of major segments of the publicly supported 
biomedical system.
In 1991, an outpatient clinic for CAM was established in the Tel Aviv area 
(Assaf Ha’rofe), followed by similar clinics under the auspices of one third of 
the public hospitals and in extensive networks by three HPs in the major urban 
areas (Shuval & Mizrachi, 2004; Shuval & Averbuch, 2012a,b). In most cases, 
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these clinics are headed by a physician who has also trained in one of the CAM 
specialties. The physician is responsible for an initial interview with all new 
patients and their referral to the desired CAM practitioner.
CAM practitioners are generally employed on a part-time basis at 
community clinics and many also maintain their own private clinics elsewhere. 
No practitioner has a regular appointment to the hospital or clinic staff and all 
work on the basis of ad hoc contracts. Patients pay on a FFS basis; however, 
this fee is reduced for 75% of the population who carry supplementary health 
care insurance to cover services not included in the universal set of health care 
entitlements (Brammli-Greenberg & Gross, 2003; Shuval & Mizrachi, 2004; 
Keidar & Horev, 2010).
Hospitalized patients are also exposed to CAM. While in 2000, CAM 
practitioners were thinly spread in a number of the public hospitals in numerous 
departments, by 2011 the CAM presence inside Israeli hospitals had increased. 
Many hospitals are inspired by American examples on which they seek to model 
their services, especially in the field of oncology (Sloan Kettering, Dana Farber, 
Anderson) to assist in alleviating the side-effects of radiological treatments and 
chemotherapy, reduce tension, lessen pain and strengthen coping strategies.
In 2010, an experimental programme was started utilizing CAM before 
and after surgery. In order to gain legitimacy, the experiment is defined as 
a research project: all the CAM procedures are meticulously monitored 
(in the patient’s biomedical clinical record), including the patient’s response 
to treatment. While the operating theatre itself remains closed to CAM, the 
boundaries of its surrounding territory in which critical pre- and postsurgical 
procedures occur have been re-contoured to admit CAM practitioners (Shuval 
& Averbuch, 2012a).
5.14 Health services for specific populations39
Persons living in Israel who do not have formal residency status are not covered 
by Israel’s NHI Law. Foreign workers are one such group. It is estimated that at 
the end of 2014 Israel had approximately 75 000 legal foreign workers (i.e. those 
with valid work visas) and an additional 15 000 foreign workers living in Israel 
without such visas. The Foreign Workers Law requires employers to provide 
health care insurance to both these groups. The coverage provided must be 
the same as that provided by NHI, with the exception of treatment abroad, 
39 This section was prepared in collaboration with Tuvia Horev.
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certain mental health services and LTC services. The NII provides coverage 
for the care of foreign workers injured on the job, just as it does in the case of 
Israeli workers.
Another significant category consists of those from the Palestinian Authority 
or Arab countries who are living in Israel in the framework of a law governing 
family reunification; there are about 8000 such people. They are entitled to 
receive care through the HPs; their benefits package is similar to NHI with the 
main exception being treatment abroad.
Children living in Israel who lack residency status can be registered with 
one of the HPs (Meuhedet), with the parents or guardians required to pay the 
insurance premiums. Approximately half of these children have been registered. 
The coverage is similar to NHI, with exclusions of treatment abroad and (in the 
case of children born outside of Israel) treatment for conditions that existed 
when the child arrived in Israel.
The government makes several services available to all people in Israel 
irrespective of their legal status. These include emergency care, preventive 
mother and child health services and treatment for tuberculosis, HIV/AIDS and 
other sexually transmitted infections.
All of the HPs sell health insurance coverage to non-residents and those who 
purchase it become members of the HP and receive most of the services in the 
public health basket.
A special clinic in the Tel Aviv area, run in the context of cooperation 
between the Ministry of Health, the municipality and various non-profit-
making organizations, provides various health care services to non-residents 
who lack health insurance.

6. Principal health reforms
In recent years, the intensity of reform efforts in Israeli health care has been greater than at any time since the passage of NHI in 1995. Many of these efforts have been, or are in the process of, being implemented. Others have 
not been realized, at least as yet.
The Ministry of Health and the health care system more broadly are in the 
midst of a major, multipronged effort to reduce health inequalities. The effort 
is based, in part, on the understanding that, as in other countries with universal 
health insurance programmes, inequalities persist despite universal coverage. 
In Israel, the growth of private insurance and private care provision, and the 
erosion of public funding relative to needs, further underscores the need to 
address health equity issues. Major components of the effort include enhancing 
financial access to services, strengthening the publicly funded health system, 
constraining the growth of the private system, enhancing the availability of 
services and key professionals in the periphery, addressing the unique needs 
of various linguistic and cultural minorities, promoting interministerial 
and intersectoral cooperation and disseminating information about health 
care disparities.
In July 2015, mental health services were added to the set of services that 
the HPs must provide to their members within the framework of NHI. As such, 
mental health care services became a carefully specified, legally guaranteed 
right of all Israeli citizens with the government specifying the set of mental 
health services that the HPs must provide to their members.
For over a decade, Israel has had an extensive and successful programme for 
monitoring quality of care in the community. In recent years, that programme has 
undergone several important developments. In addition, the Ministry of Health 
has launched an extensive programme to monitor quality in hospitals, including 
publication of comparative data on sensitive issues such as waiting times.
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Since the mid-2000s, several significant steps have been taken to increase 
the overall supply of physicians. Two key measures include the establishment of 
a new medical school in the Galilee (Israel’s northern region) and the expansion 
of class sizes in all existing medical schools. The number of new medical 
licences issued has doubled in less than 10 years.
Israel’s LTC system is seriously fragmented. Ministry of Health planners, 
and many independent analysts, took the view that this fragmentation was 
resulting in service gaps, duplication, inefficient incentives and inadequate 
investment in prevention and rehabilitation. In 2011, the Ministry of Health put 
forward a detailed plan for a major reform of the LTC system. The plan was 
not adopted at the time, but it is now being reconsidered by the government.
In June 2014, Israel’s Advisory Committee for Strengthening the Public 
Health System issued a report proposing the most comprehensive reform to 
Israel’s health care system since the introduction of NHI. However, because of 
the recent change in government, it is unclear which, if any, of the committee’s 
recommendations will be moved forward.
6.1 Analysis of recent reforms
This chapter describes Israel’s recent reform efforts related to equity 
enhancement, mental health care, quality monitoring/improvement and 
the projected physician shortage. Other recent reforms have been described 
briefly in previous chapters. These include the launching of an intersectoral 
Health for All effort (section 2.6), the expansion of NHI to include paediatric 
dental care (section 5.12), enhanced regulation of the private insurance sector 
(section 3.5), the recent efforts to establish a hospital authority (halted in the 
wake of the change in government) and an overhaul of the hospital pricing 
system (section 3.7).
6.1.1 Reducing inequalities in health and health care
Awareness of the existence of health inequalities despite the universal health 
insurance programme has generated major multifaceted efforts to reduce this 
problem. The growth of private insurance and private care and the erosion of 
public funding relative to needs have added to issues of health equity.
In 2008, in one of the earlier countrywide efforts, Clalit HP (which insures a 
majority of the national low socioeconomic status groups) introduced disparity 
reduction as one of its organizational key strategic goals. The population 
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identified as in need of particular attention and focused interventions included 
400 000 of its members in community clinics serving lower socioeconomic 
populations (in all geographic localities throughout the country). In the wake 
of these interventions, disparities between this disadvantaged population and 
the general population in the most hard-to-change health care quality measures 
were reduced by over 63% in three years, and these reductions were maintained 
even when the focus was shifted to other populations (Balicer et al., 2015). Data 
also suggest diminishing disparities in health outcomes in the 400 000 members 
targeted through this programme.
Since 2010, the Ministry of Health has included disparity reduction among 
the pillars of its overall strategic vision. It has developed a multiyear plan for 
advancing this objective and established a distinct unit dedicated to this issue 
(see also Waitzberg & Rosen, 2014).
One major initiative has been to enhance financial access to services, 
particularly for vulnerable populations and those with low incomes. This has 
involved expanding the NHI benefits package to include such vital services 
as dental care and mental health care, eliminating co-payments for mother 
and child preventive care, and reducing the burden of co-payments for 
pharmaceuticals and various NHI-financed services for vulnerable populations, 
such as the elderly and the chronically ill (see section 3.4).
A second major initiative has been to strengthen the publicly financed health 
system (which tends to be relatively equitable) and to constrain the growth 
of the private system (which tends to enlarge disparities). Indeed, this was 
the focus of a major blue ribbon panel (the German Committee, described in 
section 6.2). One of the Committee’s recommendations that has already been 
adopted was to increase the level of funding of the public system – both for 
generic uses and for targeted uses, such as reducing waiting times.
A third major initiative has been to enhance the availability of services and 
key professionals in the periphery. In recent years, the Ministry of Health has 
invested substantial financial resources in increasing the periphery’s supply 
of hospital beds, advanced medical devices, specialized hospital units and 
free-standing emergency centres.
In addition to providing direct funding, the Ministry of Health is also using 
financial incentives to encourage other health system actors to give greater 
attention to the periphery. For example, a “peripherality” parameter was added 
to the HP capitation formula and the HPs were also offered (and received) 
special (conditional) payments if they undertook specific initiatives to improve 
care in the periphery (see section 3.3.3).
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In addition, there are now major financial incentives for physicians to 
relocate to the periphery.40 Moreover, Israel established a new medical school 
in the Galilee in 2011 as part of an effort to enhance the quantity and quality 
of physicians in the region.
A fourth major initiative has been to better address the unique needs 
of various linguistic and cultural minorities. Efforts in this area include 
establishing a national call centre for translations needed in patient–clinician 
encounters, establishing cultural responsiveness requirements for all health 
care providers, developing cultural responsiveness training materials and 
programmes for health care professionals and launching targeted interventions, 
such as the National Programme to Reduce Infant Mortality among the Bedouin 
(Belmaker, 2010).
A fifth initiative involves promoting interministerial and intersectoral 
cooperation (beyond the usual health system actors) to address the social 
determinants of health. Relevant efforts include cooperation with the Ministries 
of Education and of Sport to promote healthy lifestyles, participating in a 
multiministerial effort to develop strategies for reducing poverty and its effects, 
and involving a broad range of civil society representatives in roundtable 
discussions of ways to reduce health disparities.
A sixth initiative involves the creation, analysis and dissemination of 
information about health care disparities. As part of this effort, the Ministry of 
Health has promoted transparency regarding interregional and inter-institutional 
differences in quality of care, waiting times and other key parameters. It has 
encouraged the Gertner Institute to establish a knowledge centre on inequalities 
that is collating data from a variety of sources to track and analyse inequality 
trends over time. The Ministry also encourages efforts at the MJB Institute 
and other universities and research centres to carry out in-depth studies related 
to inequalities.
The Ministry of Health is not the only health system actor working to 
reduce health inequalities. Each of the four HPs has a well-considered disparity 
reduction plan as well as a professional who has been designated to coordinate 
the HP’s activities in this area. In recent years, the HPs have been able to 
document important achievements in reducing disparities when it comes to 
quality of care and other key areas.
40 These were instituted in the framework of the latest contract between the IMA, the government and other major 
health care employers.
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Israel’s hospitals are also giving increased attention to health care disparities. 
For example, they have been responsive to the Ministry of Health directive 
on cultural responsiveness by developing translation services, pursuing staff 
diversification and training, and so on.
6.1.2 Mental health reform
Israel’s NHI Law, adopted in 1995, stipulated that the legal responsibility for the 
provision of mental health care should be transferred from the government to 
the HPs within three years. Shortly after that, the planned transfer was officially 
put on hold. Subsequently, several attempts were made to pass the legislation 
needed to effect the transfer, but these were all unsuccessful.
Accordingly, Israel’s mental health system continued to function separately 
from its physical health system in terms of financing, planning, organization and 
practice setting. The government was responsible for the provision of mental 
health care, while the country’s HPs were responsible for physical health care.
In April 2012, the Israeli cabinet decided to move ahead with the transfer on 
the basis of a cabinet decision, rather than via legislation. The cabinet stipulated 
that the implementation of this decision would be gradual, and would be spread 
over a three-year period.
The transfer of responsibility is often referred to as the “mental health 
insurance” reform (conceived as part of broader mental health reforms 
that included efforts to reduce the number of inpatient beds and to develop 
community-based rehabilitation services; see section 5.11). In July 2015, 
mental health services were added to the set of services that the HPs must 
provide to their members within the framework of NHI. As such, mental health 
care become a legally guaranteed right of all Israeli citizens, rather than a 
service where availability is highly dependent on available budgets. The 
government specified the set of mental health services that must be provided 
and substantially increased the level of HP funding to cover the costs expected 
to be incurred by the HPs because of the new responsibility (see section 3.3.3).
The main objectives of the reform include:
• better linkage between physical and mental care;
• increased availability of mental health services;
• increased efficiency (through care provision by Israel’s highly effective 
HPs, within a capitation-based, managed care environment);
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• a reduction in stigma associated with mental health and mental health 
care;
• a reduction in mental health hospitalization through the development 
of new modalities of intermediate care;
• to enable the Ministry of Health to focus on its regulatory role, rather 
than on service provision; and
• to create the incentives and the flexibility to develop new types of 
intensive community-based services that could substitute for inpatient 
care.
At the same time, various concerns have arisen with regard to the reform, 
including:
• overmedicalization of mental health care;
• insufficient linkages with the education and social welfare systems;
• insufficient attention to the needs of the chronically mental ill; and
• underfinancing, which could lead to waiting times and insufficient service 
levels for vulnerable populations.
It is important to note that even before the 2012 decision, the HPs had all 
acquired substantial experience in the provision of ambulatory mental health 
care, with the extent and duration of that experience varying across HPs. A 2013 
national survey found that, among adults who had received care for a mental 
health issue over the preceding year (from either a PCP or a mental health 
professional), 40% had sought help via their HP; if attention was restricted to 
care from a HP-affiliated mental health professional, the corresponding figure 
was 19% (I Elroy, B Rosen & I Elmakias, unpublished data).
In all the HPs, psychiatric care and mental health care provided by PCPs 
has been free of charge, while psychotherapy has generally been provided on 
a cost-sharing basis. In Maccabi, psychotherapy has been made available to all 
members, while in the other HPs it has been made available only to members 
with supplemental insurance coverage. In the three smaller HPs, psychotherapy 
has been provided predominantly via independent practitioners working on a 
contracted basis, while Clalit has used a mix of independent practitioners and 
salaried practitioners (working in Clalit mental health clinics).
During the three-year transition period, the government encouraged 
(and financed) the HPs (particularly the smaller HPs) to set up multispecialty 
mental health clinics in regions that had previously lacked such clinics. The 
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government felt that these types of clinic are vital to the care of the seriously 
mentally ill, and that the HPs needed to upgrade their capacity to deal with 
this population.
Since the early 2000s, the HPs have invested substantially in preparing for 
the new responsibilities in mental health care. For example, even before the 
2012 decision they invested in upgrading the capacities of their PCPs to identify 
and respond to mental health needs. Since the 2012 decision, they have also 
expanded the number of mental health practitioners with whom they work.
The government has prepared intensively for the reform. For example, it 
developed a set of reporting requirements for the HPs regarding their mental 
health services and established rules regarding the financial interface between 
the HPs and the governmental psychiatric clinics.
Several key issues were resolved only in the months prior to the launch 
date. These include final decisions about the amount of additional funding to 
be provided to the HPs as a group, and the formula for the division of those 
new funds among the HPs.
6.1.3 Quality monitoring and improvement
Since the early 2000s, Israel has had an extensive and successful programme 
for monitoring quality of care in the community (OECD, 2012a). In recent years, 
that programme has undergone several important developments. In addition, the 
Ministry of Health has launched an extensive programme to monitor quality in 
hospitals, and initial efforts are also under way to begin monitoring continuity 
of care between hospital and community settings.
Quality monitoring in the community
The National Programme for Quality Indicators in Community Healthcare 
monitors the performance of the HPs on approximately 50 quality indicators, 
most of which relate to primary care. The measure set is expanded and refined 
on an ongoing basis. Most of the measures relate to health care processes, 
with a focus on processes that have been shown to have a significant effect on 
important health care outcomes.
The programme’s core team consists of senior faculty from the Hebrew 
University. Representatives of the four HPs are full partners in the project; 
they initially participated in the project on a fully voluntary basis. Recently 
the data reporting aspect of cooperation became mandatory, but even today 
the extent of cooperation far exceeds the legal requirements. The programme 
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operates under the auspices of the National Institute for Health Policy and 
Health Services Research and it is funded by the government NHI Law via the 
National Health Council.
Over the years, there has been substantial and steady performance 
improvements on most of these measures (Rosen et al., 2011a; Jaffe et al., 
2012). These improvements appear to reflect, at least in part, a broad range of 
initiatives undertaken by the HPs and front-line quality improvement efforts 
by their clinicians (Rosen et al., 2011b).
An important development took place in 2014 when, for the first time, 
the National Programme for Quality Indicators in Community Healthcare 
published the performance data by HP. Previously, the project’s public reports 
did not distinguish among the HPs. The change was made primarily as a result 
of court ruling in the wake of a suit filed by an NGO dedicated to transparency 
in public services. Prior to the publication of the plan-specific data there were 
concerns that it might undermine the voluntary cooperation among the HPs, 
but these concerns have not materialized.
Quality monitoring in the hospitals
For many years, the Ministry of Health has carried out a series of in-depth 
studies of selected hospital care outcomes and related processes. These studies 
relied on data extracted from medical files and covered outcomes such as 
hospital-acquired infections, bleeding and readmissions for operations such 
as craniotomies, femur fractures and appendectomies. These in-depth studies 
facilitated the analysis of the causes of problems, identified remedial action and 
documented quality improvements.
However, a broad set of quality measures for hospitals was developed in 
Israel later than for the community. Indeed, an OECD review of quality in 
Israeli health care (OECD, 2012a) noted that “In contrast to primary care, too 
little is known about the quality of care delivered in hospitals”. However, since 
then major progress has been made.
In 2013, the Ministry of Health launched a major new initiative to develop 
a system for monitoring quality in Israeli hospitals. All public and non-profit-
making general hospitals are required to participate. The system initially 
included five process quality measures, with an additional five to be added 
each year. The initial focus was on the general acute care hospitals but the 
system is also being expanded to the psychiatric and LTC hospitals. In mid-2015, 
the Ministry of Health published its first report with hospital-specific data on 
quality of care.
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The hospital quality monitoring system was, to some extent, inspired by the 
success of the community system, and drew important lessons from it. It also 
built upon initial efforts within Clalit, Israel’s largest health care provider, to 
develop quality measures for its own hospital network.
Common elements of monitoring systems in hospitals and in the community 
include:
• use of indicators that have a strong evidence base showing that the care 
process leads to improved outcomes;
• focus on indicators of importance to the health system;
• implementation of the measure has little or no chance of inducing 
unintended adverse consequences;
• significant investment in ensuring consistency of definitions and data 
collection methods across participating organizations;
• coordination with relevant panels of clinical experts; and
• reliance on data from providers’ electronic health records.
At the same time, the hospital monitoring system differs from the community 
system in several key ways, including that it:
• relies on patient-level data reported by the hospitals (whereas the 
community system relies on aggregate data from the HPs);
• is being run directly by the Ministry of Health (whereas the community 
system is being run by a university-based team); and
• mandates participation by all hospitals (whereas participation by the HPs 
in the community system is voluntary).
Hospital–community continuity
In Israel, as in other countries, ensuring continuity of care between hospitals 
and community-based providers has emerged as one of the most important, 
and dynamic, areas for monitoring and improvement. The Israeli Society for 
Quality in Health Care, in conjunction with the National Programme for Quality 
Indicators in Community Healthcare and the Ministry of Health’s National 
Programme for Quality Indicators, has taken up this issue as one of its main 
areas of activity for the years ahead. The initiative requires all of the relevant 
players to work together. The development of a national health information 
exchange (discussed in section 4.1.4) is expected to contribute to improved 
continuity between hospitals and community-based providers and may also 
facilitate the development of relevant quality indicators.
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6.1.4 Addressing the projected physician shortage
In the late 1990s, a past chairman of Israel’s Council for Higher Education 
(which oversees Israel’s system of universities and colleges) raised concerns 
about a future shortage of physicians (Rosen, 2008). However, it took several 
years, and several study commissions, before the problem became part of the 
collective consciousness of health policy-makers as Israelis had always viewed 
their health system as being characterized by a physician surplus. Moreover, the 
projections of a shortage were based on a series of assumptions and pen-and-
paper calculations, while data showed that the physician-to-population ratio 
remained stable at levels significantly higher than the OECD average.
Over time, however, policy-makers came to understand that Israel would 
face a major decline in the physician-to-population ratio (to substantially below 
3.0 per 1000 population by 2020), unless corrective actions were taken. They 
were helped in this realization by studies carried out independently by the 
Council for Higher Education and the Ministry of Health (Rosen, 2008) and by 
the work of a 2010 Ministry of Health committee tasked with estimating future 
needs for physicians and nurses (Ministry of Health, 2010b). Moreover, Israel 
was already beginning to experience shortages in certain specialties, such as 
internal medicine and anaesthesiology. Some observers believed that relatively 
low physician wages have also contributed to the problem by encouraging 
emigration to high-wage countries, a shift in medical manpower from public 
to private health care, and abandonment of the medical profession for higher-
paying lines of work (particularly in the high-technology sector).
Accordingly, since the mid-2000s, several significant steps have been 
taken to increase the overall supply of physicians. One key measure was the 
establishment of a new medical school in the Galilee (Israel’s northern region). 
Until the new school’s establishment, Israel had only four medical schools, and 
no new medical schools had been opened since 1974. The new medical school 
opened in autumn 2011 and is part of Bar Ilan University. It was set up in 
the Galilee to contribute to the improvement of the health care services in 
that peripheral region, as well as to contribute more broadly to the region’s 
economic and social development.
Another key measure has been the expansion of class sizes in all existing 
medical schools. With government encouragement and financial support, the 
number of students admitted annually to Israel’s four long-standing medical 
schools increased from approximately 400 in 2005 to over 600 in 2012 and 
to almost 700 in 2014. To do so, the medical schools had to expand their core 
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faculty as well as the number of affiliated training sites – mostly in hospitals 
but lately in the community as well. Part of the expansion has been achieved 
by developing shorter programmes than the traditional six-year medical 
programme: four-year programmes for students with a first degree in the 
sciences and three-year programmes for returning Israelis who had completed 
the first half of their training in a medical school abroad.
As a result of these measures, and an increase in the number of Israelis 
returning to Israel after pursuing medical studies abroad, the number of new 
medical licences issued has doubled in less than 10 years.
As discussed in section 6.2, the German Committee also developed several 
strategies to increase the supply of physicians, especially in those specialties 
facing shortages:
• encouraging Israeli physicians working or studying overseas to return 
to Israel by easing the examinations for licence to physicians who 
studied abroad;
• allowing physicians to continue working after the retirement age 
mandated by law, even part-time; and
• shortening the duration of medical school and specialty training to 
increase the supply of physicians.
The first of these has already been implemented; the other two are pending.
In addition to expanding the physician supply, Israeli policy-makers are 
expanding the roles of other health care professionals in ways that can reduce 
the burden on physicians. Key examples include:
• training nurses for expanded roles in such areas as geriatrics, intensive 
care units and operating rooms;
• establishing a new profession of physician assistants, with a special 
emphasis on emergency care; and
• authorizing specially trained pharmacists with at least five years of 
experience to renew certain prescriptions for the treatment of chronic 
disease that were initially prescribed by a physician.
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6.1.5 The attempt to add institutional long-term care to the 
NHI benefits package
As described in section 5.8, Israel’s LTC system is seriously fragmented. 
Ministry of Health planners and many independent analysts took the view 
that this fragmentation was resulting in service gaps, duplication, inefficient 
incentives and inadequate investment in prevention and rehabilitation. In 2011, 
the Ministry of Health put forward a detailed plan for a major, three-phase 
reform of the LTC system. The reform sought to situate overall responsibility 
for LTC with the HPs, within the framework of NHI. In the first phase, the NII 
was expected to increase the benefit levels for community-based LTC services 
and the HPs were expected to assume professional oversight of those services. 
In the second phase, the legislature was expected to add institutional LTC to 
the set of NHI benefits for which the HPs are responsible, with the HPs also 
serving as the budget holders for institutional LTC. In the third phase, the HPs 
were expected to assume financial responsibility for community-based services 
as well. The reform also sought to increase the level of government financing 
for LTC – both in institutional and community settings.
The reform plan had several objectives, including increasing efficiency by 
having a single government agency (Ministry of Health) and a single set of 
insurer/providers (the HPs) responsible for all the aspects of LTC. The proposed 
integration would have provided incentives for the HPs to place those in need of 
LTC in the most cost-effective setting. In addition, the reform sought to reduce 
the financial and care burden on the families of people needing LTC.
By mid-2015, the reform plan had not been adopted and implemented. The 
Ministry of Finance raised concerns about the Israeli Government’s capacity 
to absorb the additional budgetary obligations. The NII and the Ministry of 
Social Welfare (whose roles in LTC would have been reduced by the proposed 
reform) voiced concerns about the potential for overmedicalization of LTC. As 
a result of resistance from these and other groups, the reform effort has been 
put on hold since 2013.
Another consideration in putting the initiative on hold was the realization 
that the HPs were in the process of assuming responsibility of mental health 
services. There was a concern that the HPs could be overwhelmed if their scope 
was expanded in two different directions simultaneously.
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The underlying problems that motivated the 2011 reform effort still prevail. 
Accordingly, many health policy analysts expect that at some point in the years 
ahead the Ministry of Health will put forward a new effort for LTC reform. It 
remains to be seen what form any such proposal would take and whether it 
would ultimately be adopted.
6.2 Future developments
The Advisory Committee for Strengthening the Public Health System was 
appointed in mid-2013 by Minister of Health Yael German, who also chaired 
the Committee (hence, it is known as the “German Committee”). In June 2014, 
the Committee issued a report proposing the most significant reform to Israel’s 
health care system since the introduction of NHI in 1995 (Advisory Committee 
for Strengthening the Public Health System, 2014). However, because of the 
recent change in government, it is very unclear which, if any, of the Committee’s 
recommendations will move ahead.
Background
The German Committee was formed against the background of major concerns 
about Israel’s health care system, including:
• a decline in the resources available to the publicly financed system;
• growing deficits in the public hospitals;
• an increase in the use of private health insurance and private health care 
to supplement (or substitute for) public care;
• the perceived movement of senior physicians and resources from the 
public to the private system; and
• erosion of the general public’s confidence in the system.
There was a growing concern that these trends had led, or were leading 
to, a situation in which Israeli citizens in need of health care in general, and 
hospital care in particular, could not count on the publicly financed system to 
provide them with high-quality, geographically accessible and timely care.
The Committee consisted of experts from the Ministry of Health, the 
Ministry of Finance, the Prime Minister’s Office, the Bank of Israel, the 
IMA and academia, as well as representatives of the general public. It worked 
intensively for a full year, with hundreds of hours of work in both plenary 
meetings and the meetings of three subcommittees (medical tourism, private 
insurance and the government hospital system). The Committee heard testimony 
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from a wide range of health system leaders, including chief executive officers 
of the four HPs and of leading hospitals, and health policy experts from Israel 
and abroad. In addition, the Committee intensively mined existing databases 
and newly created ones for input into the decision-making process.
The reform’s objectives, recommendations and avenues of operation
The main overall objective of the reform proposed by the German Committee 
appears to be to ensure that all Israeli citizens can receive consistently 
high-quality care (particularly with regard to hospital care) within the publicly 
financed care system. An additional objective (not elaborated upon here) was 
to strengthen the public and non-profit-making hospitals.
The reform seeks to achieve its main overall objective through three 
major avenues:
1. A substantial increase in the financial resources available to the public 
system
2. The introduction of a broad range of structural and organizational 
changes in the public system to enhance its efficiency and responsiveness, 
preserve equity, and enhance the general public’s confidence in it
3. The adoption of measures intended to constrain the growth of private 
insurance and private hospitals.
The key Committee policy recommendations for each of these avenues are 
outlined. Some of the measures proposed relate to more than one initiative but, 
for ease of presentation, each measure is presented in conjunction with only one 
of the three avenues, and footnotes are used to highlight links with additional 
avenues. Overall, the measures listed in these three groups are intended to 
directly move resources from the private to the public system and to ensure that 
private insurers and providers do not have unfair advantages over their public 
counterpart in their competition for patients, funding and physicians.
1. Increase in financial resources available to the public system
The main measures proposed include the following:
Changes to HP core funding levels. An immediate increase should occur in the 
health system’s core funding (which is distributed among the HPs) by about 2%. 
Future levels of core funding should be linked to an annual demographic index 
so that it automatically grows as the population grows.41
41 This will prevent, or at least greatly reduce, the troubling rate of erosion of health care resources that has 
characterized the first two decades of NHI (since 1995). Note, however, that the automatic adjustments do not 
include an adjustment for population ageing.
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Ongoing direct support for hospitals. An additional NIS 700 million (about 
€162 million) per year should be allocated from the government’s general 
revenues for distribution among the government and non-profit-making 
hospitals; this should be in conjunction with efforts to reduce waiting times 
and other structural/organizational changes (as detailed below).
Funds to support measures to reduce hospital waiting times. A one-time 
injection of NIS 300 million (about €70 million) was proposed to develop the 
infrastructure needed to reduce hospital waiting times.
As noted below, some of the measures designed to constrain the private 
sector are also expected to increase public sector revenues.
2. Structural and organizational changes
The main structural and organizational changes proposed include the following.
Quality of care and waiting times. Existing efforts to improve quality of care 
would be strengthened, including the reduction of waiting times, in accord 
with new standards that would be established. One key component involves 
developing Ministry of Health databases on quality and waiting times for 
purposes of monitoring and supervision. Comparative data will also be made 
available to the public. Giving patients more information and more choice will, 
it is hoped, reduce waiting times for treatment and improve quality of care.
Quality of service. Efforts to improve the patient experience should include 
training staff in relevant skills, providing patients with more information, using 
new technologies to improve scheduling and reminder systems, and so on.
Full-time employment for senior physicians. Giving senior physicians in public 
hospitals substantial financial and structural incentives to become full-time 
employees of the hospitals (“full timers”) should reduce the common practice 
in which doctors leave the public hospitals to work in private clinics in the 
afternoons and would, thus, significantly expand the time available to treat 
patients and perform surgery in public hospitals.42
Hospital choice. Requiring that HPs offer patients who need hospital care 
a choice from among at least three hospitals should enhance hospital 
responsiveness to aspects of care that are valued more by consumers than by 
HPs.43 It is also expected to increase hospital revenues by reducing the HPs’ 
power in price negotiations.
42 This would also be expected to reduce waiting times.
43 This would contrast with the current situation, where HPs sometimes direct patients to a particular hospital, with 
no room for choice.
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Hospital authority. Establishing a government hospital authority to manage all 
of the Ministry of Health’s hospitals should free up the time of the Ministry of 
Health leadership for policy-making and overall system monitoring, and reduce 
potential conflicts of interest.
Reimbursement reform. Refining and modernizing the system of hospital 
reimbursement to better reflect differences in case mix is intended to reduce 
the incentive and capacity of private hospitals to “cream-skim” and to provide 
public hospitals with a fairer level of reimbursement for complex cases.
Case management. Encouraging family physicians to act as case managers 
would allow them to oversee and coordinate care for their patients.
These and the other structural and organizational changes recommended 
by the German Committee are intended to enhance the efficiency and 
responsiveness of the public system. If publicized effectively, they could also 
contribute to another Committee objective – increasing the general public’s 
level of confidence in the publicly financed system.
One of the most important Committee recommendations related to a potential 
organizational and financial change that was considered, but ultimately not 
adopted. “SHARAP”, in which patients in public hospitals are allowed to choose 
their physician in return for a privately funded fee,44 will not be permitted in 
hospitals owned by the governmental and non-profit-making hospitals (aside 
from those in Jerusalem, which have long-standing SHARAP programmes).
3. Measures to constrain the growth of private insurance and private hospitals
A number of measures were suggested to constrain the growth of private 
hospitals and private insurers.
Standardized policies. Requiring all private insurers (both in the HPs and 
in the commercial insurance companies) to include, among their offerings, 
a standardized policy for choice of hospital physicians should reduce costly 
duplicate insurance coverage, enhance competition, restrain premium levels 
and improve efficiency.45
Medical tourism. Regulations governing medical tourism, in which foreigners 
come to Israel to obtain medical care and pay generously for such care, should 
be tightened to ensure that, in the Israeli context of shortages of both hospital 
44 Officially, Sharap is not supposed to entitle patients to jump the queue. However, there is some evidence that 
waiting times for Sharap patients are markedly shorter than for other patients.
45 Israelis wishing to purchase additional health insurance beyond the universal basket of services would then be able 
to choose from a more simplified and clearer array of options, with greater competition among providers.
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beds and physicians, the care for tourists does not come at the expense of care 
for Israelis. In addition, a portion of the income from medical tourism should 
be used to support the public health care system.46
Surcharges and cross-subsidies. A surcharge should be collected on services 
provided by private hospitals and transferred to the public hospital system. 
These transfers would support public hospitals’ efforts to reduce waiting times 
and increase the availability of physicians in the afternoon hours. The surcharge 
is envisioned as compensating for the private hospitals’ tendency to “cream-
skim” and to rely on physicians whose training costs were borne by the public 
sector (along with other externalities).
Incentives for private insurance use. HPs’ incentives to promote the use of 
private insurance when their members require hospital care should be reduced 
or eliminated.
An additional objective: strengthening Israel’s public and non-profit-
making hospitals
The German Committee also wanted to strengthen the public and non-profit-
making hospitals. In recent years, these hospitals have been squeezed financially 
and operationally from several directions, including:
• the basic pricing system has not reflected full costs;
• the HPs have used their market power to negotiate deep discounts;
• the annual revenue caps set by the Ministry of Health have become 
increasingly restrictive;
• the private hospitals have been drawing away many of the more lucrative 
types of cases; and
• the private hospitals have been attracting some of the public hospitals’ 
most senior physicians (particularly surgeons) for private work in the 
afternoons.
Many leaders of the Israeli health system consider the well-being of the 
public and non-profit-making hospitals to be vital for ensuring the provision of 
high-quality care for all Israelis (via the NHI’s basic benefits package), as well 
as for the training of the next generation of health care professionals.
46 Hence, the medical tourism recommendations also relate to the first avenue, increasing the financial resources 
available to the public system. They are also intended to enhance Israel’s international standing in health care 
and beyond.
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The key measures proposed by the German Committee to promote the 
well-being of the public hospitals naturally overlap with the set of measures 
recommended to promote its main objective (ensuring that all Israeli citizens 
can receive consistently high-quality care within the publicly financed care 
system). Those with a direct impact on the revenues of the public hospitals 
include the planned injection of new funds directly from the government, the 
transfer of the surcharges to be levied on the private hospitals and the provision 
for continued operation of medical tourism. Additional measures expected to 
contribute to the well-being of the public hospitals include the incentives for 
physicians to work full-time in the public hospitals, the requirement that HPs 
offer patients a choice of hospitals, the introduction of case mix adjusters to the 
hospital reimbursement system and the reduction of the incentives for the HPs 
to channel their patients to private hospitals.
As noted, the German Committee also considered, but ultimately rejected, 
SHARAP. The adoption of SHARAP would probably have contributed 
substantially to the financial health of some of the public hospitals.
Conclusions
Whether or not the measures recommended would be sufficient to ensure 
that all Israeli citizens can receive consistently high-quality care within the 
publicly financed system, and to strengthen the public and non-profit-making 
hospitals, probably will depend a great deal on the extent to which, and how, 
they are implemented. Moreover, two of the Committee’s members wrote a 
minority report (Glazer & Kendall, 2014) in which they argued that even if fully 
implemented the set of recommendations endorsed by the majority would not 
be sufficient to achieve the Committee’s stated goals.
In either case, the 2015 change in government has put a big question mark 
on which recommendations, if any, will be adopted by the new government 
and implemented. Clearly, it will be important to monitor progress – both of 
implementation and of impacts.
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7. Assessment of the health system
Israel’s NHI Law, which calls for a system of national insurance based on the principles of justice, equality and mutual aid, continues to be an inspiration and moral compass for Israel’s health care system. However, Israel’s record 
of achievements regarding financial protection and equity in financing are 
complicated and mixed. Israelis have universal health care coverage with a 
broad benefits package. Although the NHI system is financed predominantly 
via progressive taxation, approximately 40% of THE is financed privately.
National surveys show that three quarters of patients are satisfied with their 
hospital care and that almost all Israelis are satisfied or very satisfied with their 
HPs overall (~90%). Interestingly, fewer Israelis felt that way about the health 
system overall (~60%).
Access to PCPs is excellent, both in terms of travel times and waiting times. 
Waiting times for community-based specialists are also good overall, although 
waits for advanced specialties are somewhat longer in the periphery. However, 
approximately 10% of Israelis report that someone in the family had foregone 
medicines or health care over the previous year. Waiting times for publicly financed 
operations are highly variable and are problematic for some types of operation.
Life expectancy is higher and mortality lower than the OECD average, but 
Israel ranks in the mid-range among European countries for amenable mortality. 
Israel’s standing relative to the OECD average is mixed with regard to avoidable 
hospitalizations and in-hospital mortality rates, while it out-performs on several 
key safety measures. Despite this, Israel’s rate of hospital-acquired infections 
is higher than in many other developed countries.
The quality of the primary care provided by the HPs has been found to 
be good both in comparison with United States plans and from a broader 
international perspective.
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Overall, the Israeli health care system appears to be quite efficient. 
Compared with other developed countries, its expenditure on health is relatively 
low, while achievements in population health and the quality of primary care 
are significant.
Israeli health care has a history and culture that champion disease prevention 
and primary care and also has tight regulatory controls for the supply of both 
hospital beds and advanced medical equipment. Allocative efficiency is 
promoted by having HPs as the main budget holders and organizers of care, 
thus requiring them to balance cost control and quality/service imperatives.
Concurrently, there are several features of the system that appear to limit 
its ability to channel resources where they could have the greatest benefit. 
For example, the growth of public health care financing is much more tightly 
controlled than the growth of private financing, despite the recognition 
that a shekel of public funds is likely to yield more benefit than a shekel of 
private funds. Moreover, the most tightly controlled budgets are those for 
services provided by the Ministry of Health itself, despite the vital nature of 
those services (public health, LTC, etc.) The lack of clarity regarding who is 
responsible for certain services (i.e. health promotion) also leads to missed 
opportunities. Finally, the multiple roles of the Ministry of Health as regulator, 
provider and funder creates conflicts of interests (or at least perceived conflicts 
of interests) that may be creating various barriers to efficiency. 
Israeli health care also has a number of features which promote its capacity 
to secure high levels of output per unit of input. These include: a system of 
regulated competition among HPs, a strong system of health professional 
education and training, a high degree of alignment between the incentives of 
the HPs and those of the professionals whom they employ, and a well-developed 
system of electronic health records.
At the same time, there are some significant barriers to technical efficiency, 
including: an outdated hospital pricing system, a capitation formula that does 
not adequately take into account differences in health status, and bureaucratic 
barriers that limit the hours during which operating theatres are in use.
In recent years, the Ministry of Health has made transparency one of its 
main goals and it has made major strides in increasing the public’s access to 
comparative data on quality, finances, and patient satisfaction. These advances 
in transparency have also facilitated greater accountability – both to the 
government and to the general public.
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7.1 Stated objectives of the health system
Israel’s NHI Law, adopted in 1995, calls for a system of national insurance 
based on the principles of justice, equality and mutual aid. Several years ago, 
the Ministry of Health began to publish more specific, annual sets of strategic 
objectives, called its “Pillars of Fire”. The set of objectives as of October 2014 were:
1. Strengthen the public attributes of the health system
2. Reduce health inequality
3. Prioritize public health
4. Enhance quality in health and medical services
5. Align infrastructure to future health needs
6. Strengthen the role of the Ministry of Health as regulator and insurer
7. Promote national health informatics and e-health.
The relevant statements on the Ministry of Health web site, as of April 2015, 
were as follows (Ministry of Health, 2015a):
The Ministry’s vision
Upholding the basic right to health and health promotion for the entire Israeli 
population, through a medical system striving for the utmost excellence and 
egalitarianism, while respecting the values of human and social dignity.
Goals
Quality
Improvement of the diagnostic, therapeutic, rehabilitative and preventive 
medical services, by setting quality indices and implementing them through a 
system of incentives, supervision and enforcement.
Reducing Social Gaps
Reducing health gaps between different societal groups.
Community-Facing
Strengthening the network of community health services, through preference 
and emphasis on preventive services, health promotion and rehabilitation within 
the community.
Efficiency
Ensuring an optimum level of medical and health services, through prioritizing 
according to budgetary constraints.
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Research
Promotion of medical research.
Promotion of Health and Prevention
Promotion of health-friendly lifestyles, emphasizing personal and community 
responsibility.
Public and Individual Participation
Promotion of an involved, erudite public on health matters and fostering an 
atmosphere conducive to its inclusion in the determination and implementation 
of health policy.
Organizational Changes
Amplification of the ministry’s function as a ministry responsible for the entire 
health system, separation of the ministry from its role as a service provider.
Mental Health
Inclusion of mental health in a comprehensive conception of health.
Geriatrics
Promotion of health services for senior citizens through emphasis on home and 
community treatment.
7.2 Financial protection and equity in financing
The story regarding financial protection and equity is complicated and mixed. 
On the one hand, Israel has universal health care coverage, and all Israelis 
have a legal right to a broad benefits package. Moreover, the NHI system 
is financed predominantly via progressive taxation. In recent years, several 
steps have been taken to make the financing of NHI even more progressive: 
the ceiling on income liable to the NHI tax was increased; more protections 
from the burden of co-payments have been put in place for various vulnerable 
populations; and the capitation formula was updated to include “residence in 
the periphery” as a risk adjuster. Moreover, in recent years the scope of NHI 
has been increasing to include mental health care and dental care for children. 
In addition, since 2010 one of the Ministry of Health’s strategic objectives has 
been to narrow inequalities.
On the other hand, the following facts persist.
• Approximately 40% of THE is financed privately. Moreover, this rate is 
among the highest in the OECD countries, and it is growing (OECD, 2015).
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• Private health care is financed regressively, with those in the lower 
income deciles spending a substantially greater proportion of their income 
than others on privately financed care. For example, in 2011 that figure 
was 17% for the lowest decile compared with 4% for the highest decile 
and 6% overall (CBS, 2013b).
• At the same time, the highest income decile spends on average four times 
more than the lowest decile on privately financed care (CBS, 2013b); it 
presumably also receives four times as much privately financed care.
• In 2014, 11% of Israelis reported foregoing a prescription drug or health 
care service because of cost, at least once during the previous year. In 
2012, 25% of Israelis indicated that health care expenditure (including 
both private spending and the health tax) constituted a financial burden to 
a great or very great extent (Brammli-Greenberg & Medina-Artom, 2015).
• In 2012, 60% indicated a lack of confidence that, if they became 
seriously ill, they would be able to afford the necessary care (Brammli-
Greenberg & Medina-Artom, 2015). That may be one of the main reasons 
why a relatively large, and still growing, percentage of Israelis have 
purchased VHI.
• Several key services, such as dental care for adults and LTC, remain 
outside the scope of NHI.
In light of all the above, it is difficult to give a simple summary statement 
about the extent to which the Israeli health system provides a good level of 
financial protection. Much depends on an assessment of the extent to which 
the benefits provided through privately financed care are vital for health and 
well-being. Many Israelis appear to think that they are, and they may well 
be correct, but more research is needed before that perception can be either 
confirmed or denied.
7.3 User experience and equity of access to health care
In 2014, the Ministry of Health carried out a national survey of patients in 
general hospitals, the first such survey in over two decades: 75% of respondents 
indicated that they were satisfied with the hospital care overall and over 80% 
were satisfied with the care received from both the physicians and the nurses. 
A lower rate of satisfaction (73%) was found for receipt of information and 
explanations (Ekke-Zohar et al., 2015)
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Over the two decades since the launch of NHI, the MJB Institute has been 
carrying out a biannual survey of the public’s experience with the health care 
system, with a particular focus on services provided by the HPs. In 2014, 
89% of Israelis were satisfied or very satisfied with their HPs overall, and 61% 
felt that way about the health system overall; 55% of respondents indicated 
that they were able to see a specialist within two weeks (Brammli-Greenberg 
& Medina-Artom, 2015). However, 37% of respondents in the survey were 
unable to choose their providers for specialized services (such as hospital care), 
22% experienced difficulties in securing HP authorizations for such services, 
and 18% experienced difficulty in accessing care in the evening or on weekends 
and holidays. In terms of not accessing care, 9% reported foregoing medical 
care because of distance for themselves or a family member over the past year 
and 12% reported having foregone care because of the waiting time involved. 
The financial burden of paying for health care was great or very great for 25%.
In another MJB Institute survey from 2012, patients reported good access 
to secondary care in the community (non-urgent), with average waiting times 
of three weeks to see a specialist. There are wide variations among specialties 
and place of residence. Patients living in the periphery waited longer to see a 
non-common specialist than patients in the centre; in the periphery: 56% waited 
more than a month compared with 38% in the centre. In general, half of the 
patients were satisfied with their waiting times and said they were “reasonable”. 
Those who said that they were not reasonable would have preferred to wait 
no more than one and a half weeks (Brammli-Greenberg, Waitzberg & 
Guberman, 2015).
In its report on the 2009 survey, the MJB Institute team included an 
in-depth analysis of the survey findings for various vulnerable populations: 
low income persons, Arabs, immigrants from the former USSR, the elderly 
and the seriously ill (Brammli-Greenberg & Medina-Artom, 2015). Not 
surprisingly, the financial burden and the likelihood of foregoing services are 
generally somewhat greater than average for most of these groups. The situation 
regarding satisfaction is complex, varying by aspect of care and population 
group. Moreover, it is important to keep in mind that satisfaction is affected 
by the interplay of expectations and experience, and expectations may well be 
below average for some of the vulnerable populations.
In recent years, there have been important improvements in several of the 
survey findings for some of the vulnerable populations. For example, several 
years ago the survey pointed to low mammography rates among the Arab 
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population in some of the HPs, and this was subsequently corroborated by 
data from the national quality indicators programme. The HPs then undertook 
intensive remedial action and the next round of the survey found a significant 
improvement in the mammography rates. Similarly, the 2014 survey found 
substantial improvements in peripheral regions along a variety of indicators, 
which was consistent with recent governmental and HP initiatives to improve 
services in those areas.
7.4 Health outcomes, health service outcomes and 
quality of care
7.4.1 Population health
As indicated in Table 7.1 in Israel, life expectancy is higher than the OECD 
average and the mortality rate is lower than that average. On these measures, 
Israel ranks among the highest for men and slightly above the average for 
women among OECD countries (OECD, 2013).
However, when it comes to amenable mortality, Israel ranks in the mid-range 
among European countries (Gay et al., 2011; Goldberger & Haklai, 2012). The 
decrease in amenable mortality in Israel over time is also less than that in many 
other Western countries.
Table 7.1 also indicates that Israel outperforms the OECD average regarding 
maternal mortality, infant mortality and survival rates for various types of 
cancer (breast, cervical and colorectal). Israel’s vaccination rates for measles 
and DPT (diphtheria, tetanus and pertussis) (for children) are similar to the 
OECD average, while its vaccination rate for influenza among the elderly is 
markedly above the OECD average.
As in other countries, Israel has significant differences in life expectancy, 
mortality and amenable mortality across income groups, ethnic and nationality 
groups, and regions (Averbuch & Avni, 2014; see also sections 1.4 and 8.2 in 
Rosen, Samuel & Merkur, 2009). Generally speaking, the magnitudes of these 
gaps have not changed substantially in recent years.
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Table 7.1
Selected health and health services outcomesa
Israel OECD countries
Life expectancy (years) 81.8 80.1
Mortality rate (per 100 000 population) 707.7 813.2
Maternal mortality (per 100 000 live births) 1.2 6.7
Infant mortality (per 1000 live births) 3.5 4.1
Five-year survival rates :b
Breast cancer 86.2 84.2
Cervical cancer 71.4 66.0
Colorectal cancer 67.1 62.0
Vaccination rate (%) :
Measles (children) 96.0 94.4
DPT (diphtheria, pertussis, tetanus; children) 94.0 96.0
Influenza (elderly) 61.0 50.2
Avoidable hospital admission rate (%) :
Asthma 61.4 45.8
Chronic obstructive pulmonary disease 229.2 203.0
Congestive heart failure 258.5 238.9
Diabetes relatedc 93.4 164.4
In hospital mortality rates (%) for admissions following :
Acute myocardial infarction 7.1 7.9
Haemorrhagic stroke 24.7 22.6
Ischaemic stroke 6.3 8.5
Safety indicators (%) :
Foreign body left in during surgical procedure 1.6 5.0
Postoperative pulmonary embolism or deep vein thrombosis 409.1 603.5
Postoperative sepsis 97.6 783.5
Obstetric trauma for vaginal laceration, vaginal delivery 
with instrument
1.3 6.0
Obstetric trauma for vaginal laceration, vaginal delivery 
without instrument
0.3 1.6
Sources : OECD, 2012b, 2013.
Notes : aData from 2010 or 2011, unless otherwise indicated; bData for the OECD average are for 2006–2011 or nearest available years, 
data for Israel are for 2004–2009; cIncludes admissions related to short-term complications, long-term complications or uncontrolled 
diabetes without complications.
7.4.2 Health service outcomes and quality of care
Israel’s relative standing with regard to avoidable hospitalizations is mixed; 
its rate is well below the OECD average for complications of diabetes but 
somewhat above the OECD average for asthma, chronic obstructive pulmonary 
disease and congestive heart failure.
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In-hospital mortality rates in Israel are similar to the OECD average for the 
three conditions on which comparative data are available, with Israel somewhat 
above the OECD average for haemorrhagic stroke, and somewhat below it for 
ischaemic stroke.
Israel outperforms the OECD average on all the safety issues included in 
Table 7.1, in some cases markedly so. However, Israel’s rate of hospital-acquired 
infections is higher than in many other developed countries (OECD, 2015), 
although additional work is needed to assess the reliability, completeness and 
consistency of reporting on the various safety indicators.
More and more Israeli hospitals are undergoing the Joint Commission’s 
accreditation processes, which might contribute to significant improvements 
in quality of care and safety. In addition, the Ministry of Health has recently 
begun to increase the intensity with which it monitors and promotes the quality 
of hospital care.
The quality of the primary care provided by the HPs has been found to be 
good in comparison with similar plans in the United States (Rosen et al., 2011b) 
and also on a broader international perspective (Jaffe et al., 2012; OECD, 2012a). 
Moreover, Israeli HPs have demonstrated a capacity for rapid, and ongoing, 
quality improvements in primary care. Various structural characteristics of the 
health system (discussed in section 5.3), combined with a highly professional 
national quality monitoring effort and vigorous quality improvement initiatives 
on the part of the HPs, have apparently played significant roles in these 
achievements. Strategic, well-targeted, HP efforts have also contributed greatly 
to the narrowing of quality gaps between key population groups (Balicer et al., 
2011, 2015; Rosen 2011b; Wilf-Miron et al., 2010).
To date, use of patient-reported outcome measures has been quite limited 
in Israel.
7.5 Health system efficiency
Compared with other developed countries, the Israeli expenditure on health 
is relatively low (whether measured in per capita terms or as a percentage of 
GDP). Nonetheless, it appears to be efficient and its achievements in population 
health are impressive. In addition, with regard to community-based care (and 
particularly primary care), Israel appears to do relatively well on a broad range 
of measures of user experience and quality of care.
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As indicated in sections 7.3 and 7.4, the availability and accessibility of 
services is generally good for community-based services in general, and for 
primary care services in particular. However, a not negligible proportion of 
the population reports barriers to access related to distance, waiting time 
or costs, with the barriers probably more substantial for specialty care and 
pharmaceuticals than for primary care. The barriers tend to be more substantial 
in the periphery and for those with low incomes.
Waiting times appear to be more problematic when it comes to non-emergency 
hospital care. Important questions also remain about the quality of care and the 
patient experience in hospital settings, as Israel is only just beginning to collect 
systematic data on these issues.
In addition, as noted in section 7.2, the situation regarding financial 
protection is complex – not so much because of lack of data but because of 
questions about how available data should be interpreted.
It is known, from both survey data and consumer behaviour, that many 
Israelis want and expect more from their health system than what they perceive 
to be provided at present by the publicly financed system. In light of that, many 
analysts believe that the level of public funding for the health system should 
be increased. Others point out that, while that might be desirable, it may prove 
difficult to free up all of the necessary resources in light of Israel’s relatively 
high defence expenditure and debt financing costs.
Accordingly, almost all Israeli health policy analysts feel that it is important 
to seek ways to enhance system efficiency. This section summarizes key factors 
contributing to Israel’s current level of efficiency as well as key barriers to 
further efficiency. Readers are referred to section 6.2 for a review of several 
recent proposals aimed at increasing system efficiency.
7.5.1 Allocative efficiency
Israeli health care has a number of features that promote the targeting of health 
care resources on the types of service likely to yield significant gains in terms 
of health and well-being. These include:
• a history and culture of disease prevention and primary care that are 
embedded in a set of organizations and policies;
• using the HPs as the system’s main budget holders and its main organizers 
of care supports allocative efficiency in that the HPs are organizations 
that need to balance cost control and quality/service imperatives in order 
to survive;
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• gatekeeping roles for the HPs and their PCPs;
• tight regulatory controls on the supply of hospital beds, advanced medical 
equipment and other very expensive health care inputs;
• revenue caps on hospitals, along with governmental control of hospital 
prices;
• a highly structured and highly professional process for determining which 
new medications and other technologies will be added to the NHI benefits 
package, subject to a budget constraint;
• relatively limited reliance on FFS payments, both for professionals (such 
as physicians) and for organizations (such as hospitals and HPs);
• risk sharing between the government and the HPs through a combination 
of prospective and retrospective payment schemes; and
• the absence of co-payments for vital services, such as well-baby care and 
primary care.
At the same time, there are several features of the system that appear to 
limit its ability to channel resources where they could have the greatest benefit. 
For example, the growth of public health care financing is much more tightly 
controlled than the growth of private financing, despite the recognition that a 
shekel of public funds is likely to yield more benefit than a shekel of private 
funds. Moreover, the most tightly controlled budgets are those for services 
provided by the Ministry of Health itself (e.g. public health, LTC), despite the 
vital nature of those services The lack of clarity regarding who is responsible for 
certain services (such as health promotion) also leads to missed opportunities. 
Finally, the multiple roles of the Ministry of Health as regulator, provider and 
funder creates conflicts of interests (or at least perceived conflicts of interests) 
that may be creating various barriers to efficiency.
7.5.2 Technical efficiency
Israeli health care also has a number of features which promote its capacity to 
secure high levels of output per unit of input. These include:
• a system of regulated competition among HPs;
• a strong system of health professional education and training;
• a high degree of alignment between the incentives (and values) of the 
HPs and those of the professionals whom they employ;
• well-developed electronic health records and a growing capacity to 
share relevant health information across settings and organizations;
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• well-developed systems for monitoring HP financing, quality and 
user experience, along with the emergence of analogous systems for 
hospital care;
• a collective bargaining system that enables the Ministry of Finance 
and the major employers to constrain the rate of increase in physician 
wage levels;
• a tradition of strong uptake of generic pharmaceuticals and other 
strategies for controlling pharmaceutical expenditure; and
• cost-sharing mechanisms for secondary care and medications, with 
protections for vulnerable populations.
Some of the indicators of the success of these measures include Israel’s low 
average length of hospital stay along with a high bed occupancy rate and quick 
access to most community-based services.
At the same time, there are some significant barriers to technical efficiency, 
including:
• an improving, but still outdated hospital pricing system;
• a capitation formula that does not adequately take into account differences 
in health status;
• bureaucratic and other barriers that limit the hours during which operating 
theatres are in use;
• fragmentation of responsibility, in such areas as LTC and mental health 
care; and
• various linguistic and cultural barriers to care
In short, the Israeli health care system has functioned well with relatively 
few resources, which may indicate a good level of efficiency overall. However, 
there continue to be various pockets of inefficiency, and various barriers to 
efficiency improvement, which should be addressed.
7.6 Transparency and accountability
In recent years, the Ministry of Health has made transparency one of its main 
goals. The notion behind this is that insurees/patients/citizens have a right to 
information about their health, health care and health care rights, as well as 
the quality of care provision. The provision of information is seen as making 
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it easier for consumers to make informed choices and receive better care. 
Consequently, there is a belief that providing such information is good for the 
population and for the health system.
This objective has been advanced through a number of initiatives, several of 
which have been mentioned in earlier chapters. They include:
• establishment of a web site with extensive information on consumer 
rights related to both the NHI system and the supplemental insurance 
programmes (Brammli-Greenberg et al., 2014);
• publication of data from the National Programme for Quality Indicators 
in Community Healthcare for each HP;
• collection of data on hospital quality, with the intention of publishing 
the findings by hospital in the near future;
• surveys of patient experiences in general hospitals, with the results 
published by hospital; and
• publication of hospital-specific waiting times.
These new initiatives come on top of several long-standing initiatives 
to share key data with the public, such as publication of the HPs’ financial 
statements and publication, by HP, of key findings from the MJB Institute’s 
biannual consumer survey on satisfaction with plan services and access to 
service (Almog et al., in press).
Health policy development processes are also characterized by a good deal 
of transparency and the involvement of a broad range of interested parties. 
The National Health Council, which is a statutory body charged with advising 
the Minister of Health on major policy issues, includes representatives of the 
government, the HPs, the hospitals, professional associations and the general 
public. Similarly, the committee that recommends priorities for additions to the 
NHI benefits package includes representatives of a broad set of institutions and 
of the general public. The subcommittees dealing with the capitation formula 
and with hospital pricing include members of the HPs, the Ministry of Finance, 
the Ministry of Health and (in the latter case) the hospitals as well. Moreover, 
proposals for major policy changes, such as extending NHI to include dental 
care for children, are given substantial time for consideration and refinement; 
typically there are quite a few public forums in which such proposals are 
presented and debated, along with vigorous commentary in the mass media. 
When policy changes require legislation, the extent of public discussion – and 
involvement of elected representatives – is often particularly great.
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Accountability is also given substantial attention in Israeli health care, 
proceeding along several tracks. The Ministry of Health plays a major role in 
ensuring that health care providers meet various quality and financial standards 
(Rosen, Israeli & Shortell, 2012). The public is also involved in promoting 
market accountability through competition among hospitals and among HPs. 
The performance of the Ministry of Health is also held up to public scrutiny by 
the media, the Knesset, other health system actors and independent researchers 
and analysts. Another key component is the involvement of international 
organizations, such as WHO, the European Observatory on Health Systems 
and Policies, and the OECD; for example, the Ministry of Health recently 
commissioned an OECD review of quality in Israeli health care that has been 
both informative and influential. Finally, every few years the government or 
the Ministry of Health has appointed a blue ribbon panel of one sort or another 
to assess the health system’s performance and to recommend reforms.
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8. Conclusions
The Israeli health care system has demonstrated a remarkable capacity to innovate, improve, establish goals, be tenacious and prioritize – all of which have enabled it to achieve good health outcomes with limited 
resources. In the years ahead, Israel must find ways to draw on these capacities 
to address the major challenges now facing its health care system.
Israel has been a pioneer of successful innovations in such areas as electronic 
health records, telemedicine, the financing and provision of community-based 
LTC services and systemic response to large-scale health care emergencies. 
Newer pioneering innovations, whose degree of success is as yet unknown, 
include the establishment of a national health information exchange, public 
dissemination of detailed web-based information on health rights, the use of 
predictive modelling in clinical practice and the integration of physical and 
mental health within a managed care framework.
Israel’s capacity to improve has been highlighted by its documented, and 
rapid, improvements in quality of care in the community. Evidence-based 
information systems have played a vital role but also crucial has been the 
commitment of the HPs to improve the health of their members, the HPs’ 
capacity to translate strategy into action and their close working relationships 
with their professionals.
The recently introduced mental health reform highlights the system’s 
capacity for tenacity, resource mobilization and flexibility. While numerous 
attempts to implement the reform (spread over two decades) did not succeed, its 
supporters did not give up; in 2015, they ultimately succeeded in changing the 
nature of Israeli mental health care while bringing substantial new resources 
into the system. They did so in part by taking seriously concerns raised by 
opponents and improving the reform plan.
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Israel’s internationally recognized process for prioritizing new technologies – 
which twins rigorous information with political sensitivity – is perhaps the most 
prominent example of the country’s ability to make tough choices, and to do 
so wisely. Another important example has been the channelling of resources to 
community-based services while constraining the growth of hospital capacity.
One of the greatest current challenges for Israeli health care is its growing 
reliance on private financing. As described in Chapters 3 and 6, the ongoing 
shift from public to private financing has troubling implications for both equity 
and efficiency.
Why are more and more Israelis signing up for private health insurance? 
There does not appear to be a full answer, but motivating factors appear to 
include concerns that the mainstream, publicly financed system will not 
give them access to all necessary medical services, will require them to wait 
inordinately for covered services, will not be sufficiently patient centred and 
will entrust their operations to surgeons who are not sufficiently experienced 
or sufficiently talented.
To address these concerns, Israeli health care would do well to draw on the 
strategies and demonstrated capacities noted above. Taking the waiting time 
challenge as an example, policy-makers should consider including the following 
in their response to the challenge:
• a commitment at the policy level to shortening waiting times, combined 
with the mobilization of the necessary financial resources and tenacity 
in implementing the necessary changes;
• prioritization by deciding which types of operation usually need to be 
carried out quickly and which are usually less urgent;
• specification of clear goals and standards for waiting times;
• effective communication to the public of the rationale for waiting time 
priorities and provision of trustworthy information about what constitutes 
a reasonable waiting time;
• creation of systems for the ongoing monitoring of hospital-specific and 
operation-specific waiting times (an effort already under way), and the 
sharing of that information with the public;
• development of innovative mechanisms, at the hospital and departmental 
level, for reducing waiting times; and
• creation of close collaboration between hospitals and the relevant health 
care professions through the development of a shared vision, alignment 
of incentives and joint problem solving at the field level.
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Parallel measures should also be considered in addressing the public’s 
concerns about the comprehensiveness of the NHI benefits package, the extent 
to which publicly financed care is patient centred and the qualifications of 
surgeons in publicly financed operations. Doing so could greatly strengthen 
Israel’s publicly financed health care system and enable it to continue to provide 
high-quality, equitable and accessible care to all of Israel’s citizens.
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9.4 HiT methodology and production process
HiTs are produced by country experts in collaboration with the Observatory’s 
research directors and staff. They are based on a template that, revised periodically, 
provides detailed guidelines and specific questions, definitions, suggestions for 
data sources and examples needed to compile reviews. While the template offers 
a comprehensive set of questions, it is intended to be used in a flexible way to 
allow authors and editors to adapt it to their particular national context. The 
most recent template is available online at: http://www.euro.who.int/en/home/
projects/observatory/publications/health-system-profiles-hits/hit-template-2010.
Authors draw on multiple data sources for the compilation of HiTs, ranging 
from national statistics, national and regional policy documents to published 
literature. Furthermore, international data sources may be incorporated, such as 
those of the OECD and the World Bank. The OECD Health Data contain over 
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1200 indicators for the 34 OECD countries. Data are drawn from information 
collected by national statistical bureaux and health ministries. The World Bank 
provides World Development Indicators, which also rely on official sources.
In addition to the information and data provided by the country experts, 
the Observatory supplies quantitative data in the form of a set of standard 
comparative figures for each country, drawing on the European Health for All 
database. The Health for All database contains more than 600 indicators defined 
by the WHO Regional Office for Europe for the purpose of monitoring Health 
in All Policies in Europe. It is updated for distribution twice a year from various 
sources, relying largely upon official figures provided by governments as well 
as health statistics collected by the technical units of the WHO Regional Office 
for Europe. The standard Health for All data have been officially approved 
by national governments. With its summer 2013 edition, the Health for All 
database started to take account of the enlarged EU of 28 Member States.
HiT authors are encouraged to discuss the data in the text in detail, including 
the standard figures prepared by the Observatory staff, especially if there are 
concerns about discrepancies between the data available from different sources.
A typical HiT consists of nine chapters.
1. Introduction: outlines the broader context of the health system, including 
geography and sociodemography, economic and political context, and 
population health.
2. Organization and governance: provides an overview of how the health 
system in the country is organized, governed, planned and regulated, as 
well as the historical background of the system; outlines the main actors 
and their decision-making powers; and describes the level of patient 
empowerment in the areas of information, choice, rights, complaints 
procedures, public participation and cross-border health care.
3. Financing: provides information on the level of expenditure and the 
distribution of health spending across different service areas, sources of 
revenue, how resources are pooled and allocated, who is covered, what 
benefits are covered, the extent of user charges and other out-of-pocket 
payments, voluntary health insurance and how providers are paid.
4. Physical and human resources: deals with the planning and distribution 
of capital stock and investments, infrastructure and medical equipment; 
the context in which information technology systems operate; and human 
resource input into the health system, including information on workforce 
trends, professional mobility, training and career paths.
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5. Provision of services: concentrates on the organization and delivery 
of services and patient flows, addressing public health, primary care, 
secondary and tertiary care, day care, emergency care, pharmaceutical 
care, rehabilitation, long-term care, services for informal carers, palliative 
care, mental health care, dental care, complementary and alternative 
medicine, and health services for specific populations.
6. Principal health reforms: reviews reforms, policies and organizational 
changes; and provides an overview of future developments.
7. Assessment of the health system: provides an assessment based on the 
stated objectives of the health system, financial protection and equity 
in financing; user experience and equity of access to health care; health 
outcomes, health service outcomes and quality of care; health system 
efficiency; and transparency and accountability.
8. Conclusions: identifies key findings, highlights the lessons learned from 
health system changes; and summarizes remaining challenges and future 
prospects.
9. Appendices: includes references, useful web sites and legislation.
The quality of HiTs is of real importance since they inform policy-making 
and meta-analysis. HiTs are the subject of wide consultation throughout the 
writing and editing process, which involves multiple iterations. They are then 
subject to the following.
• A rigorous review process (see the following section).
• There are further efforts to ensure quality while the report is finalized that 
focus on copy-editing and proofreading.
• HiTs are disseminated (hard copies, electronic publication, translations 
and launches). The editor supports the authors throughout the production 
process and in close consultation with the authors ensures that all stages 
of the process are taken forward as effectively as possible.
One of the authors is also a member of the Observatory staff team and 
they are responsible for supporting the other authors throughout the writing 
and production process. They consult closely with each other to ensure that 
all stages of the process are as effective as possible and that HiTs meet the 
series standard and can support both national decision-making and comparisons 
across countries.
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9.5 The review process
This consists of three stages. Initially the text of the HiT is checked, reviewed 
and approved by the series editors of the European Observatory. It is then 
sent for review to two independent academic experts, and their comments 
and amendments are incorporated into the text, and modifications are made 
accordingly. The text is then submitted to the relevant ministry of health, or 
appropriate authority, and policy-makers within those bodies are restricted to 
checking for factual errors within the HiT.
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